Phenotypic and genotypic characterisation of biofilm formation in staphylococcus capitis by Cui, B
 
 
 
 
 
Phenotypic and Genotypic Characterisation of 
Biofilm Formation in Staphylococcus capitis 
 
 
 
 
 
 
 
 
 
 
A thesis is presented for the degree of Doctor of Philosophy 
 
Bintao Cui 
B.Sc, M.Sc 
 
 
 
 
 School of Applied Sciences Science, Engineering and Technology Portfolio RMIT University August 2012 
i 
 
Declaration 
This thesis is presented as part of the requirement for a doctorate of philosophy in 
biotechnology in RMIT University. The work described in this thesis is my own work 
unless otherwise stated, and has not been previously submitted for a degree at any 
tertiaty educational institute. The work was carried out under the supervision of Professor 
Margaret Deighton. 
 
 
 
Bintao Cui 
ii 
 
Acknowledgements 
 
I wish to thank for the government of Australia for giving me the opportunity to pursue my 
PhD at RMIT University, Melbourne.  
This dissertation wouldn’t have been possible without the guidance and help of several 
individuals who in one way or another contributed the valuable assistance in completion 
of this study. 
I am heartly thankful to my supervisor Margaret Deighton, whose encouragement, 
kindness from initial to the final enable me to develop an understanding of the subject. My 
research wouldn’t go this far without her support. 
I would like to show my gratitude to Dr Duncan Rouch for his friendship, guidance, 
constructive comments and input. He was made available his support in a number of 
ways. 
I am grateful to Vennessa Fleming and Nerida Thurbon, for their kindness, patience and 
helps whenever in need. They always make me feel the lab like a family. 
I would like to thank everyone in the laboratory for their friendship, accompany me 
through the most unforgettable moments in my life. 
And most of all, thanks to my parents and sister for their love, care and encouragement. 
 
 
 
iii 
 
Table of Contents 
 
 
Phenotypic and Genotypic Characterisation of Biofilm Formation in Staphylococcus 
capitis ................................................................................................................................ i 
A thesis is presented for the degree of Doctor of Philosophy ............................................. i 
Bintao Cui .......................................................................................................................... i 
B.Sc, M.Sc ........................................................................................................................ i 
School of Applied Sciences ............................................................................................... i 
Science, Engineering and Technology Portfolio................................................................. i 
RMIT University ................................................................................................................. i 
August 2012 ...................................................................................................................... i 
Declaration ........................................................................................................................ i 
Acknowledgements .......................................................................................................... ii 
Table of Contents ............................................................................................................. iii 
List of Figures ................................................................................................................... x 
List of Tables .................................................................................................................. xiv 
Table 5.1. Primers used for gene regulations in this study .............................................. xv 
List of Abbreviations and Symbols .................................................................................. xvi 
CHAPTER 1 ..................................................................................................................... 1 
Introduction and Literature Review 1.0 Introduction .......................................................... 1 
1.1 What is biofilm? .......................................................................................................... 3 
1.2 Biofilm formation and dispersal ................................................................................... 4 
1.2.1 Diversity in biofilms ................................................................................................ 4 
1.2.2 Biofilm development ............................................................................................... 5 
1.2.3 Biofilm dispersal ...................................................................................................... 6 
1.3 Clinical impact of bacterial biofilm ............................................................................... 8 
1.3.1 Biofilm infections .................................................................................................... 9 
1.3.2 Antimicrobial resistance of biofilm ......................................................................... 9 
1.4 Coagulase-negative staphylococci (CoNS) in human infections ............................... 10 
1.4.1 Coagulase-negative staphylococci as pathogenic agents ....................................... 10 
1.4.2 Coagulase-negative staphylococci infections in neonatal intensive central unit 
(NICU) ............................................................................................................................ 11 
1.5 Staphylococcal biofilm adhesion ............................................................................... 12 
1.5.1 Staphylococcus epidermidis biofilm as a virulence factor ..................................... 13 
1.5.2 Biofilm formation in Staphylococcus aureus ........................................................ 20 
1.5.3 Biofilm formation of other coagulase-negative staphylococci .............................. 22 
1.6 Genetic regulation of polysaccharide and protein biofilms of staphylococci .............. 25 
1.6.1 Signals inducing biofilm formation in staphylococci ............................................ 25 
1.6.2 Global regulators of biofilm formation in staphylococci ....................................... 28 
1.7 Anti-biofilm strategies ............................................................................................... 37 
1.7.1 Development of new devices ................................................................................. 37 
1.7.2 Targeting staphylococcal biofilm factors............................................................... 38 
1.7.3 Vaccination ............................................................................................................ 39 
1.8 Conclusions .............................................................................................................. 39 
1.9 Objectives of the current project ............................................................................... 40 
CHAPTER 2 ................................................................................................................... 42 
iv 
 
General Materials and Methods ...................................................................................... 42 
2.1 Clinical Staphylococcus capitis isolates .................................................................... 43 
2.2 General Materials ..................................................................................................... 43 
Reagents and kits ........................................................................................................... 43 
Supplier .......................................................................................................................... 43 
QIAEX® II Gel Extraction Kit ........................................................................................... 43 
QIAGEN Pty Ltd - Australia ............................................................................................ 43 
QIAquick® Gel Extraction Kit ........................................................................................... 43 
QIAGEN Pty Ltd - Australia ............................................................................................ 43 
QIAprep® Spin Miniprep Kit ............................................................................................ 43 
QIAGEN Pty Ltd - Australia ............................................................................................ 43 
RNeasy® Mini Kit ............................................................................................................ 43 
RNeasy® Protect Bacteria Mini Kit .................................................................................. 43 
Taq DNA Polymerase ..................................................................................................... 43 
QIAGEN Pty Ltd - Australia ............................................................................................ 43 
TURBO DNA-free™ ....................................................................................................... 43 
Applied Biosystems, Australia ........................................................................................ 43 
Wizard® PCR Preps DNA Purification System ................................................................ 43 
Promega, Australia ......................................................................................................... 43 
Chemicals, media and solutions ..................................................................................... 44 
Supplier .......................................................................................................................... 44 
Acetic Acid Glacial .......................................................................................................... 44 
Merck Pty Limited, Australia ........................................................................................... 44 
Agar Bacteriological (NO.1) ............................................................................................ 44 
Oxoid, Australia .............................................................................................................. 44 
Agarose (Electrophoresis) .............................................................................................. 44 
Bioline (Aust) Pty Ltd ...................................................................................................... 44 
Ampicillin ........................................................................................................................ 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Ammonium Oxalate ........................................................................................................ 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Bigdye Premix (V3.1) for DNA Sequencing .................................................................... 44 
Monash University, Australia .......................................................................................... 44 
Brain Heart Infusion Broth .............................................................................................. 44 
Oxoid, Australia .............................................................................................................. 44 
Cetyl Trimethyl Amnomium Bromide (CTAB) .................................................................. 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Crystal Violet .................................................................................................................. 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Deoxynucleotide Triphosphate Mix (dNTP), ................................................................... 44 
Bioline (Aust) Pty Ltd ...................................................................................................... 44 
Diethyl pyrocarbonate (DEPC) ....................................................................................... 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Electroporation Cuvette .................................................................................................. 44 
Molecular Bioproducts, U.S. ........................................................................................... 44 
Ethanol Absolute GR for Analysis ................................................................................... 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Ethidium Bromide ........................................................................................................... 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
v 
 
Sigma-Aldrich, Australia ................................................................................................. 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Glycerol .......................................................................................................................... 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Isopropyl Alcohol ............................................................................................................ 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Kanamycin ..................................................................................................................... 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Lambda DNA .................................................................................................................. 44 
Promega Corporation, Sydney, Australia ........................................................................ 44 
Lysostaphin from Staphylococcus staphyloliticus ........................................................... 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
MassRulerTM Low Range DNA Ladder, 1Kb ................................................................... 44 
Thermo Fisher Scientific, Australia ................................................................................. 44 
6 x MassRulerTM DNA Loading Dye ................................................................................ 44 
Thermo Fisher Scientific, Australia ................................................................................. 44 
β-mercaptoethanol .......................................................................................................... 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
3-[N-morpholino]propanesulfonic acid (MOPS)............................................................... 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Nuclease Free Water...................................................................................................... 44 
QIAGEN Pty Ltd - Australia ............................................................................................ 44 
Phenol-Chloroform for DNA Isolation .............................................................................. 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Phosphate Buffered Saline (PBS) .................................................................................. 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Proteinase K ................................................................................................................... 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Restriction Enzymes ....................................................................................................... 44 
New England Biolabs and Promega, Australia ............................................................... 44 
RNAse A, DNAse Free ................................................................................................... 44 
Promega Corporation, Sydney, Australia ........................................................................ 44 
Sodium acetate .............................................................................................................. 44 
Sigma-Aldrich, Australia ................................................................................................. 44 
Sodium Chloride ............................................................................................................. 44 
Astral Scientific, Australia ............................................................................................... 44 
Sodium Dodecyl Sulfate (SDS) ....................................................................................... 45 
Sigma-Aldrich, Australia ................................................................................................. 45 
Sodium Hydroxide Pellets .............................................................................................. 45 
Merck Pty Limited, Australia ........................................................................................... 45 
Sucrose .......................................................................................................................... 45 
Sigma-Aldrich, Australia ................................................................................................. 45 
T4 DNA ligase (400,000 cohesive end units/ml) ............................................................. 45 
Trizma Base ................................................................................................................... 45 
Sigma-Aldrich, Australia ................................................................................................. 45 
Tryptone ......................................................................................................................... 45 
Oxoid, Australia .............................................................................................................. 45 
Tryptone Soy Broth ........................................................................................................ 45 
Oxoid, Australia .............................................................................................................. 45 
Uvette ............................................................................................................................. 45 
vi 
 
Crown Scientific, Australia .............................................................................................. 45 
Yeast Extract .................................................................................................................. 45 
Oxoid, Australia .............................................................................................................. 45 
2.3 Oligonucleotides ....................................................................................................... 45 
2.4 General methods ...................................................................................................... 45 
2.4.1 DNA based methods .............................................................................................. 45 
2.4.1.5 Restriction digestion ........................................................................................... 48 
2.4.1.6 Electrophoresis ................................................................................................... 49 
All PCR and restriction digestion products were detected on 1-2% agarose according to 
Sambrook et al. (1989) where the products were electrophoresed at constant voltage in 
1X TAE running buffer (0.4 M Tris-acetate, 0.01 M EDTA; adjusted pH 8.0 with glacial 
acetic acid). The gel was stained with 0.5 µg/mL of ethidium bromide for 5-10 mins and 
photographed using Gel Doc of Quantity One (Bio-rad Laboratories Pty. Ltd., Australia) 
under UV light................................................................................................................. 49 
One Shot® TOP10 Electrocomp™ E. coli and DH5α from Invitrogen Australia Pty Limited 
were applied for plasmid transformation in this study. There follows a brief description 
about these cells and their genotypes. ........................................................................... 50 
E. coli DH5α, genotype is: F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(r K - m K +), λ-..................................... 50 
PCR Component ............................................................................................................ 53 
Final Concentration ........................................................................................................ 53 
dH 2 O .......................................................................................................................... 53 
X µL................................................................................................................................ 53 
10 X PCR Buffer ............................................................................................................. 53 
1 X PCR buffer ............................................................................................................... 53 
dNTP .............................................................................................................................. 53 
200-250 µM .................................................................................................................... 53 
Primer F ......................................................................................................................... 53 
0.4 µM ............................................................................................................................ 53 
Primer R ......................................................................................................................... 53 
0.4 µM ............................................................................................................................ 53 
Taq DNA Polymerase ..................................................................................................... 53 
2.5 U .............................................................................................................................. 53 
DNA Template ................................................................................................................ 53 
1 µL ................................................................................................................................ 53 
Total .............................................................................................................................. 53 
25 µL .............................................................................................................................. 53 
Reagent ......................................................................................................................... 54 
Quantity .......................................................................................................................... 54 
BigDye Premix (3.1) ....................................................................................................... 54 
1 µL ................................................................................................................................ 54 
Reaction Buffer (5 X) ...................................................................................................... 54 
3.5 µL ............................................................................................................................. 54 
Plasmid DNA .................................................................................................................. 54 
300 ng ............................................................................................................................ 54 
Primer ............................................................................................................................ 54 
3-5 µmoles ..................................................................................................................... 54 
Water ............................................................................................................................. 54 
X µL................................................................................................................................ 54 
Total ............................................................................................................................... 54 
vii 
 
20 µL .............................................................................................................................. 54 
2.4.2 RNA based methods .............................................................................................. 55 
CHAPTER 3 ................................................................................................................... 58 
Differences between two clinical Staphylococcus capitis subspecies revealed by biofilm, 
antibiotic resistance and PFGE profiling ......................................................................... 58 
3.1 Introduction............................................................................................................... 59 
3.2 Materials and methods ............................................................................................. 60 
3.2.1 Bacterial isolates and growth conditions ............................................................... 60 
3.2.2 Antibiotic susceptibility testing and screening for mecA gene .............................. 61 
3.2.3 Detection of biofilm production............................................................................. 61 
3.2.4 PFGE analysis ........................................................................................................ 62 
3.2.5 Statistical analysis .................................................................................................. 63 
3.3 Results ..................................................................................................................... 64 
3.3.1 Molecular epidemiology of clinical Staphylococcus capitis isolates over 6-year 
period .............................................................................................................................. 64 
3.3.2 Quantitative and qualitative biofilm formation in clinical S. capitis isolates ........ 66 
3.3.3 Antibiotic susceptibility profile and relationship to biofilm production ............... 68 
3.3.4 Genotype of subspecies and their relatedness to antibiotic resistance and biofilm 
production. ...................................................................................................................... 70 
3.4 Discussion ................................................................................................................ 72 
3.4.1 Significance of antibiotic resistance profile ........................................................... 72 
3.4.2 Biofilm formation of clinical S. capitis isolates and their prevalence in the NICU
......................................................................................................................................... 74 
3.4.3 Relatedness of biofilm production and antibiotic resistance to two subspecies .... 75 
CHAPTER 4 ................................................................................................................... 76 
Sequence analysis of ica operon in Staphylococcus capitis............................................ 76 
4.1 Introduction............................................................................................................... 77 
4.2 Materials and methods ............................................................................................. 78 
4.2.1 Bacterial isolates and growth conditions ............................................................... 78 
4.2.2 PCR amplification, cloning, southern blot, DNA sequence assembling and 
analyses ........................................................................................................................... 78 
4.2.3 Detection of ica operon using expand long PCR ................................................... 81 
4.2.4 PCR-Restriction Fragment Length Polymorphism (RFLP) ................................... 81 
4.2.5 Bioinformatics tools ............................................................................................... 82 
4.2.6 Nucleotide submission ........................................................................................... 83 
4.3 Results ..................................................................................................................... 83 
4.3.1 Sequence of the ica operon in S. capitis ................................................................ 83 
4.3.2 Sequence comparison with S. epidermids, S. aureus and S. caparae .................... 84 
4.3.3 Sequence comparison between biofilm-positive and -negative isolates ................ 85 
4.3.4 Sequence-structure relationships of Ica proteins in S. capitis ................................ 89 
4.3.5 Putative mechanisms of Ica proteins in the polysaccharide synthesis pathway .... 96 
4.4 Discussion .............................................................................................................. 102 
4.4.1 The status of ica operon in S. capitis ................................................................... 102 
4.4.2 The putative function of Ica proteins in S. capitis ............................................... 104 
4.4.3 Origin of the ica operon in S. capitis ................................................................... 105 
CHAPTER 5 ................................................................................................................. 107 
viii 
 
Effects of sub-inhibitory concentrations of erythromycin on the expression of biofilm-
related genes and biofilm formation in clinical Staphylococcus capitis isolates ............. 107 
5.1 Introduction............................................................................................................. 108 
5.2 Materials and methods ........................................................................................... 109 
5.2.1 Bacterial strains and growth conditions ............................................................... 109 
5.2.2 Phenotypic characterization of biofilm formation by microtitre plate assay (MtP)
....................................................................................................................................... 110 
5.2.3 Growth curve construction for isolates 6 and 44 ................................................. 111 
5.2.4 RNA isolation ...................................................................................................... 111 
5.2.5 Quantification of specific transcripts with real-time RT-PCR ............................ 112 
Table 5.1. Primers used for gene regulations in this study. ........................................... 114 
5.2.6 Validation of housekeeping genes for quantitative PCR ..................................... 115 
5.2.7 Statistical analysis ................................................................................................ 117 
5.2.8 Sequence alignment ............................................................................................. 117 
5.3 Results ................................................................................................................... 117 
5.3.1 Biofilm formation of S. capitis in response to erythromycin............................... 117 
5.3.2 Growth curves ...................................................................................................... 119 
5.3.3 Validation of housekeeping genes for reverse transcriptase real-time PCR ........ 121 
5.3.4 Primary sequence analysis of intergenic region located between the icaR and icaA 
in S. capitis .................................................................................................................... 123 
5.3.5 Example of calculation to demonstrate calculation of relative gene expression . 124 
5.4 Discussion .............................................................................................................. 128 
5.4.1 Validation of housekeeping genes ....................................................................... 128 
5.4.2 Transcriptional analysis of biofilm-related genes in response to erythromycin .. 129 
CHAPTER 6 ................................................................................................................. 132 
ica operon disruption for the analysis of its function in clinical Staphylococcus capitis 
isolate ........................................................................................................................... 132 
6.1 Introduction............................................................................................................. 133 
6.2 Materials and Methods ........................................................................................... 134 
6.2.1 Antibiotic susceptibility tests ............................................................................... 134 
6.2.2 Bacterial strains and growth conditions ............................................................... 134 
6.2.3 Construction of the tetracycline resistance cassette plasmids .............................. 135 
6.2.4 Plasmid isolation .................................................................................................. 139 
6.2.5 Introduction of recombinant plasmid DNA into S. capitis isolate ....................... 139 
6.2.6 Confirmation of the transformants ....................................................................... 142 
6.2.7 Induction of tetracycline resistance in S. capitis .................................................. 142 
6.2.8 Glycerol stock ...................................................................................................... 143 
6.2.9 Optimized procedure for gene replacement in S. capitis ..................................... 143 
6.3 Results ................................................................................................................... 146 
6.3.1 Confirmation of the constructed tetracycline resistance cassette in E. coli ......... 146 
6.3.2 Selection of a clinical isolate as a host strain for allele exchange ....................... 147 
6.3.3 Optimization of electroporation transformation .................................................. 148 
6.3.4 Induction of tetracycline resistance in S. capitis .................................................. 157 
6.3.5 Allele exchange .................................................................................................... 158 
6.3.6 Allele replacement in S. capitis ........................................................................... 163 
6.4 Discussion .............................................................................................................. 163 
6.4.1 Optimization of the procedures for transformation ............................................. 163 
ix 
 
6.4.2 Inducible resistance to tetracycline in the recombinant strain 60 ........................ 166 
6.4.3 Allelic exchange................................................................................................... 168 
CHAPTER 7 ................................................................................................................. 172 
General discussion ....................................................................................................... 172 
7.1 Correlation of phenotypic biofilm formation, antibiotic resistant profiling and 
epidemiology of clinical S. capitis isolates .................................................................... 173 
7.2 The role of ica operon in the biofilm formation in S. capitis and its origin ................ 175 
7.3 Clinical implication of biofilm formation of S. capitis in blood-stream infections in 
newborn infants ............................................................................................................ 179 
7.4 The prevalence of biofilm-negative, subsp. capitis isolates in neonatal intensive care 
unit (NICU) ................................................................................................................... 180 
7.5 Improvement of the hospital practices for controlling the spread of S. capitis ......... 181 
References ................................................................................................................... 182 
Appendices .................................................................................................................. 200 
Appendix 1    Urease and Maltose Fermentation Tests on the clinical S. capitis isolates
....................................................................................................................................... 200 
aw:weak ........................................................................................................................ 200 
Appendix 2    Minimum inhibition concentration (MIC) test on the clinical S. capitis 
isolates........................................................................................................................... 201 
Appendix 3     Biofilm assays by microtitre plate tests ................................................ 203 
Appendix 4     Biofim assays of S. capitis in erythromycin .......................................... 204 
Appendix 6    RNA integrity and the removal of DNA contamination ........................ 205 
Appendix 7   Validation of housekeeping genes in the presence and absence of 
erythromycin with isolate 6 .......................................................................................... 206 
Appendix 8    Target gene expression data ................................................................... 207 
Appendix 9    Data for ica gene Knock out .................................................................. 209 
x 
 
List of Figures 
Figures in Chapter 1  
Figure 1.1. Bacterial biofilm formation and dispersal. 8 
Figure 1.2. Structure of the ica operon in S. epidermidis. 18 
Figure 1.3. The pathway leading to the activation of σB. 31 
Figure 1.4. σB operon structures in S. aureus and S. epidermidis. 32 
Figure 1.5. A model for the regulation of σB in S. aureus. 33 
Figure 1.6. The map of the sar region in S. aureus. P1, P2, and P3 represent 
promoters. 
34 
Figure 1.7. The staphylococcal agr quorum-sensing system. 37 
Figures in Chapter 3  
Figure 3.1. PFGE digested with SmaI in S. capitis. 67 
Figure 3.2. PFGE digested with SacII in S. capitis. 68 
Figure 3.3. Contributions of PFGE clusters to the total infections in each year. 69 
Figure 3.4. Biofilm assay with 96-well microtiter plate. 70 
Figure 3.5. Detection of biofilm formation with congo red agar in clinical S. 
capitis.  
70 
Figure 3.6. PCR detection of mecA gene in isolates of S. capitis. 73 
Figure 3.7. Pulsed-field gel electrophoresis dendogram of the clinical S. capitis 
isolates. 
74 
Figures in Chapter 4  
Figure 4.1. Map of the ica locus and surrounding chromosomal region in S. 
capitis strain 6. 
87 
Figure 4.2. PCR of the ica operon in S. capitis. 89 
xi 
 
Figure 4.3. PCR-RFLP profiles of the ica operon in S. capitis isolates 90 
Figure 4.4. Alignment of IcaA with its homologues. 95 
Figure 4.5. Alignment of IcaB with its homologues. 96 
Figure 4.6. Alignment of amino acid sequence of IcaC with several 
acyltransferases. 
97 
Figure 4.7. Alignment of S. capitis IcaD with its counterparts of S. epidermidis. 98 
Figure 4.8. Interaction of IcaR and the ica operator in S. epidermidis. 98 
Figure 4.9. Comparison of the Deduced IcaR palindromic sequence of S. 
capitis with that of S. epidermidis. 
98 
Figure 4.10. The position of the deduced palindromic sequence of S. capitis in 
the ica operon of isolate 6. 
98 
Figure 4.11. Alignment of the helix-turn-helix of S. epidermidis with other 
staphylococcus icaR genes. 
99 
Figure 4.12.  The putative catalytic mechanism for an inverting nucleotide-
sugar glycosyltransferase. 
99 
Figure 4.13. Schematic representation of a nucleotide-diphosho-sugar 
transferase from Bacillus subtili, SpsA. 
100 
Figure 4.14. Hydrophobicity plots of IcaA of S. capitis 6. 101 
Figure 4.15. Hydrophobicity plots of IcaD of S. capitis 6.  102 
Figure 4.16. Signal protein prediction of IcaB. 103 
Figure 4.17. Hydrophobicity plot of IcaB of S. capitis 6. 103 
Figure 4.18. Hydrophobicity plot of IcaC of S. capitis. 105 
Figure 4.19. Hydrophobicity plot of IcaA of isolate 17. 107 
Figures in Chapter 5  
Figure 5.1. Biofilm formation of isolate 6 in the presence of sub-inhibitory 121 
xii 
 
concentrations of erythromycin. 
Figure 5.2. Biofilm formation of isolates in the presence and absence of 
erythromycin. 
122 
Figure 5.3. Growth of isolate 6 in the presence of 16 µg/mL (1/32 × MIC) of 
erythromycin compared with no erythromycin. 
123 
Figure 5.4. Growth of isolate 44 in the presence of 0.25 µg/mL (1/2 × MIC)of 
erythromycin compared with no erythromycin. 
123 
Figure 5.5. Effects of erythromycin (16 µg/mL) on the expression of 
housekeeping genes. 
125 
Figure 5.6. The primary intergenic region of isolate 6. 126 
Figure 5.7. Alignment of intergenic region of ica operon in isolates 6 and 44. 127 
Figure 5.8. Relative quantification with different PCR efficiencies. 128 
Figures in Chapter 6  
Figure 6.1. Construction of the mutant vector pBT2∆tetA(K). 141 
Figure 6.2. Allelic exchange mutagenesis. 148 
Figure 6.3. PCR confirmations for the flanking regions which inserted into 
pBT2-A and pBT2-B. 
149 
Fgure 6.4. Verification of the mutant construction with restriction digestion. 150 
Figure 6.5. Growth curve of the recombinant strain 60 in TSB. 152 
Figure 6.6. Effect of growth phase on transformation efficiency. 152 
Figure 6.7. Cell viability after heat treatment within 5 minutes. 154 
Figure 6.8. Effect of heat-treatment on transformation efficiency. 154 
Figure 6.9. The effect of plasmid DNA amount in the electroporation mixture on 
the transformation frequency. 
155 
Figure 6.10. Effects of pre-incubation of DNA with cells on transformation 156 
xiii 
 
efficiency. 
Figure 6.11. Effects of different temperatures during electroporation on the 
transformation efficiency. 
157 
Figure 6.12. Effects of electroporation buffer on transformation efficiency. 158 
Figure 6.13. Effects of field strength on the transformation efficiency. 159 
Figure 6.14. Verification of the transformation from plasmid isolations of the 
mutant vector from S. capitis. 
160 
Figure 6.15. Viable counts for inducible tetracycline resistance in the 
recombinant S. capitis. 
161 
Figure 6.16. Recombinant strain grown at 42°C with and without EB in TSB. 162 
Figure 6.17. Recombinant strain grown at 44°C with and without EB in TSB. 163 
Figure 6.18. Recombinant strain grown at 46 °C with and without EB in TSB. 163 
Figure 6.19. Recombinant strain grown at 37°C without EB in TSB. 164 
Figure 6.20. Recombinant strain grown at 40°C without EB in TSB. 164 
Figure 6.21. Mutant construct of pBT2∆tetA(K). 173 
 
xiv 
 
List of Tables 
 
Tables in Chapter 1 
 
Table 1.1. Factors accounting for biofilm resistance 13 
Table 1.2. Biofilm associated infections of staphylococci in the presence of 
foreign bodies 
16 
Table 1.3. Virulence Factors of S. epidermidis 22 
Table 1.4. Virulence factors present in coagulase-negative staphylococci  27 
Table 1.5. Other regulatory loci in staphylococci 40 
Tables in Chapter 2  
Table 2.1 General kits 46 
Table 2.2 General chemicals, media and solutions 47 
Table 2.3. Ligation reaction 55 
Table 2.4. PCR reaction 56 
Table 2.5. DNA sequencing reaction 57 
Tables in Chapter 3  
Table 3.1. MIC antibiotic susceptibility pattern and mecA gene carriage and 
their correlations between biofilm formation phenotype in clinical S. capitis 
72 
Table 3.2. Correlations of antibiotic susceptibility profiles and mecA gene 
carriage with pulsed-field gel electrophoresis (PFGE) clusters in S.capitis 
clinical isolates 
76 
Tables in Chapter 4  
Table 4.1. Primers used for PCR experiments 83 
Table 4.2. Sequence comparison of the ica locus between other species 88 
xv 
 
Table 4.3. Summary of the mutations in the ica operon of S. capitis clinical 
isolates 
91 
Tables in Chapter 5  
Table 5.1. Primers used for gene regulations in this study 117 
Table 5.2. Primers of the housekeeping gene used in this study 119 
Table 5.3. Data used to generate standard curve of icaA gene 130 
Table 5.4. Quantification and normalization of icaA and gyrB expression levels 130 
Table 5.5. Relative gene expression of biofilm-related genes in S. capitis in the 
presence of erythromycin at mid-log phase 
131 
Tables in Chapter 6  
Table 6.1. Strains and plasmids used in this study 138 
Table 6.2. Plasmid curing during passage at 42 °C 165 
 
xvi 
 
List of Abbreviations and Symbols 
 
 
bp Base pair 
BSA Bovine serum albumin  
DIG probe Digoxigenin labelled probe 
DNA Deoxyribonucleic acid 
cDNA Complementary DNA 
DNase Deoxyribonuclease 
dNTP Deoxyribonucleotide tiphoosphate 
kb Kilo base pairs 
kV Kilo volts 
mg Miligram 
ml Mililiter 
mM Millimole 
M Molarity 
NaCl Sodium chloride 
ng Nanogram 
OD Optical density 
PCR Polymerase chain reaction 
RNA Ribonucleic acid 
RNase Ribonuclease 
TAE Tris acetic acid and EDTA buffer 
Tris Tris(hydrochloride) amino methane 
Tris-HCl Tris hydrochloride 
U Unit 
µg Microgram 
µL Microliter 
µm Micrometre 
UV Ultraviolet 
Ω Ohms 
λ Lambda 
δ Sigma 
xvii 
 
Abstract 
Biofilm formation is a major concern in nosocomial infection caused by staphylococci. 
Staphylococcus epidermidis and S. aureus are the most recognized species. The ica 
operon has been identified encoding an extracellular polysaccharide, which mediates 
bacterial cell-cell adhesion, is required for biofilm formation and regulated by numerous 
environmental factors. 
 
The pathogenesis of S. capitis is of increasing concern due to its major clinical impact, 
especially in neonates, and its multi-resistance including hetero-resistance to 
vancomycin. 
 
Little is known about the molecular basis of biofilm formation in this species, and the 
relations to its two subspecies. To address this question, the phenotypic and genotypic 
biofilm formation, antibiotic resistance, molecular epidemiology and the functional role 
and regulation of the ica operon in clinical S. capitis isolates from neonates in Royal 
Woman’s Hospital in Melbourne were investigated.   
 
Of 60 S. capitis isolates, biochemical tests showed that 52 belonged to the subspecies 
urealyticus and the remaining eight to the subsp. capitis. The two subspecies were 
separated into distinctive clusters by pulsed-field gel electrophoresis. This approach 
revealed that five clusters and unclustered isolates occurred in the unit between 2000 
and 2005. The most prevalent cluster persisted for a prolonged 6-year period, and 
belonged to subsp. urealyticus. Biofilm formation and antibiotic resistance were also 
mainly displayed by subsp. urealyticus. 
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Sequence analysis showed that the ica operon in S. capitis was 4160 bp in length. PCR 
demonstrated its presence in all the isolates. The ica operon harboured in S. capitis is 
closely related to those of S. epidermidis, S. aureus and S. caprae. It contains four 
structural genes icaA, icaD, icaB and icaC, which are co-transcribed from the icaA 
promoter. A negative regulator icaR gene is located upstream of icaA and transcribed in 
an opposite orientation. The ICA proteins exhibited from 66% to 94% identity to those of 
the same three species. Further analysis in five isolates (two biofilm-positive subsp. 
urealyticus, one biofilm-negative subsp. urealyticus and two biofilm-negative subsp. 
capitis) revealed that the ica oprerons were identical in biofilm-positive subsp. urealyticus 
isolates, however, the biofilm-negative isolates showed variations; these point mutations, 
STOP codon or the modification of membrane protein topology could explain the inability 
to produce biofilm in these isolates. 
 
In sillico analysis of ica operon demonstrated the putative function and mechanisms of 
ICA proteins in polysaccharide biosynthesis and the origin on ica genes present in S. 
capitis genomes. 
 
In vitro biofilm formation and the expression of biofilm-related genes induced by sub-
inhibitory concentrations of erythromycin were explored in the two subspecies. Results 
revealed different responses. The expression of icaA and sarA genes were up-regulated, 
and icaR was down-expressed in the subsp. urealyticus isolate biofilm producer, as 
occurs in S. epidermidis. In contrast, a reverse expression was displayed by the biofilm-
negative subsp. capitis isolate. This suggests biofilm formation in S. capitis is regulated 
by icaR and sarA, and the two subspecies may adopt different regulatory pathways in the 
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two subspecies. Also, the erythromycin induced biofilm formation may have clinical 
implications according to the doses of erythromycin used clinically. 
 
In addition, transformation protocols for S. capitis were developed and optimised and will 
be used as a platform for future work. 
 
This study revealed distinctive phenotypic and genotypic characteristics of the two 
subspecies of S. capitis which was relate to their epidemiology under the clinical setting 
of neonate intensive care. Isolates of the predominant subsp. urealyticus clones were 
characterised by their higher antibiotic resistance and biofilm formation ability, and distinct 
gene expression profiles. Differentiating the subspecies S. capitis revealed be valuable in 
order to understand their role in bloodstream infections of newborns in hospitals. 
 
 
 
1 
 
 
 
 
 
CHAPTER 1 
 
     Introduction and Literature Review 
2 
 
1.0 Introduction 
Coagulase-negative staphylococci (CoNS) are the most documented pathogens involved 
in catheter-related infections in modern hospitals (Venkatesh et al., 2006b). The ability to 
form biofilm on medical devices has been recognized as the main mechanism of 
pathogenesis. Bacteria in the biofilm are protected from host defences and antibiotic 
therapies, although they may appear susceptible to antibiotics, infections are difficult to 
clear, causing an increased morbidity and mortality. Also, the densely compacted bacteria 
in a biofilm matrix facilitate spreading antibiotic resistance by horizontal gene transfer 
(Otto, 2009). 
  
Staphylococcus epidermidis biofilm infections associated with indwelling medical devices 
are the most studied among CoNS biofilm-related infections. The best studied biofilm 
component, polysaccharide intercellular adhesin (PIA) has been shown to be an essential 
virulence factor of S. epidermidis (Fitzpatrick et al., 2005). The ica operon, which encodes 
the enzymes for PIA synthesis, has been identified in some other staphylococcal species, 
suggesting a more common pathogenic role in biofilm infections (Cramton et al., 2001, 
Fredheim et al., 2009). Additionally, various surface proteins have been found to mediate 
the initial attachment in the process of biofilm formation, suggesting alternative 
mechanisms of biofilm formation (Otto, 2004). Biofilm bacteria are subject to a series of 
gene regulations, leading to the resistant phenotype revealed by transcriptional profiling 
data (Lazazzera, 2005, Kong et al., 2006b). Also, studies by using animal models provide 
more realistic information on biofilm formation in vivo (Rupp et al., 1999a, Rupp et al., 
1999b). All these constitute the fundamental knowledge of the study of staphylococcal 
biofilms. 
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Recently, S. capitis has become endemic in Royal Women’s Hospital, Melbourne, 
Australia.  In contrast to S. epidermidis, much less is known about biofilm formation of S. 
capitis and of the two subspecies. A study on mechanisms underlying biofilm formation 
will facilitate the understanding of the particular role of the subspecies in infections in 
hospitals, and also may help to develop novel, efficient therapeutics for this species in the 
clinical setting. 
 
1.1 What is biofilm? 
A biofilm is a compacted assemblage of microorganisms enclosed in a matrix primarily 
composed of polysaccharide, and attached on a surface. Biofilms have been found on a 
variety of surfaces such as indwelling medical devices, industrial water system pipes or 
aquatic systems in the natural environment. The microbial organisms growing in a biofilm 
are physiologically distinct from their planktonic counterparts (Hall-Stoodley et al., 2004).  
 
Biofilm formation has been recognized as a protective mode of cell growth which allows 
for survival in hostile environments, and also under certain circumstances, such as 
nutrient deprivation. Biofilm dispersal in the form of clumps plays an important role in 
helping the cells to colonize new niches (Abee et al., 2011).  
 
At present, the general resistance of biofilms has been explained by several possible 
mechanisms. First, the biofilm matrix might react with superoxides, neutralized charged 
metals or dilute antimicrobial agents to generate sub-lethal concentrations. Moreover, 
resistant phenotypes referred to as “persisters”, which have been found in a biofilm, 
contribute to the resistance. Whether these are indeed a unique resistant phenotype or 
are simply the most resistant cells remains unclear (Hall-Stoodley et al., 2004). 
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1.2 Biofilm formation and dispersal 
1.2.1 Diversity in biofilms 
Biofilm displays a variety of phenotypes depending on the specific system studied. The 
extracellular polymeric substance (EPS) matrix of biofilm plays a role in numerous 
processes including attachment, cell-to-cell interconnection, interactions between 
subpopulations, tolerance, and exchange of genetic material  (Molin and Tolker-Nielsen, 
2003, Friedman and Kolter, 2004, Jackson et al., 2004, Ma et al., 2009, Yang et al., 
2009). The composition of biofilm matrix is determined by surrounding environmental 
conditions, biofilm age, and even the particular strain that forms the biofilm (Hall-Stoodley 
and Stoodley, 2002). 
 
(Ventre et al., 2006)identified several signal sensor kinases (RetS, LadS, and GacS) 
responsible for the induction of   biofilm components of Pseudomonas aeruginosa under 
certain environmental conditions. Listeria monocytogenes biofilms are grown as two types 
under static and flowing conditions, respectively (Rieu et al., 2008). The SOS responsor, 
YneA, which is essential in cell elongation, mediates biofilm formation under flowing 
cultural conditions (van der Veen and Abee, 2010). (Habimana et al., 2009) observed that 
densely layered cells were embedded in the EPS matrix of static and flowing cultural 
biofilms of Lactobacillus plantarum and Lactococcus lactis. (Branda et al., 2001) 
demonstrated that two types of Bacillus spp. biofilms are usually developed under 
laboratory conditions; one is formed at the air-liquid interface where it develops pellicle 
structures floating on the liquid media, and the other forms colony complexes on solid 
agar surfaces, and then develops sites for sporulation. Moreover, Bacillus spp. were 
found to be capable of forming submersed biofilms under both static and continuous flow 
conditions (Wijman et al., 2007). 
Ventre et al. (2006) 
Habi ana et al. (2009) 
randa et l. ( ) 
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1.2.2 Biofilm development 
1.2.2.1 The process of biofilm formation  
Recent advances have been made to show that biofilm development experiences a 
multiple-stage and differentiated process rather than a simple, uniform step. Five 
sequential regulated stages have been proposed for biofilm formation. During the first two 
stages, the cells are loosely adhered to surfaces. Further, the attached cells aggregate 
together and form micro-colonies; subsequently mature biofilm develops on surfaces in 
stages three and four. Then, under certain circumstances, the biofilm cells are shed off, 
return to the mobile mode characterized in stage five. The cells eventually attach to a 
surface when conditions are appropriate, start a new cycle of biofilm formation.  Figure 
1.1 shows the bacterial biofilm formation and detachment (Hall-Stoodley and Stoodley, 
2002).  
 
 
  
 
 
 
 
 
 
 
Figure 1.1. Bacterial biofilm formation and dispersal.  1. The bacterial cells attach loosely to the surface. 2. 
The cell attachment is mediated mainly by EPS, this is reversible. 3. Development of the early biofilm 
structure. 4. The fully mature biofilm complexes are formed. 5 cells are shed off (dark cells on the figure) from 
the mature biofilm microcolonies. Adapted from (Stoodley et al., 2002). 
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1.2.2.2 Biofilm determinants  
There are intensive studies on the initial stages of biofilm formation. Considering the 
diversity in biofilms, the determinants of biofilm structure is a long-term debate in terms of 
the contributions of genetics and environmental conditions (Kjelleberg and Molin, 2002).  
 
Numerous molecular strategies, such as gene knock-out, transposon mutagenesis, have 
been employed to identify the gene function in biofilm formation. In these studies, by 
comparison of biofilm forming ability of a mutant strain and that of its isogeneic wild-type, 
a particular role of a gene is defined. Also, arrays of gene loci and signals have been 
identified to be essential or required for biofilm formation by comparing the synthesis of 
biofilm components under different environmental conditions (Caiazza and O'Toole, 2003, 
Cucarella et al., 2001, Sarah E. Cramton, 1999 , Hamon and Lazazzera, 2001, Froeliger 
and Fives-Taylor, 2001, Gavín et al., 2002, Whitchurch et al., 2002, Valle et al., 2003). In 
addition, (Davies et al., 1998)found that cell signalling, controlled by the quorum sensing 
system, plays an essential role in biofilm differentiation. In sum, both the environmental 
conditions and genetics show significant influence on the biofilm formation based on a 
series of laboratory experiments and naturally formed biofilm. 
 
1.2.3 Biofilm dispersal  
Biofilm bacteria can detach from food and water production facilities (Zottola and 
Sasahara, 1994, Piriou et al., 1997), or medical and dental devices (Hall-Stoodley and 
Stoodley, 2005). Bacterial dispersal from mature biofilms allows for the colonization of 
new niches, and presumably, contributes to biological dispersal, bacterial survival. 
Disease transmission is believed to be an active process and an essential step for the 
biofilm life (Sauer et al., 2002). 
Davies et al. (1998) 
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Research on biofilm dispersal is in its very early stages. Like other stages of biofilm 
development, dispersal can be regulated by numerous environmental signals, signal 
transduction pathways, and effectors.  No single mechanism of biofilm dispersal is 
applied by all bacteria. In general, mechanisms of biofilm detachment can be divided into 
two broad categories: active and passive. Active detachment refers to mechanisms that 
are initiated by the bacteria themselves, such as endogenous enzymatic degradation 
(Kaplan, 2010). A number of degradative enzymes specific for biofilm components have 
been found to be produced by some species. For example, DspB (dispersin β-
hexosaminidase), secreted by E. coli and several other bacteria, specifically hydrolyses 
the glycosidic linkages of exropolysaccharide of the biofilm matrix, therefore inhibits the 
biofilm formation of the host bacteria (Boles and Horswill, 2008, Nijland et al., 2010)  Also, 
(Boles et al., 2005) showed that Pseudomonas aeruginosa biofilm dispersal was caused 
by rhamnolipids, surfactants produced by this organism. Another possible mechanism of 
biofilm dispersal involves cell detachment due to cell division at the outer surface of the 
biofilm colony (Costerton et al., 1999). Passive dispersal refers to biofilm cell detachment 
that is mediated by external forces such as fluid shear, abrasion (collision of solid 
particles with the biofilm), predator grazing, and human intervention (Ymele-Leki and 
Ross, 2007).   
 
Many studies on the regulation of biofilm dispersal have focused on the identification of 
environmental conditions that trigger the dispersal process (Karatan and Watnick, 2009).  
In addition to environmentally induced biofilm dispersal, it is likely that mechanisms of 
genetically programmed biofilm dispersal also exist. In Aggregatibacter 
actinomycetemcomitans, biofilms undergo a reproducible, periodic detachment of biofilm 
biomass, even under conditions where nutrients are not limited (Kaplan, 2010). 
Boles et al. (2005) 
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In sum, biofilm formation is the primary mode of growth for bacteria in most natural and 
clinical environments. Biofilm dispersal acts as an essential role in the transmission of 
bacteria from the environment to humans, from human to human, and also the spread 
within a single host. A better conception of the process and mechanisms underlying 
biofilm formation and dispersal will facilitate development novel strategies in prevention of 
bacterial biofilm infections. 
 
1.3 Clinical impact of bacterial biofilm  
The study of bacteria residing in biofilms as an interactive community has recently gained 
a great deal of interest, in part, because a number of human diseases are involved in 
biofilms. Several mechanisms have been proposed to explain why pathogens in biofilms 
are more virulent  than their planktonic counterparts. First, pathogens in biofilms can 
initiate an infection through the seeding or dispersal of biofilm clumps which contain large 
numbers of cells. Second, among the phenotypically heterogeneous pathogens within a 
biofilm, certain virulent phenotypes might survive and spread within biofilm matrix. Finally, 
the closely related cells within biofilms might initiate quorum sensing networks which 
regulate virulence gene expressions (Xu et al., 2006b). Taken together, the dense 
aggregated virulent organisms within the context of biofilms might be a major contributor 
to the pathogenesis of bacterial biofilm related infections. 
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1.3.1 Biofilm infections 
 Many pathogenic microorganisms have been found capable of forming biofilm on the 
surface of indwelling medical devices, such as catheters, artificial heart valves. These 
orgnisms have been identified as the causative agents for a wide range of nosocomial 
infections. These infections include indwelling-device-associated infections caused by 
CoNS. Once established, these infections are almost impossible to be eradicated, the 
patients are subjected to long-term antimicrobial therapy, and sometimes the foreign body 
has to be replaced. Another classic case of biofilm infection is Legionnaire’s disease, an 
acute respiratory infection caused by aspiration of clumps of Legionella biofilms floating in 
the air (Fields et al., 2002). Biofilms have been associated with a list of chronic infections 
including cystic fibrosis, native valve endocarditis, and chronic bacterial prostatitis, even 
though these have not been verified by Koch’s postulates (Hall-Stoodley et al., 2004). 
 
1.3.2 Antimicrobial resistance of biofilm 
Biofilm bacteria generally display increased antibiotic resistance. Factors attributed to 
biofilm resistance are summarized in Table 1.1. 
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Table 1.1. Factors accounting for biofilm resistance 
Factors Mechanisms References 
Limited penetration The inability of antibiotics to reach all areas within biofilms (Davies, 2003) 
Decreased growth rate  The lowered metabolic activity in biofilms  (Shah et al., 2006) 
Cell density Higher cell density in biofilm compared with their planktonic counterpart  
(Mikkelsen et al., 
2007) 
Unique cell physiology  The altered transcription profiling of the biofilm bacteria  (Stanley et al., 2003) 
Persister cells Persisters are possibly a new resistant phenotype or just a group of very resistant cells within biofilms (Lewis, 2005 ) 
Altered chemical 
microenvironment 
The extreme microenvironment within a biofilm 
compromises the activity of certain antimicrobials, such 
as low or high pH.  
(Dunne, 2002) 
 
 
1.4 Coagulase-negative staphylococci (CoNS) in human 
infections 
 
1.4.1 Coagulase-negative staphylococci as pathogenic agents 
Staphylococci are gram-positive, AT-rich cocci, which are often arranged in grape-like 
clusters. Historically, coagulase-negative staphylococci were treated as a group, 
designated Staphylococcus albus or S. epidermidis, distinguished from S. aureus by their 
inability of clotting blood plasma. This group of CoNS normally maintain a benign 
relationship with their host and were considered non-pathogenic. Currently, at least 38 
species of CoNS have been identified, and 13 of them have been isolated from humans 
(Takahashi et al., 1999). S. epidermidis represents the most commonly found and studied 
coagulase-negative staphylococcal species in humans (Weinstein et al., 1998). Often, 
staphylococcal species have been each found occupying specific niches, for example, S. 
capitis on the head, S. auricularis in the external auditory canal, S. saprophyticus in the 
inguinal area and the perineum.  
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During the past few decades, increasing cases of nosocomial infections implicating to 
CoNS, such as bacteraemia, native and prosthetic valve endocarditis, established CoNS 
as human pathogens. The surveys from Nosocomial Infections Surveillance System 
reveal that coagulase-negative staphylococci represent the leading isolated nosocomial 
pathogens from intensive care unit patients. Two main reasons may account for the 
infections: the increasing spreading of antibiotic resistance among clinical CoNS and 
biofilm formation on indwelling medical devices (Venkatesh et al., 2006b). Coagulase-
negative staphylococci as opposed to the S. aureus species, are not equipped with such 
widespread spectrum of virulence factors, infections incited by CoNS are not generally 
acute (except for native valvular endocarditis) but appear predominantly in chronic forms 
(Otto, 2004). 
 
1.4.2 Coagulase-negative staphylococci infections in neonatal intensive 
central unit (NICU) 
 
Coagulase-negative staphylococci are identified as the most common pathogens causing 
late-onset sepsis (>72 hours of age) in infants born weighing less than 1500g at birth 
(VLBW infants). Most of these infections are catheter-related, since central venous 
catheters (CVCs) are needed for delivering nutrients and drugs for critically ill infants. The 
using of catheters in neonates increase the occurrence of bloodstream infections (BSIs), 
primarily caused by CoNS. This is responsible for significant mortality and morbidity in 
very-low-weight infants (VLBW; < 1500g) in neonate intensive central unit (Cheung and 
Otto, 2010).  
 
The capability of CoNS to adhere to catheters and form biofilms plays an important role in 
the pathogenesis of CoNS-induced infections.  The catheter hub and skin insertion site 
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are recognized as the most possible pathogen sources on catheters. The microorganisms 
colonized in the contaminated hub may transfer along the catheter and enter into the 
bloodstream, causing acute late-onset sepsis infections. Moreover, CVCs-related 
infections in neonates tend to relapse after treatment, most likely due to the biofilm 
formation on the catheters. The detachment of cell clusters from the mature biofilm forms 
the basis for continuous transmission of bacteria into the bloodstream (Raad, 1998). A 
recent study by Hira et al. (2010), using restriction fragment length polymorphism (RFLP) 
showed that personnel play an important role of cross-contamination with these CoNS in 
NICU, which carry more resistant biofilm-forming CoNS than community strains. 
Furthermore, almost all blood isolates were shown to be from the hands of personnel.  
 
1.5 Staphylococcal biofilm adhesion 
Staphylococcus species are commensal bacteria that reside on human skin and mucous 
membranes, and are found worldwide. Staphylococci has been recognized as the most 
frequent pathogens associated with medical device infections; it is likely due to their 
presence on the skin in the vicinity of medical device (Table 1.2). 
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Table 1.2. Biofilm associated infections of staphylococci in the presence of foreign bodies  
Biofilm 
Infections Indwelling Foreign Body Reference 
Bacteraemia Almost all cases of bacteraemia due to CoNS are associated with an indwelling foreign body. (von Eiff et al., 2005) 
Infections of 
joint prostheses Hip, knee, elbow (von Eiff et al., 2005) 
Endophthalmitis Lens prostheses (von Eiff et al., 2005) 
Peritonitis Implanted perioneoventricular shunts and chronic outpatient’s peritoneal dialysis systems (von Eiff et al., 2005) 
Ventriculitis Implanted internal or external shunts (von Eiff et al., 2005) 
Urinary 
infections Urinary catheters (von Eiff et al., 2005) 
 
 
1.5.1 Staphylococcus epidermidis biofilm as a virulence factor 
Staphylococcus epidermidis is recognized as the leading CoNS mediating medical 
devices infections (for example, catheters and prostheses). Eighty per cent of the cells 
within the biofilm are identified as S. epidermidis in medical device related infections. In 
contrast with biofilms formed in the natural environment, the microbial community 
consists of multiple species.  Biofilm formation in S. epidermidis is extensively studied. 
Cells of S. epidermidis are present and embedded in polysaccharide in multiple layered 
biofilms on polymer surface as revealed by scanning electron micrographs (Uçkay et al., 
2009). 
 
1.5.1.1 Biofilm formation of S. epidermidis 
Before biofilm formation, the surfaces of medical device are coated with human serum 
proteins forming a conditioning film. This film plays an important role in bacterial adhesion 
(McCann et al., 2008). A range of surface proteins, known as ‘microbial surface 
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components recognizing adhesive matrix molecules’ (MSCRAMMs), have been identified 
for binding serum proteins in staphylococci (Sillanpää et al., 2009). 
 
Biofilm attachment 
Initial bacterial attachment is the first critical step for the development of implant-
associated infection. Two mechanisms are believed to be involved in the initial 
colonisation. One is that planktonic microorganisms non-specifically bind to native 
surfaces of medical devices. These reactions are mediated by a number of 
physiochemical variables such as electrostatic forces, surface tension, and temperature 
(Dunne, 2002). In S. epidermidis, several surface proteins, such as SSP-1 (280kDa) and 
SSP-2 (250kDa) with specific adherence functions have been identified to be involved in 
this type of attachment (von Eiff et al., 2002). 
 
The second mechanism is that bacteria interact with host proteins which appear in the 
conditioning film formed following implantation on medical devices (Wang et al., 1993). 
Several bacterial cell surface proteins contribute significantly to the initial attachment. 
(Heilmann et al., 1997) showed that the surface associated autolysin (AtlE) mediates the 
initial attachment by adhesion to vitronectin and fibrinogen-binding Fbe. Cell-surface-
associated proteins, SdrG, SdrF and SdrH specifically bind host proteins (McCrea et al., 
2000). Moreover, charged cell wall teichoic acids play an important role in the initial steps 
of biofilm formation (Vergara-Irigaray et al., 2008). 
 
Biofilm accumulation 
Polysaccharide intercellular adhesion was identified as an essential functional component 
involved in accumulation of multilayered biofilm in S. epidermidis (Mack et al., 1996). It is 
Heil ann et al. (1997) 
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a linear ß-1,6-linked glucosaminoglycan, synthesised by enzymes encoded by ica operon 
which comprise four genes, icaA, icaD, icaB and icaC in this order. There is a negative 
regulator (icaR) gene located upstream of icaA gene, transcribed in an opposite direction 
(Mack et al., 1996).  
 
 
 
 
Figure 1.2. Structure of the ica operon in S. epidermidis (adapted from Mack et al., 1996). 
 
 
Functional analysis of IcaADBC proteins revealed that proteins IcaA, IcaD and IcaC, are 
present the on cell membrane; IcaB is secreted in the culture supernatant. During PIA 
synthesis, IcaA displays N-acetylglucosaminyltransferase activity; co-expression of icaA 
and icaD gene increases the transferase activity. The combination of IcaA and IcaD can 
produce N-acetylglucosamine oligomers in maximal length of 20 residues. IcaB, a 
deacetylase, has shown sequence similarity to the Rhizobium NodB protein. It is likely a 
signal protein. It was found that only when icaAD co-expressed with the icaC gene, were 
full-length of oligomers have synthesised, which could be detected by anti-PIA antisera. 
IcaC, a transmembrane protein, may facilitate the translocation of the growing 
polysaccharide to cell surface (Gerke et al., 1998).  
 
Transcription studies of the ica operon have shown it is regulated by a variety of  
environmental stress stimuli, such as in the presence of salt, ethanol, temperature, 
nutrition, oxygen, and several antibiotics (Vuong et al., 2005). 
icaR icaA icaD icaB icaC 
16 
 
Previous work has shown that biofilm formation in S. epidermidis can be inactivated by 
insertion element IS256 inserted in the icaA or icaC gene loci, with the former more 
frequently. Cells revert to a biofilm-positive phenotype by excision of IS256 from the 
target region, displayed as a phase variable process (Ziebuhr et al., 1999). 
(Kiem et al., 2004) observed a similar phenomenon in S. aureus. The reversal of biofilm 
formation can also be mediated by an alternative strategy, promoted by proteinaceous 
factors (Hennig et al., 2007). The phase variation in biofilm formation is believed to play a 
role in long-term persistence and relapse of bacteria. 
 
In addition to exopolysaccharide, surface proteins are identified to be crucial for the 
second phase of biofilm development. Accumulation associated protein (Aap), which is a 
220 kDa LPXTG protein in S. epidermidis, was found more prevalent in isolates colonised 
on catheter surfaces than on skin, and was essential for biofilm accumulation 
(Vandecasteele et al., 2003).  Biofilm-associated protein, Bhp in S. epidermidis, 
homologous to Bap of S. aureus, was identified mediating the multilayered biofilm 
accumulation without PIA (Rohde et al., 2007). Giant extracellular matrix-binding protein 
(Embp) has recently been shown to be multifunctional, playing a role in several 
processes. It contributes significantly to biofilm architecture development in S. 
epidermidis (Otto, 2012).  
 
Biofilm maturation and detachment 
A mature biofilm is constituted of multilayered structures, including the main biofilm 
substances, host conditioning film and the substratum to which the biofilm is attached. 
Groups of microcolonies were found embedded in the mature biofilm structure, separated 
by micro-channels filled with fluid.  These channels are used by the cells in the biofilm for 
Kie  et al. ( ) 
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exchanging substances with the outside world to ensure basic living (Galiana et al., 
2008).  
 
Gene expression profiles of cells in a mature biofilms of both S. epidermidis and S. 
aureus are distinct from those grown planktonically, as revealed by microarray studies 
(Yao et al., 2005, Secor et al., 2011). Four metabolic types of cells are growing in S. 
epidermidis biofilms defined by (Rani et al., 2007)  These contribute to the antibiotic 
tolerance within a biofilm. It is, therefore, hypothesised that the antibiotic efficacy against 
biofilm infections might be improved if drugs are designed to target a particular biofilm 
region (e.g., aerobic grown cells). 
 
Individual cells or cell clumps in a biofilm can detach and attach to new niches, and these 
are believed to be crucial for transmission of biofilm associated infections (Kong et al., 
2006b). The underlying mechanisms are largely unknown. The accessory gene regulator 
(agr) QS system was suggested play a role in this process. S. epidermidis agr mutant 
was shown to form a thicker biofilm in a rabbit model compared with its wild-type strain 
(Vuong et al., 2004). It is likely due to the loss of phenol-soluble modulins upregulated by 
agr system in the agr mutant which act as surfactants and inhibit non-covalent 
interactions of biofilm bacteria on surfaces (Otto, 2009).      
 
1.5.1.2 Review of the S. epidermidis virulence factors 
Virulence properties of S. epidermidis are fewer compared with those of S. aureus, and 
biofilm formation has been identified as a virulence factor related to a range of acute and 
chronic diseases, as demonstrated by a series of animal models demonstrating in vivo 
conditions of biofilm formation (Rupp et al., 1999a). In addition, a list of other factors have 
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been recently recognized in S. epidermidis responsible for defeating innate immune 
system activities (Kocianova et al., 2005), for example, phenol-soluble modulins and poly-
γ-DL-glutamic acid. Table 1.3 shows a review of virulence factors in S. epidermidis 
species. These include factors involved in biofilm formation, exo-enzymes and other 
factors. 
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Table 1.3. Virulence Factors of S. epidermidis 
Factors Functions References 
Biofilm   
Attachment to 
hydrophobic surfaces   
AtlE 
Autolysin/adhesin: attachment to polystyrene, 
vitronectin binding (Heilmann et al., 1997) 
SSP1, SSP2 Attachment to polystyrene (Veenstra et al., 1996) 
Delta-toxin Inhibits binding to polystyrene (McKevitt et al., 1990) 
Attachment to host matrix 
proteins   
Fbe/SdrG Fibrinogen binding, inhibition of phagocytosis (Vernachio et al., 2006) 
Embp Fibronectin binding (Williams et al., 2002) 
GehD Collagen binding (Bowden et al., 2002) 
Accumulation   
PIA 
Exopolysaccharide: cell-cell adhesion, 
haemagglutination (Gerke et al., 1998) 
AAP Accumulation (Hussain et al., 1997) 
Exoenzymes   
Lipases Persistence in fatty secretions 
(Rosenstein and Götz, 
2000) 
Cysteine protease Possibly tissue damage (Dubin et al., 2001) 
Metalloprotease Sep-P1 Lipase maturation, possibly tissue damage (Teufel and Götz, 1993) 
Serine protease GluSE 
Possibly biofilm formation, degradation of 
fibrinogen and complement factor C5 (Otto, 2009) 
Fatty acid-modifying 
enzyme (FAME) 
Detoxification of host-produced bactericidal fatty 
acids (Otto, 2009) 
Virulence regulators    
agr Affects lipase and protease production (Vuong et al., 2000) 
sar Regulation of virulence factors production (Tormo et al., 2005) 
sigB Affects biofilm formation (Knobloch et al., 2001a) 
Others   
Phenol-soluble modulin 
(PSM) Several inflammatory effects (Cogen et al., 2010) 
Staphyloferrin A and B Siderophores: iron uptake 
(Konetschny-Rapp et al., 
1990) 
SitABC Possibly involved in iron uptake (Massonet et al., 2006) 
Lantibiotics (epidermin, 
Pep5) Possibly bacterial interference (Marsh et al., 2010) 
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1.5.2 Biofilm formation in Staphylococcus aureus  
Biofilm formation in S. aureus experiences a similar process to that of S. epidermidis; it 
begins with the initial reversible bacterial adherence to a surface by some non-specific 
adhesion, followed by an irreversible bacterial specific attachment mediated mainly by an 
array of MSCRAMMS (Foster and Höök, 1998). Then a mature biofilm is developed 
characterized by multilayered bacterial cells stuck together and producing extracellular 
polymeric substances (EPS). In circumstances such as nutrient deprivation, or under 
heavy shear forces, detachment of clumps of the biofilm bacteria occurs. The released 
bacterial clumps start to attach to new niches, and initiate a new cycle of biofilm formation 
(Stoodley et al., 2002). 
 
1.5.2.1 Polysaccharide intercellular adhesin (PIA) mediated biofilm formation in S. aureus 
Polysaccharide intercellular adhesin was initially purified from S. epidermidis. It was 
identified in S. aureus later and shown to have a similar function. Since the structure of 
the N-acetylglucosamine residues in S. aureus is shown totally succinylated, it was 
designated as poly-N-succinyl β-1, 6-glucosamine (PNSG) (McKenney et al., 1999).  
 
Polysaccharide intercellular adhesin has been defined as an important virulence factor for 
S. epidermidis pathogenicity in various foreign-body animal infection models (Rupp et al., 
2001, Rupp et al., 1999a, Rupp et al., 1999b). However,  the results showed 
inconsistency for S. aureus: It seems that biofilm formation in methicillin-resistant S. 
aureus (MRSA) is predominantly mediated by surface proteins, which are regulated by 
agr expression, while the icaADBC-encoded PIA mediated cell to cell adhesion was 
suggested to be the major mechanism of biofilm formation in methicillin-susceptible S. 
aureus (MSSA) (Izano et al., 2008). Moreover, PIA production in S. aureus did not lead to 
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an increased persistence of infection in a tissue cage model of infection with this species 
(Kristian et al., 2004). 
 
1.5.2.2 Surface protein associated biofilm formation in S. aureus 
(Clarke and Foster, 2006) demonstrated that most S. aureus surface proteins belong to 
the MSCRAMM protein family and are covalently linked to the cell wall peptidoglycan. A 
number of surface proteins were found to be involved in the biofilm formation in S. 
aureus. The first protein characterized mediates PIA-independent biofilm formation in S. 
aureus was biofilm associated protein (Bap). It was suggested to be essential for both 
initial adherence and maturation during biofilm development by the S. aureus bovine 
mastitis isolate V329 (Cucarella et al., 2001). A group of over 100 surface proteins from 
diverse bacterial species have been found so far which have conserved functional 
structure with that of Bap protein, and play a similar role in biofilm formation (Lasa and 
Penadés, 2006).  
 
Other proteins, such as surface protein SasG have shown global similarities to Aap from 
S. epidermidis. Multiple successive repeats were recognized as being responsible for its 
intercellular adhesin (Gruszka et al., 2012). The N-terminal domain of surface protein C 
(SasC) was reported to mediate the initial attachment and accumulation of biofilm 
development (Schroeder et al., 2009).  A role of protein A in biofilm development was 
detected and this protein is down-regulated by the accessory gene regulator agr (Merino 
et al., 2009). 
 
Furthermore, S. aureus surface protein-mediated biofilm infections were evaluated by 
different animal model systems. Protein Spa was suggested to be the major factor 
larke and Foster ( ) 
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responsible for biofilm formation in a murine model of subcutaneous catheter infection 
(Vergara-Irigaray et al., 2009). FnBPA and FnBPB were also found mediate PIA-
independent biofilm formation in MRSA strains, and were responsible for biofilm formation 
in a catheter-associated murine infection model (O'Neill et al., 2008). 
S. aureus biofilm infections represent a reservoir of S. aureus dissemination in the body. 
Due to the difficulties in treatment and a greater array of virulence factors, S. aureus 
biofilm infections need more intensive care than those of S. epidermidis. 
 
1.5.3 Biofilm formation of other coagulase-negative staphylococci 
In comparison with S. epidermidis and S. aureus, biofilm-associated infections with other 
staphylococci are far less frequent. The underlying molecular basis foreign body-
associated infections are largely unknown.  
 
A recent study showed that the biofilm structures are fundamentally different between S. 
haemolyticus and S. epidermidis. In S. haemolyticus, biofilms were mainly composed of 
eDNA and protein. An ica operon has been identified in S. haemolyticus, while its biofilm 
formation function is not elucidated (Fredheim et al., 2009). Similarly in S. lugdunensis, 
(Frank and Patel, 2007) reported PIA was not the major component of the extracellular 
slime although the homologous ica operon has been identified in isolates. Only about 
25% of clinical isolates are capable of producing icaADBC encoded PIA in in vitro studies 
(von Eiff et al., 2002). 
 
In addition, cell surface proteins have been suggested to play a significant role in cell 
attachment in other CoNS species. S. saprophyticus is more capable to adhere 
specifically to uroepithelial cells than other staphylococcal species.  Several surface 
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proteins have been identified to mediate this binding. One is a 160KDa surface-exposed 
protein, designated Aas. Its amino acid sequence is homologous to the Atl and AtlE from 
S. aureus and S. epidermidis, respectively. Protein Ssp is identified in nearly all clinical 
isolates, and proved to have adhesive properties. Protein Sdrl is highly homologous in 
sequence and structure to the Sdr proteins from S. aureus and S. epidermidis and was 
confirmed to possess adhesive features. Furthermore, a previous study revealed that S. 
schleiferi expresses cell-wall-anchored fibronectin-binding protein which mediates 
adhesion in this species (Peacock et al., 1999). A series of virulence factors of CoNS 
were summarized in Table 1.4.   
 
In general, the molecular basis of biofilm formation is largely unknown in other coagulase-
negative staphylococcus species other than S. epidermidis, they probably follow the 
similar basic principles to that of S. epidermidis and S. aureus, while different for some 
specific molecular determinants. 
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Table 1.4. Virulence factors present in coagulase-negative staphylococci  
Species Virulence Factors Functions References 
S. saprophyticus 
autolysin Aas 
 
Mediates adherence to fibronectin and 
promotes haemagglutination. (Hell et al., 1998) 
Ssp (S. saprophyticus 
surface-associated 
protein) 
Produces of surface-associated 
material, clumping, and binding to 
uroepithelial cells. 
(Gatermann et al., 
1992) 
Urease 
Damaging bladder tissues. Has of 
lipase, elastase, and FAME activity. 
(Gatermann and 
Marre, 1989) 
S. haemolyticus 
Gonococcal Growth 
Inhibitor (GGI) 
Cause cytoplasmic leakage of 
gonococcal cells. 
(Frenette et al., 
1984) 
S. lugdunensis 
Slush (S. lugdunensis 
synergistic 
haemolysin) 
Similar to PSM-β of S. epidermidis, 
and to GGI of S. haemolyticus 
(Donvito et al., 
1997) 
S. warneri Lipase 
Similar to other staphylococcal lipases, 
shows broad substrate specificity. 
(Talòn et al., 
1995) 
S. simulans 
Lipase, FAME, and 
urease 
Damaging bladder tissues, similar to 
other staphylococcus, cause a variety 
of animal as well as human infections. 
(Gatermann and 
Marre, 1989 
S. capitis Lipase and FAME Similar to other staphylococcus lipases 
(Gatermann and 
Marre, 1989 
S. hominis 
Esterase, lipase, 
FAME, and urease  Similar to other staphylococcus lipases 
(Gatermann and 
Marre, 1989 
S. cohnii 
Lipase and FAME; Similar to other staphylococcus lipases 
(Gatermann and 
Marre, 1989 
Lantibiotic Similar to epidermin 
(Furmanek et al., 
1999) 
S. saccharolyticus  
Cause anaerobic endocarditis and 
bacteremia 
(Krishnan et al., 
1996) 
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1.6 Genetic regulation of polysaccharide and protein 
biofilms of staphylococci 
 
A number of environmental signals have been identified that guide biofilm formation in 
bacteria. Some of which have been extensively studied in Staphylococcus spp.  
 
1.6.1 Signals inducing biofilm formation in staphylococci 
1.6.1.1 Glucose and related sugars  
Glucose and related sugars are essential nutrients for the metabolism of many 
organisms, where they function in numerous processes. Some bacteria use sugar as a 
source of energy, others use them to build and repair cells.  These substances are also 
proved to have various effects on bacterial biofilm formation depending on species. They 
are biofilm inducers in some bacteria such as Streptococcus mutans, Staphylococcus 
aureus, and Staphylococcus epidermidis (Lim et al., 2006, Shemesh et al., 2007).  
(Mack et al., 1992) observed that glucose induced adherence to plastic surfaces in a 
time-dependent manner, using stationary-phase cultures of S. epidermidis in a medium 
lacking glucose. Glucose and other sugars serve as biofilm inhibitors in some bacteria, for 
example, P. aeruginosa and P. aureofaciens (Dusane et al., 2008).  
 
1.6.1.2 Iron acquisition 
Iron is an important nutrient for bacteria, yet it is toxic to bacteria at higher concentrations. 
As with almost all bacteria, Staphylococcus spp. is dependent on iron acquisition for 
growth. Bacteria colonizing or infecting humans have invented two principle mechanisms 
to deal with the low availability of iron in human body fluids. The first involves high affinity 
iron binding molecules called siderophores and specific import systems, to which 
siderophore/iron complexes bind (Miethke and Marahiel, 2007). The second mechanism 
Mack et al. (1992) 
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depends on direct binding of transferrin to a membrane bound bacterial receptor (Otto, 
2004).  
 
Bacterial biofilm formation has been shown to be influenced by iron in some bacteria. 
(Banin et al., 2005) has shown that a certain level of intracellular iron was critical for iron-
signalling pathway, and hence for biofilm development in Pseudomonas aeruginosa.  Fur 
protein has been identified in many bacteria. This protein functions as a global regulator 
for iron responsive genes. In Pseudomonas spp. the fur gene was shown to be essential 
for biofilm formation, and was also found to be involved in the regulation of biofilm 
formation at low iron conditions in S. aureus (Johnson et al., 2008).  
 
 
1.6.1.3 Stress-inducing stimuli (anaerobiosis, osmolarity, ethanol, temperature and 
antimicrobials) 
 
Several studies demonstrated the effects of oxygen on the biofilm formation in 
Staphylococcus spp. Cramton et al. (2001) observed increased biofilm production in both 
S. epidermidis and S. aurues under anaerobic conditions in vitro. They further 
demonstrated that the increased activity of σB under the anaerobic conditions, repressed 
the transcription of the negative regulation icaR, and augmented icaADBC expression, 
leading to a more biofilm production. However, this regulation was more stringent in S. 
epidermidis. It was suggested that the staphylococcal respiratory response regulator 
(SrrA) in S. aureus can directly promote ica transcription under anaerobic conditions, 
without modulating the icaR expression, therefore σB appeared less important under 
anaerobic conditions in this species. Moreover, Cotter and his colleagues made a similar 
observation of the influence of oxygen on biofilm development via activated σB, by using a 
rotating-disk reactor, a more precise system which controls the concentration of dissolved 
anin et al. ( ) 
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oxygen. It seems that the activity of σB is greater under low-oxygen conditions in S. 
epidermidis (Cotter et al., 2009).  
 
It was shown that environmental osmolarity played a significant role in biofilm formation in 
S. epidermidis. PIA synthesis and biofilm formation were up-regulated under high 
osmolarity (Knobloch et al., 2001), likely mediated through the σB, where rsbU, the first 
gene of σB was induced by NaCl or/and glucose. It has been shown in S. epidermidis that 
the rsbU mutants M 15 and 8400 M15 were completely deprived of the capability of 
biofilm formation. However, another biofilm inducer, ethanol appeared to promote biofilm 
formation through an rsbU independent pathway, by modulating the negative regulator 
IcaR. In addition, Møretrø et al. (2003) revealed that quantitative biofilm production in S. 
capitis is linearly induced by sodium chloride. 
 
Several antimicrobial agents are biofilm inducers in S. epidermidis in vitro. Sub-inhibitory 
concentrations of tetracycline, erythromycin, clindamycin, semisynthetic streptogramin, 
quinupristin-dalfopristin were all found to significantly enhance ica expression in S. 
epidermidis (Rachid et al., 2000, Wang et al., 2010) 
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1.6.2 Global regulators of biofilm formation in staphylococci 
1.6.2.1 Sigma factor (σB) 
The alternative sigma factor, σB, is the best studied global regulator for stress response. It 
is activated by a serial of relayed signals stimulated by stress, and this confers the 
protection of the cells against adverse conditions (Francez-Charlot et al., 2009).  
 
Once a stress is sensed, the σB will interact with core RNA polymerase and initiate the 
transcriptions of σB regulons. σB regulons then produce protective protein for the cells. 
Here is an overview of this process (van Schaik and Abee, 2005) (Figure 1.3): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. The pathway leading to the activation of σB. Adapted from (van Schaik and Abee, 2005). 
 
 
The σB operons of S. epidermidis and S. aureus are homologous to the four genes of B. 
subtilis, rsbU, rsbV, rsbW and sigB (Figure 1.4). RsbU and RsbV are positive σB factors 
and RsbW is a negative factor in both Staphylococcus species (Knobloch et al., 2004), 
similar to that of B. subtilis.  
29 
 
 
 
 
 
 
 
 
Figure 1.4. σB operon structures in S. aureus and S. epidermidis. Adapted from (Kazmierczak et al., 2005). 
 
Based on the knowledge of B. sutilis, RsbV is normally inactivated by RsbW 
phosphorylation, in the form of RsbV-P, and leaving the latter complex with σB, thus σB is 
unable to bind to RNA polymerase core enzyme to initiate transcription. Whenever stress 
is signalled, the positive σB factor, RsbU, becomes activated and specifically 
dephosphorylates RsbV-P, and complexes with RsbW, therefore releasing σB, then 
leaving the latter free to interact with RNA polymerase.   
 
Conflicting results were obtained on the role of σB in biofilm formation in S. aureus. Data 
from three S. aureus strains using full-genome microarray revealed that a number of cell 
adhesion genes have been recognized being up-regulated by σB, and increasing biofilm 
formation in these strains (Rachid et al., 2000). However, (Valle et al., 2003) observed no 
differences in PNAG production and biofilm formation between a σB mutant and its 
isogenic wild-type strain.   
 
In S. aureus, although the mechanism of σB operon activation remains unclear, RsbU is 
essential in these serial reactions, however, the mechanism is different from that of the 
homologous RsbU in B. subtilis. Studies on S. aureus mutants of rsbU and rsbV revealed 
Val e et al. (2003) 
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that an unidentified factor may exist regulating RsbV expression, and this is independent 
of RsbU (Senn et al., 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. A model for the regulation of σB in S. aureus. Adapted from (Senn et al., 2005). 
 
 
Studies in S. epidermidis suggested that σB primarily functions through its influence on 
biofilm formation in this species. They suggest that the effect of σB on ica expression 
could be indirect, as the ica promoter does not appear to contain a consensus σB binding 
site. Conlon et al. (2002) demonstrated that stress induction of σB in S. epidermidis 
increased biofilm formation and synthesis of PIA by alleviation of IcaR-repression, and 
therefore increased icaADBC operon expression by stimuli such as ethanol but not in 
response to others (e.g. NaCl).  These findings may suggest that σB plays a more 
important role in biofilm regulation in S. epidermidis than in S. aureus.                 
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1.6.2.2 Structure and biofilm regulation of sarA locus in Staphylococcus species. 
(Bayer et al., 1996) described a global regulator, SarA, which controls numerous 
expressions of other virulence determinants in S. aureus, such as a-hemlysin, protein A, 
and fibronectin-binding proteins.  The functional sar locus in S. aureus was shown to be a 
1.2 Kb fragment, containing three overlapping transcripts designated sarA (0.58 kb), sarC 
(0.84 kb), and sarB (1.15 kb). These transcripts originated from three distinct promoters 
(P2, P3 and P1), have common 3’ ends, and all encode the major 372-bp sarA open 
reading frame (Figure 1.6). SarA up- or down- regulates its target genes by binding its 
consensus SarA recognition motif to the target promoter regions.  
 
 
 
 
 
 
 
 
Figure 1.6. The map of the sar region in S. aureus. P1, P2, and P3 represent promoters. The arrows 
represent the sar transcripts. The distances between the 5’ ends of the transcripts and the start codon of sarA 
are expressed by negative position numbers (Cheung et al., 2008) 
 
 
SarA has been shown to be crucial for biofilm formation in Staphylococcus spp. As shown 
by (Beenken et al., 2004), in S. aureus, the SarA protein binds specifically to the bap 
promoter region and regulates the expression of the bap gene, which encodes Bap, 
involved in biofilm formation.  sarA mutants diminished the capability of Bap-dependent 
biofilm formation.  In S. epidermidis, SarA has been shown by electrophoretic mobility 
shift assays to directly up-regulate the transcription of the ica locus by specifically binding 
to the icaA promoter region (Tormo et al., 2005).  
Bayer et al. ( ) 
Beenken et al. (2004), 
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A recent study by (Weiss et al., 2009) showed a sarA mutation led to a significant 
increase in antibiotic susceptibility in S. aureus in the specific context of biofilm formation. 
This suggests inhibitors of sarA could have the capacity to enhance the efficacy of 
antimicrobial therapy of a S. aueus biofilm-associated infection. This finding 
demonstrated the importance of SarA-regulated biofilm formation in staphylococci in 
another way. 
        
1.6.2.3 Quorum signals 
Among bacterial global regulatory systems, cell-cell communication or quorum-sensing 
(QS) systems have gained broad attention in the scientific community.  
 
agr QS system 
Staphylococci have one well-characterized QS system called agr for accessory gene 
regulator (Figure 1.7) which controls the expression of virulence and other accessory 
genes by a classical two-component signalling module. Like QS modalities in other Gram-
positive bacteria, agr encodes an autoactivating peptide (AIP), the inducing ligand for 
AgrC, and the agr signal receptor. Unlike other such systems, agr variants have shown 
strong cross-inhibition in heterologous combinations with important evolutionary 
implications. Also, unlike other systems, the effector of global gene regulation in the agr 
system is a major regulatory RNA, RNAIII.   
 
i. Structure of agr system 
As in other gram-positive bacteria, the agr system structure contains two divergently 
transcribed units, RNAII and RNAIII, the transcription of which is driven by the P2 and P3 
promoters, respectively (Bischoff et al., 2001). The RNAII contains four genes, agrB, 
eiss et al. (2009) 
33 
 
agrD, agrC, and agrA. AgrA and C constitute a classic two-component signalling module 
(TCS), and the AgrB and D combine to generate the activating ligand AIP. The AIP is an 
autoinducing peptide of ~8 amino acids in length, which is encoded within the agrD gene. 
The staphylococcal AIP binds to a transmembrane protein, AgrC, which acts as the 
sensor kinase of the bacterial two-component regulatory system. Upon binding to the AIP, 
AgrC activates the response regulator, AgrA, which in turn induces the transcription of 
RNAII and RNAIII. AgrA is a DNA-binding protein that recognizes a pair of direct repeats 
with a consensus sequence 5 ‘ -ACAGT-TAAG-3 ‘ separated by a 12-bp spacer region. It 
is generally believed that RNAIII is the effector molecule of the accessory gene 
regulation. 
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Figure 1.7. the staphylococcal agr quorum-sensing system. The extracellular signal of the agr quorum-
sensing system is a posttranslationally modified peptide autoinducer, which contains a thiolactone or, in one 
case, a lactone ring structure. The membranelocated enzyme AgrB is responsible for the maturation and 
export of the autoinducing peptide. AgrA and AgrC form a twocomponent signal transduction system, which in 
an auto-regulatory fashion, after binding of the autoinducer to AgrC, is responsible for a rapid increase of agr 
activity at the onset of stationary growth phase. Target genes are controlled by a regulatory RNA molecule, 
RNAIII, in a yet unknown way. The RNAIII region contains a gene (hld) coding for the peptide delta-toxin 
(PSMg), the expression of which does not affect the quorum-sensing mechanism. Adapted from (Kong et al., 
2006a). 
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ii. The role of agr system in staphylococcal biofilm formation 
The QS system plays an important role in staphylococcal biofilm formation (Novick and 
Geisinger, 2008), and mediates biofilm formation at different stages. The agr system 
facilitates the initial attachment of staphylococci to a polystyrene surface, due to the up-
regulation of attachment and down-regulation of detachment molecules. The surface-
attached AtlE protein, a member of the staphylococcal autolysin family, is overexpressed 
in an agr mutant of S. epidermidis. In contrast, the homologous Atl protein in S. aureus is 
not under agr control, showing that the agr regulons of the two species comprise different 
genes. However, the production of PIA is not regulated by the agr system in either 
species (Vuong et al., 2000) 
 
luxS QS system in staphylococcal biofilm formation  
Apart from agr system, the luxS QS system has been identified in a variety of Gram-
negative and Gram-positive bacteria. In S. epidermidis, luxS appears to function in a way 
similar to agr system in biofilm formation. The luxS mutant strain formed a thicker and 
more compact biofilm than its isogenic wild-type strain and was a more successful 
colonizer in an animal model of central venous catheter infection. However, different from 
the effects of agr, luxS affects biofilm formation by down-regulation of the ica gene locus 
and thus, by reducing production of PIA (Xu et al., 2006a). 
 
In sum, QS systems have manifested numerous impacts on staphylococcal virulence, by 
regulating the expression of a number of toxin and other virulence factors in pathogenic 
staphylococci. Also, QS has shown to enhance biofilm detachment in staphylococci. In S. 
epidermidis, both the luxS and agr QS systems have shown a similar mode of regulation 
of biofilm formation. luxS represses biofilm by down-regulating PIA synthesis (Xu et al., 
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2006a), and agr by up-regulation of  a detergent-like substances. It was shown that QS 
systems control different regulons in S. epidermidis and S. aureus. It is crucial to analyse 
the entire regulons of QS systems and other regulation systems, and their interaction in a 
genome-wide manner. This will facilitate the finding of new therapeutic strategies for 
staphylococcal infections. 
 
1.6.2.4 Other regulatory loci that regulate biofilm formation in staphylococci 
Apart from the regulation systems mentioned above, several other regulatory loci have 
been summarized in Table 1.5. 
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Table 1.5. Other regulatory loci in staphylococci 
Regulator Mechanism Reference 
icaR 
icaR encodes a transcriptional repressor, down-regulates ica 
operon expression related to environmental factors in S. 
epidermidis. 
(Conlon et al., 
2002) 
tcaR TcaR bound to the ica promoter region, appeared to be a weak negative regulator of transcription of the ica locus. 
(Chang et al., 
2010) 
codY CodY represses icaA expression in exponential phase, the regulation is independent IcaR. 
(Majerczyk et al., 
2008) 
spx Spx is a repressor of polysaccharide intercellular adhesion in S. aureus by modulating the expression of icaR gene. 
(Pamp  et al., 
2006) 
rbf 
Rbf belongs to the AraC/Xyls family regulators. It is not 
known which gene  involved in biofilm formation are 
regulated by Rbf. 
(Luong et al., 
2009) 
mgrA Mgr represses biofilm formation by partially regulating agr system RNAIII. 
(Trotonda et al., 
2008) 
LytSR  
regulatory 
system 
LytSR two-component system down-regulates the formation 
of matrix-associated eDNA in the biofilm in S. aureus. (Sharma-Kuinkel et al., 2009) 
clp proteases 
Biofilm formation was reduced in the absence of ClpX or 
ClpC whereas it was enhanced in the absence of ClpP with 
unknown mechanisms in S.aureus. 
(Frees et al., 
2004) 
 
 
1.7 Anti-biofilm strategies  
Biofilm formation on medical devices contributes significantly to the difficulties 
encountered in treatment. Once established, device-related infections are almost 
impossible to eradicate. Numerous strategies have been developed to decrease the 
incidence of medical device related infection. 
 
1.7.1 Development of new devices 
Due to the complex mechanisms underlying specific adhesion, most approaches 
developed recently are focused on surface modifications of medical devices, where it is 
hoped to reduce the incidence of microbial adherence. The main targets are physical-
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chemical modification of device surfaces and anti-infective agents coating the surface of 
biomaterial. However, the success is modest due to the diverse ways of bacterial 
colonization. It was found that the reduction of bacterial adherence by chemical and 
physical modification is species specific. The effect of coating with anti-infective agents is 
limited only to the initial batch of incoming bacteria; the bactericidal efficacy tends to be 
weak once dead cell layers form (Costa et al., 2011).   
 
Recently, biosurfactants turned out to be a promising approach preventing microbial 
adherence on medical devices because of both their surface modification properties and 
antimicrobial activity. The use of biosurfactants has been evaluated by numerous 
researchers. Biosurfactants produced by lactic acid bacteria have been shown to exert 
anti-adhesive ability against 76.8% of S. aureus and 72.9% of S. epidermidis (Gudiña et 
al., 2010). However, insufficient data on toxicity to humans and the cost of large scale 
production are the constraints for using biosurfactants. 
 
1.7.2 Targeting staphylococcal biofilm factors 
Studies have also been involved in targeting the biosynthesis of factors related to 
staphylococcal biofilm formation. (Burton et al., 2006) found that the GlmU inhibitors 
possessed a universal property of prevention of biofilm formation on medical devices in a 
range of pathogens. Additionally, dispersin B is an enzyme with anti-adhesive property, 
was initially found in Actinobacillus actinomycetemcomitans was evaluated by (Kaplan, 
2010). Lysostaphin has been used for detachment of mature biofilm structures and killing 
of the released bacteria (Wu et al., 2003). Moreover, biofilm components of S. 
epidermidis including PIA, cell wall proteins and adhesins have been used as the targets 
Burton et al. ( ) 
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for vaccine development against biofilm infections. However, the results obtained so far 
are controversial due to the versatility of this organism. 
 
In sum, there is no guaranteed solution to increase the anti-biofilm properties of medical 
device, although the use of biosurfactants seems to be a promising method.  The 
structure-function relationships as well as binding ability to the device surfaces are still 
challenges for the future research.     
 
1.7.3 Vaccination 
Whether immunoprophylaxis is a promising strategy for the prevention of staphylococcal 
device-related infections is controversial. Surface-expressed components of S. 
epidermidis, including PIA, techoic acids, proteinaceous adhesins and CWA proteins, 
have been identified as promising targets for vaccine development and 
immunomodulation (Götz, 2004). As multiple determinants are involved in the 
establishment of S. epidermidis biofilm formation, given the extraordinary versatility 
exhibited by this microorganism, further investigations, both pre-clinical and clinical, are 
warranted before an optimal approach is achieved. 
 
1.8 Conclusions 
A large amount of recent research has illustrated the key structural and regulatory factors 
mediating Staphylococcus spp. biofilms. PIA is the best characterized and most crucial 
determinant of staphylococcal biofilm infection by far; although a range of other factors 
have been identified.  Additionally, animal models mimic the reality of in vivo environment 
and provide a better understanding of the detailed roles of particular components in a 
biofilm infection. Finally, genome wide approaches facilitate our understanding of biofilm 
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physiology in greater details and constitute the molecular basis for the development of 
anti-staphylococal drugs and vaccines. 
 
1.9 Objectives of the current project 
Staphylococcus capitis has received increasing concern due to its heteroresistance to 
vancomycin (Van Der Zwet et al., 2002), has been implicated in infections associated with 
biofilm such as catheter-related bacteraemia, endocarditis, necrotizing enterocolitis in 
neonates and others (Nalmas et al., 2008). This species can be further divided into two 
subspecies subsp. urealyticus and subsp. capitis. The two subspecies are distinct 
primarily by five properties: the urease activities, abilities to produce acid from maltose in 
anaerobic conditions, fatty acid profiles, colony sizes, and their DNA sequences 
differentiation (BANNERMAN and KLOOS, 1991). S. capitis can bind to a variety of 
human matrix proteins, including laminin, collagen and fibrinogen. The first collagen-
binding Sdr protein was identified in S. capitis. SdrX, a member of the Sdr family of 
MSCRAMM proteins, has the typical features of other staphylococcal surface-associated 
proteins, i.e. the serine-aspartate repeat regions and the LPXTG amino acids motif (Liu et 
al., 2004) 
 
In contrast to S. epidermidis, the molecular basis of the virulence of S. capitis in general 
and in the context of foreign material-associated infections is largely unknown. The 
presence of an ica operon in S. capitis has been reported, but to date its contribution to 
biofilm formation is unclear. S. capitis displays biofilm-forming capacity under 
experimental conditions only in media with high osmolarity. Quantitative biofilm 
production is linearly induced by sodium chloride (Møretrø et al., 2003). This suggests 
biofilm formation in S. capits is subject to the regulation by certain environmental factors. 
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Biofilm formation is considered the most important virulence factor in CoNS foreign 
material-associated infections. The study of biofilm characterization in clinical S. capitis 
isolates of both subspecies, its relation to the antibiotic resistance and also the regulation 
of biofilm formation under realistic clinical conditions may facilitate improvement in the 
therapy efficacy and a better control of hospital infections of this species. The topics 
examined to achieve the aims of this thesis were: 
(i) examine the molecular epidemiology, antibiotic resistance and biofilm capacity of 
clinical isolates of S. capitis in a neonatal intensive care unit, 
(ii) determine the prevalence of the ica operon in these clinical isolates by PCR,  
(iii) compare the ica operons of biofilm-positive and biofilm-negative isolates by PCR-
RLFP and sequencing, 
(iv) use bioinformatics tools to analyse the function of the Ica proteins of S. capitis, 
(v) examine the role of the ica operon in biofilm production by S. capitis by gene 
knock-out, 
(vi) examine the effect of sub-inhibitory concentrations of erythromycin of expression 
of the ica gene. 
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CHAPTER 2 
 
General Materials and Methods 
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2.1 Clinical Staphylococcus capitis isolates   
A total of 60 clinical isolates consisting of 52 of subspecies urealyticus and eight of capitis 
were used in this thesis. These isolates were labelled as where they were collected from 
the Neonate Intensive Care Unit (NICU), Royal Children Hospital (RCH), Melbourne, 
Australia. All isolates had been previously assured as clinically significant, causes of 
bloodstream infection in babies.  
 
The isolates were cultured on Tryptone Soya Agar or Nutrient Agar plates (Oxoid, 
Australia) for 24-48 hours at 37 °C. For long term storage, bacterial cultures were mixed 
with 15% glycerol in a cryotube and frozen at -80 °C.  
 
2.2 General Materials  
Table 2.1 General kits 
Reagents and kits Supplier 
QIAEX® II Gel Extraction Kit QIAGEN Pty Ltd - Australia 
QIAquick® Gel Extraction Kit QIAGEN Pty Ltd - Australia 
QIAprep® Spin Miniprep Kit QIAGEN Pty Ltd - Australia 
RNeasy® Mini Kit QIAGEN Pty Ltd - Australia 
RNeasy® Protect Bacteria Mini Kit QIAGEN Pty Ltd - Australia 
Taq DNA Polymerase QIAGEN Pty Ltd - Australia 
TURBO DNA-free™ Applied Biosystems, Australia 
Wizard® PCR Preps DNA Purification System Promega, Australia 
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Table 2.2 General chemicals, media and solutions 
Chemicals, media and solutions Supplier 
Acetic Acid Glacial Merck Pty Limited, Australia 
Agar Bacteriological (NO.1) Oxoid, Australia 
Agarose (Electrophoresis) Bioline (Aust) Pty Ltd 
Ampicillin Sigma-Aldrich, Australia 
Ammonium Oxalate Sigma-Aldrich, Australia 
Bigdye Premix (V3.1) for DNA Sequencing Monash University, Australia 
Brain Heart Infusion Broth Oxoid, Australia 
Cetyl Trimethyl Amnomium Bromide (CTAB) Sigma-Aldrich, Australia 
Crystal Violet Sigma-Aldrich, Australia 
Deoxynucleotide Triphosphate Mix (dNTP),  Bioline (Aust) Pty Ltd 
Diethyl pyrocarbonate (DEPC) Sigma-Aldrich, Australia 
Electroporation Cuvette Molecular Bioproducts, U.S. 
Ethanol Absolute GR for Analysis Sigma-Aldrich, Australia 
Ethidium Bromide Sigma-Aldrich, Australia 
Ethylenediaminetetra acetic acid (EDTA)  Sigma-Aldrich, Australia 
Formaldehyde 37% (12.3 M) Sigma-Aldrich, Australia 
Formamide Sigma-Aldrich, Australia 
Glycerol Sigma-Aldrich, Australia 
Isopropyl Alcohol Sigma-Aldrich, Australia 
Kanamycin Sigma-Aldrich, Australia 
Lambda DNA Promega Corporation, Sydney, Australia 
Lysostaphin from Staphylococcus staphyloliticus Sigma-Aldrich, Australia 
MassRulerTM Low Range DNA Ladder, 1Kb Thermo Fisher Scientific, Australia 
6 x MassRulerTM DNA Loading Dye Thermo Fisher Scientific, Australia 
β-mercaptoethanol Sigma-Aldrich, Australia 
3-[N-morpholino]propanesulfonic acid (MOPS) Sigma-Aldrich, Australia 
Nuclease Free Water QIAGEN Pty Ltd - Australia 
Phenol-Chloroform for DNA Isolation  Sigma-Aldrich, Australia 
Phosphate Buffered Saline (PBS) Sigma-Aldrich, Australia 
Proteinase K Sigma-Aldrich, Australia 
Restriction Enzymes New England Biolabs and Promega, Australia 
RNAse A, DNAse Free Promega Corporation, Sydney, Australia 
Sodium acetate Sigma-Aldrich, Australia 
Sodium Chloride Astral Scientific, Australia 
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Sodium Dodecyl Sulfate (SDS) Sigma-Aldrich, Australia 
Sodium Hydroxide Pellets Merck Pty Limited, Australia 
Sucrose Sigma-Aldrich, Australia 
T4 DNA ligase (400,000 cohesive end units/ml) New England Biolabs  
T4 ligase buffer  New England Biolabs  
Trizma Base Sigma-Aldrich, Australia 
Tryptone Oxoid, Australia 
Tryptone Soy Broth Oxoid, Australia 
Uvette Crown Scientific, Australia 
Yeast Extract Oxoid, Australia 
 
2.3 Oligonucleotides 
All the oligonucleotides used for PCR, sequencing and cloning were designed in-house 
with the software, Clone Manager 7, Version 7.11 and obtained from Sigma-Aldrich, 
Australia. The lyophilized powder was reconstituted at 100 µM in nuclease free water, 
and then diluted to 10 µM at working concentration, stored in -20 °C. 
 
2.4 General methods 
2.4.1 DNA based methods 
2.4.1.1 Chromosomal DNA isolation from clinical Staphylococcus capitis isolates 
The S. capitis DNA extraction was carried out according to the CTAB method of (Wilson, 
1997) with modifications. Growth from a lawn culture with a bacterial strain of interest was 
taken off with a wire loop into a sterile eppendorf tube. The bacterial cells were washed 
with PBS solution once, centrifuged at 13,200 rpm for 2 mins, the supernatant was 
removed, and the cells were resuspended in 555 µL TE buffer (10 mM Tris-HCl, 1mM 
EDTA, pH 8.0) thoroughly. Lysostaphin and lysozyme were added at final concentrations 
300 µg/mL, and the suspension was incubated at 37 °C for 30 mins to lyse the cell wall. 
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After incubation, 30 µL of 10% SDS and 3 µL of 20 mg/mL proteinase K were added to 
give 100 µg/mL proteinase K in 0.5% SDS in the final mixture. After thoroughly mixing, 
the mixture was incubated 1 hour at 37 °C for cell protein removal. Then 100µL of 5 M 
NaCl was added, mixed thoroughly for subsequent CTAB-nucleic acid precipitation. 
Eighty microliters of CTAB/NaCl solution which contains 0.7 M NaCl, 10% CTAB were 
added. To prepare, 0.7 M NaCl was preheated to 55-65 °C; CTAB was slowly added to 
dissolve, then the solution was autoclaved, and incubated 10 mins at 65 °C. An equal 
volume of phenol : chloroform : isoamyl alcohol (25 : 24 : 1) was added to 600 µL of the 
mixture, mixed thoroughly, and centrifuged at 13, 200 rpm for 5 mins. Five hundred 
microliters of the top (aqueous) layer was collected and 0.6 volume isopropanol was 
added. The mixture was inverted a few times and then incubated at room temperature for 
10 mins to precipitate the nucleic acids. The precipitated DNA was collected by 
centrifuging the mixture at 13, 200 rpm for 5 mins. The DNA pellet was washed with 70% 
ethanol twice and left to air dry for 30 mins. The dried DNA pellet was suspended in an 
appropriate volume of nuclease free water and stored at -80 °C. 
 
2.4.1.2 Plasmid isolation from E. coli recombinant strains 
The difference in topology of plasmid DNA and chromosome DNA is the basic 
mechanism used for selective precipitation of plasmid DNA from chromosomal DNA and 
proteins. Minipreps were used to extract plasmid from transformed E. coli strains 
according to the method in QIAprep® Miniprep Kit. The procedure is based on alkaline 
lysis of bacterial cells followed by adsorption of DNA onto silica in the presence of high 
salt concentrations. Three basic steps are involved: a). Preparation of bacterial lysates, 
b). Adsorption of DNA on the membrane, then c). Elution of plasmid DNA.  Cell lysis is a 
critical step. Cells were partially lysed using the alkaline solution in the kit; this allows 
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small MW plasmid DNA escape from the broken cell wall, while large MW genomic DNA 
remains within the cells, therefore, this step was carried out within just enough time in 
case the cell wall was completely lysed resulting in genomic DNA contamination. In 
addition, the operation should be gentle throughout the procedure, otherwise sheared 
genomic DNA may be released.  
 
Generally, a single colony was first picked from a fresh plate and inoculated in 5-10 mL 
Luria-Bertani (LB) or nutrient broth containing an appropriate selective antibiotic in a 50-
mL falcon tube, and incubated 16 hours at 37 °C, shaking at 170 rpm. The cells were 
harvested by centrifuging 15 mins at 4700 rpm, 4 °C.  The cells were resuspended with 
250 µL of cell suspension buffer from the kit, and mixed thoroughly to ensure no cell 
clumps were visible. The 250 µL of cell lysis buffer was added and mixed by inverting the 
mixture six times and the suspension was incubated at room temperature for no more 
than 5 mins. The cell lysis was stopped by adding 350 µL of neutralization buffer and 
mixed by inverting the tube six times. The cell lysate was then centrifuged at 13, 200 rpm 
for 10 mins at room temperature. The supernatant was applied on a QIAprep spin 
column, and then centrifuged at full speed for 1 min. The plasmid DNA was absorbed on 
the membrane. After washing with alcohol buffer, the DNA was eluted and stored in -20 
°C. 
 
2.4.1.3 Measurement of DNA concentration 
The concentration of the extracted genomic DNA and plasmid DNA was determined 
spectrophotometricly using BioPhotometer (Eppendorf AG, Hamburg, Germany). This 
was carried out by quantifying diluted samples at OD 260 nm. An absorbance of 1.0 
corresponds to 50 µg/mL of double stranded DNA. The concentration of DNA can be 
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determined by the following formula: Concentration of DNA = OD 260 X 50 µg/mL X 
Dilution factor. The ratio A260/A280 provides the purity of DNA; pure preparations of DNA 
samples have ratios 1.80-2.0. The ratio A260/ A230 provides the salt concentration in the 
sample; low salt samples have ratios between 2.2 and 2.5.  
 
2.4.1.4 General PCR amplifications 
Polymerase chain reaction (PCR) amplification of DNA templates was performed 
according to their relevant applications in the chapters of this thesis. 
 
PCRs were performed using Taq DNA polymerase from QIAGEN. Generally, PCR master 
mixes were prepared containing 1x PCR buffer, 200-250 µM dNTPs, 0.2-0.4 µM of each 
forward and reverse primer, 2.5 U Taq DNA polymerase and 10-100 ng DNA. PCR 
reactions were performed on a PCR Express thermal cycler at one cycle at 94-95 °C for 5 
mins, followed by 25-35 cycles of 94-95 °C, 30 sec; 45-62 °C, 30 sec; 72 °C for 30 sec-3 
mins, final elongation 7 mins at 72 °C for 1 cycle and hold at 4 °C. 
 
2.4.1.5 Restriction digestion 
Restriction enzymes have their unique DNA reorganization sequences, cleave DNA at 
specific sites. The restriction digestion was performed by incubation of DNA with the 
enzymes in a buffer which is appropriate for its optimal performance. To set up a 
restriction digest with two enzymes, one common buffer was used. The amount of 
enzyme required and procedure varies depending on DNA samples subjected to 
digestion. An analytical restriction digestion was usually performed in a volume of 20 µL 
with 0.2-1.5 µg of substrate DNA and two- to ten-fold excess of enzyme. In a sterile tube 
the components were assembled as follows: nuclease free water 16.3 µL, restriction 
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enzyme 10X buffer 2.0 µL, Bovine serum albumin (BSA) 10 µg/mL 0.2 µL and DNA 1 
µg/µL1.0 µL, then added restriction enzyme 10 U/µL 0.5 µL, mixed gently by pipetting, 
centrifuged for a few seconds, incubated at the enzyme’s optimal temperature for 2-4 
hours. 
 
2.4.1.6 Electrophoresis 
All PCR and restriction digestion products were detected on 1-2% agarose according to 
Sambrook et al. (1989) where the products were electrophoresed at constant voltage in 
1X TAE running buffer (0.4 M Tris-acetate, 0.01 M EDTA; adjusted pH 8.0 with glacial 
acetic acid). The gel was stained with 0.5 µg/mL of ethidium bromide for 5-10 mins and 
photographed using Gel Doc of Quantity One (Bio-rad Laboratories Pty. Ltd., Australia) 
under UV light. 
 
2.4.1.7 Extraction and purification of DNA from agarose gel 
The QIAQuick Gel Extraction Kit was used for purification of the DNA fragments obtained 
from the agarose gel. QIAquick Kit contains a silica membrane assembly for binding of 
DNA in high-salt buffer and elution with low-salt buffer or water. The purification 
procedure removes primers, nucleotides, enzymes, mineral oil, salts, agarose, and other 
impurities from the DNA samples. 
  
After restriction analysis or after running the PCR product in the agarose gel, the band of 
expected size was excised from the agarose gel with a clean scalpel and then the 
protocol given by manufacturers was followed. After purification, approximate 
concentration of DNA was checked on a 1% agarose gel. 
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2.4.1.8 Cloning techniques 
2.4.1.8.1 Setting up Luria-Bertani (LB) medium and plates 
LB medium (pH 7.0) contains 10 g tryptone, 5 g yeast extract and 10 g NaCl per litre of 
deionized water. After preparation of the medium it was autoclaved at 121 °C, 21 mins. 
The solution was allowed to cool to 55°C and antibiotic was added if needed. LB agar 
plates were prepared by adding 15 g/L agar into the above medium before autoclaving. 
After autoclaving, the medium was cooled to ~55°C, antibiotic was added, and the 
medium was poured into a plate, let to harden then stored at 4 °C in dark. 
 
2.4.1.8.2 Competent Escherichia coli strains 
One Shot® TOP10 Electrocomp™ E. coli and DH5α from Invitrogen Australia Pty Limited 
were applied for plasmid transformation in this study. There follows a brief description 
about these cells and their genotypes. 
One Shot® TOP10 Electrocomp™ E. coli cells, genotype is: F
- 
mcrA Δ(mrr-hsdRMS-
mcrBC) φ80lacZΔM15 ΔlacΧ74 recA1 araD139 Δ(ara-leu) 7697 galU galK rpsL (StrR) 
endA1 nupG λ-  
 
These cells do not require IPTG to induce expression from the lac promoter. The 
genotype of these cells is:  
E. coli DH5α, genotype is: F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK- mK+), λ- 
 
This is a suitable strain for plasmid maintenance and growth, and was used to make 
competent cells for plasmid transformation in this study.  
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2.4.1.8.3 Preparation of electroporation competent cell with E. coli DH5α 
The preparation of E. coli DH5α electro-competent cells was carried out according to 
Hanahan (1983). Briefly, 5-10 mL of autoclaved LB broth (1% w/v Tryptone, 0.5% w/v 
Yeast extract, 0.5% w/v NaCl, pH 7.0) was inoculated with 3-4 fresh host E. coli DH5α 
colonies, and incubated overnight at 37 °C on a shaker. The overnight culture was diluted 
1 : 100 into 200 mL fresh LB broth. The cells were grown with shaking at 37 °C, 
harvested by centrifugation at 4700 rpm for 15 mins, then transferred to 4 °C when the 
OD600nm value reached 0.3-0.4. Then the cells were chilled on ice for 30-45 mins to stop 
the cell growth. The cells were washed twice with 200 mL then 100 mL ice-cold sterile 
deionized water, respectively. A subsequent wash was performed in 4 mL of ice-cold 10% 
v/v glycerol. The cell pellet was resuspended in an 800 µL ice-cold 10% v/v glycerol. The 
cell concentration should be about 1-3 X 1010 cells/mL. Finally, 60 µL aliquots of cells 
were immediately transferred for storage to a -80 °C freezer. 
   
 2.4.1.8.4 Ligation of insert into a vector 
The plasmid vector and insert DNA were pre-digested respectively with the same enzyme 
to produce compatible cohesive ends for efficient ligation. Generally, a 50-100 µL 
digestion reaction was set up. An excess of restriction enzyme and 16 hours incubation 
were used to cut the DNA fragments. After digestion, the cut vector and insert were run 
on the same crystal violet gel. To prepare the gel, the agarose gel solution was 
microwaved, allowed to cool to 65 °C, then 40 µL crystal violet solution (2 mg/mL) was 
added per 50 mL gel. After running, the DNA bands should be visible directly from the 
gel, there is no need to visualize the bands under UV light, this is critical to protect the 
ends of DNA fragments. Then the cut vector and insert were purified by QIAquick Gel 
Extraction Kit. After this, the same volume of the purified vector and insert were run on 
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one gel again to determine the ratio of vector and insert used in the subsequent ligation 
reaction. The amount of DNA was estimated by the brightness of the bands, compared 
with ladder DNA. Ratios of vector to insert from 1 : 1 to 1 : 12 have been successfully 
used. Usually, a 20 µL volume of ligation reaction was set up as follows:  
                        Table 2.3. Ligation reaction 
Components Volume 
Vector DNA 1 µL (~25 ng) 
Insert DNA 4-12 µL (add 1 µL for positive control) 
10 X Ligation Buffer 2 µL 
Sterile dH2O X µL 
T4 DNA Ligase 1 µL 
 
The ligation mixture was incubated at 14 °C for 16 hours, then heated at 65 °C for 10 
mins to inactive the enzyme, the ligation product was purified with QIAEX II Kit according 
to the manufacturer’s instruction, and resuspended with 16-20 µL dH2O.  
 
2.4.1.8.5 Electroporation 
Two to five microliters of the above ligation product were used in the electroporation. The 
electro-competent cells were thawed on ice, and after mixing with DNA, 50-100 µL of the 
cells were transferred to a 2-mm gap electroporation cuvette and electrotransformed with 
Bio-Rad MicroPulser (Bio-Rad Laboratories, Australia), using a voltage of 2.5 kV, Ω 200 
and capacitance 25 µFD. The complete electroporation procedure was performed at 4 °C, 
immediately after electroporation, 1 mL of fresh LB broth was added to the cuvette, and 
the cells were transferred to a 14-mL tube and incubated at 37 °C at 100 rpm for 1 hour 
for bacterial recovery and induction of antibiotic resistance. Finally, the cells were diluted 
1/100 and 1/200 in LB medium, spread on LB agar with appropriate antibiotics, and 
incubated at 37 °C for 24-48 hours. 
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Calculation of transformation efficiency: 
(Number of colonies on plate/ng of DNA plated)×1000 ng/µg. 
 
2.4.1.8.6 Screening of recombinants 
Ten colonies were selected for PCR screening. A 200-µL tip was gently touched on a 
small portion of each colony, the cells of each colony were suspended in 200-500 µL 
sterile dH2O, mixed thoroughly by vertexing, then 1 µL of each of these cell suspensions 
was used in PCR reactions.  
 
Each 25 µL PCR mixture contained:  
                                  Table 2.4. PCR reaction 
PCR Component Final Concentration 
dH2O X µL 
10 X PCR Buffer 1 X PCR buffer 
dNTP 200-250 µM 
Primer F 0.4 µM 
Primer R 0.4 µM 
Taq DNA Polymerase 2.5 U 
DNA Template 1 µL 
Total 25 µL 
 
 
The following PCR program was used: 1 cycle for 94 °C, 10 mins. 30-35 cycles for 94 °C 
30 s; 50-60 °C 30 s; 72 °C 30 s-1 min, final extension at 72 °C for 5 min. Then check the 
PCR products were examined on a 1.0-1.5% agarose.  
 
Minipreps of recombinant plasmid were carried out by using QIAprep Spin Mini Kit.  This 
was performed according to the description in section 2.5.1.2. Then the isolated plasmid 
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was digested with specific restriction enzymes and run on a gel to examine whether the 
expected sizes of vector and insert were obtained. And then DNA sequencing was 
performed for the final confirmation. DNA sequencing was conducted as follows:  
 
                                     Table 2.5. DNA sequencing reaction 
Reagent Quantity 
BigDye Premix (3.1) 1 µL 
Reaction Buffer (5 X) 3.5 µL 
Plasmid DNA  300 ng 
Primer 3-5 µmoles 
Water X µL 
Total  20 µL 
 
Cycle sequencing: 96 °C for 1 min. 30 cycles: 96 °C for 10 s; 50 °C for 5 s; 60 °C for 4 
mins. 
 
After running the program, ethanol/NaOAc precipitation was performed to clean up the 
sequencing products as follows: For each sequencing reaction, 2.0 µL of sterile 3 M 
sodium acetate (pH 5.2) and 50 µL of absolute ethanol were added, mixed thoroughly by 
pipetting and vortexed and left at room temperature for 10 mins to precipate the extension 
products. The tubes were centrifuged for 20 mins at 13, 200 rpm, then the supernatant 
was carefully removed and the pellet was washed twice with 250 µL of 70% ethanol. 
Finally the pellet was air dried for 25 mins at room temperature. The products were then 
sequenced by 3730 Capillary Sequencer of Micromon DNA Sequencing, Monash 
University, Australia.  
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2.4.1.8.7 Glycerol stock of transformants 
For long term storage of positive transformants, bacterial cultures were mixed with 15% 
sterile glycerol and appropriate antibiotics in cryotubes, and frozen down at -80 °C. 
 
2.4.2 RNA based methods 
2.4.2.1 RNA isolation from clinical Staphylococcus capitis isolates 
Total RNA from S. capitis isolates was extracted by using glass beads to break the cell 
wall, following the protocol of the RNeasy Mini Kit in combination with RNAprotect 
Bacteria Reagent with slightly modifications. The latter provides in vivo stabilization of 
RNA in bacteria to ensure reliable gene expression analysis. Prepared RNA was used for 
transcriptional analysis. 
 
First, the bacterial cell pellet preparation was carried out using RNAprotect Bacteria 
Reagent. Bacteria were initially grown in Tryptone Soy Broth (TSB) medium, however, the 
cell pellets formed were too sticky to be resuspended thoroughly. Brain Heart Infusion 
(BHI) broth was then used for bacterial growth. All cell pellets were prepared from fresh 
cultures. The cells were harvested in mid-logarithmic growth throughout the study. Five 
millilitres of cell suspension was centrifuged at 5000 g, 4 °C, 10 mins, the supernatant 
was removed, and the cells were resuspended in 1 mL BHI broth. Two millilitres of 
RNAprotect Bacteria Reagent was added to a 15-mL falcon tube. The mixture was 
vortexed for 5 s, incubated at room temperature for 5 mins, then centrifuged for 10 mins 
at 5,000 g, 4 °C. The supernatant was decanted and the pellet was stored at -20 ºC. For 
the RNA isolation, the prepared bacterial pellets were thawed at room temperature. One 
millilter of RLT buffer containing β-mercaptoethanol was added to resuspend the cell 
pellet, and the suspension was transferred into an RNase-free, 2-mL tube containing 0.5 
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mL glass beads. This was followed by beating for 10 mins at 4 °C with Mini Beadbeater 
(DainTree Scientific PTY, Australia). The samples were placed on ice for cooling if 
necessary. Then they were centrifuged for 10 s at 13, 200 rpm, and the supernatant was 
transferred into a new tube. Then 1000 µL of 80% ethanol was added, mixed by pipetting 
or shaking vigorously. Subsequently the procedure described in the RNAeasy Mini Kit 
was followed. 
 
2.4.2.2 Removal of DNA contamination 
The TURBO DNA-free kit was used to remove any DNA contamination in the isolated 
RNA as follows: the sample was diluted to 10 µg/50µL nucleic acid. In a 50 µL reaction, 5 
µL of 10 X buffer and 5 U of DNase were mixed with 42.5 µL sample, and incubated at 37 
° C for 20 mins. Next 5 µL of DNase Inactivate Reagent was added, incubated at room 
temperature 2 mins, centrifuged at 10, 000 g, 1.5 mins. Finally, about 42 µL of 
supernatant was transferred into another RNase-free tube, and stored in -80 °C. 
 
2.4.2.3 Quantification and purity of RNA 
The concentration of RNA was determined by measuring the absorbance at 260 nm 
(A260) in a spectrophotometer. An absorbance of 1 unit at 260 nm corresponds to 44 µg of 
RNA per mL. The calculation of RNA quantification is shown below:  Concentration of 
RNA sample=44 µg/mL×A260×dilution factor. The ratio of the readings at 260 nm and 280 
nm (A260/A280) provides an estimate of the purity of RNA with respect to contaminants that 
are absorbed in UV spectrum. Pure RNA has an A260/A280 ratio of 1.9-2.1 in 10 mM 
Tris·HCl, pH 7.5. 
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2.4.2.4 Integrity of RNA  
The integrity and size of total RNA was finally checked by denaturing agarose gel 
electrophoresis and ethidium bromide staining. The respective ribosomal RNAs should 
appear as sharp bands on the gel. If the ribosomal bands are not sharp, but appear as a 
smear, it is likely the sample suffered major degradation. 
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CHAPTER 3 
 
Differences between two clinical 
Staphylococcus capitis subspecies revealed 
by biofilm, antibiotic resistance and PFGE 
profiling 
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3.1 Introduction 
Coagulase-negative staphylococci (CoNS) have emerged as major causes of nosocomial 
infections, and of nosocomial bacteraemia in particular. These microorganisms usually 
infect premature neonates and immunocompromised patients, particularly those 
hospitalised for chemotherapy and managed with indwelling devices such as central 
venous catheters (Pessoa-Silva et al., 2001, Chaves et al., 2005). 
 
Biofilm formation is a major mode of growth for bacteria in many natural and clinical 
environments, and is generally considered the most important virulence trait of clinical 
isolates. Research on biofilm formation in S. epidermidis started relatively early and has 
served as a model for other staphylococci, including S. aureus and other coagulase-
negative staphylococcal species. In contrast to S. epidermidis, S. capitis displays the 
biofilm-forming capacity under particular experimental conditions, for example, in media 
with high osmolarity. Quantitative biofilm production is linearly induced by sodium chloride 
(Møretrø et al., 2003). Polysaccharide intercellular adhesin (PIA) is the best studied factor 
involved in S. epidermidis biofilm formation. It consists of glycan of beta-1,6-linked 2-
acetamido-2-deoxy-D-glucopyranosyl subunits, and its synthesis has been shown to be 
essential for S. epidermidis virulence. The ica operon encodes components of PIA, and 
comprises the icaA, icaD, icaB and icaC genes, in this order, downstream from the icaA 
promoter that controls expression of the entire operon. In addition, a regulatory gene 
called icaR is located upstream, and is transcribed in the opposite direction (Begun et al., 
2007). 
 
Staphylococcus capitis has been implicated in biofilm related infections such as 
endocarditis (Nalmas et al., 2008), urinary tract infection (Kloos and Bannerman, 1994).  
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Humans are likely to be the main sources or vehicles of transmission of S. capitis (Hira et 
al., 2010). This species can be divided into two subspecies; subsp. urealyticus and 
subsp. capitis. Subsp. urealyticus can be distinguished from subsp. capitis by its urease 
activity, ability to produce acid from maltose in anaerobic conditions, fatty acid profile, 
larger colony size, and DNA sequence differentiation (BANNERMAN and KLOOS, 1991). 
 
Staphylococcus capitis has been endemic in the NICU of the Royal Women’s Hospital in 
Melbourne for several years. The aim of this study was to characterize and compare the 
two subspecies of Staphylococcus capitis isolated from newborn babies with bloodstream 
infection.  This is the first report to investigate the correlation between molecular 
epidemiology and phenotypic properties in clinical S. capitis isolates at a subspecies 
level. 
 
3.2 Materials and methods 
3.2.1 Bacterial isolates and growth conditions  
Sixty clinical S. capitis isolates from babies at the NICU, Royal Women’s Hospital, 
Melbourne were collected between 2000 and 2005. These isolates were considered to be 
clinically significant based on the isolation of the same organism from more than one 
blood culture collected within a 14-day period and/or the presence of clinical or laboratory 
findings suggestive of neonatal sepsis (Isaacs, 2003).They had been identified by the ID 
32 Staph system (bioMérieux, Marcy l’Etoile, France).  All isolates were stored in nutrient 
broth (Oxoid, Australia) with 15% glycerol at -80 °C and were recovered for the present 
study on tryptone soya agar (TSA) (Oxoid, Australia) incubated at 37 °C for 24-48 hours. 
Urease activity and maltose fermentation tests were performed to discriminate subsp. 
urealyticus and capitis (BANNERMAN and KLOOS, 1991). 
annerman and Kloos, 1991). 
annerman and Kloos, 1991). 
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3.2.2 Antibiotic susceptibility testing and screening for mecA gene  
Six antibiotics were chosen for this study based on use in the hospital. These were 
penicillin, erythromycin, clindamycin, teicoplanin, vancomycin, and oxacillin. Antibiotic 
susceptibility was determined by minimum inhibitory concentration (MIC) and inducible 
clindamycin resistance according to Clinical Laboratory Standards Institute guidelines 
(Wikler, 2006).   
 
The mecA gene was detected by PCR, using forward primer MECAP4 and reverse primer 
MECAP7 (Oliveira and Lencastre, 2002), obtained from Sigma-Genosys, Sydney, 
Australia. PCRs were performed as described in Chapter 2.  Five microliter reaction 
mixtures were analysed by 1% agarose (Bioline, Australia) gel electrophoresis. 
Nucleotide sequence determination was performed by Microcom Sequencing Facilities, 
Monash University, Melbourne. 
 
3.2.3 Detection of biofilm production  
Quantitative determination of biofilm production was performed using a microtitre plate 
assay. Each plate contained S. epidermidis RP62a and SP2 as positive and negative 
biofilm-producing controls, respectively (Christensen et al., 1985). In brief, bacteria were 
inoculated into 10 mL of tryptone soya broth (TSB) (Oxoid, Australia) and incubated 
overnight with shaking at 37 °C aerobically. This suspension was diluted 1:100 in TSB 
and TSB with 4% NaCl, respectively, and then 200 µL volumes were inoculated into 96-
well polystyrene microtitre plates. The plates were incubated overnight at 37 °C in air, 
washed, and stained with 1% crystal violet. The optical density of the adherent biofilm 
was determined at 595 nm using POLARstar Omegar (BMG LABTECH Pty, Ltd., 
Australia). The phenotype of biofilm formation is categorised by the OD values: strong 
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biofilm producer, OD ≥ 0.24; weak biofilm producer 0.24 ≥ OD ≥ 0.12; biofilm-negative 
isolates, OD ≤ 0.12. Four wells were inoculated per isolate in a given experiment, and all 
isolates were tested independently on three occasions. 
 
Qualitative detection of biofilm formation of these isolates was performed using Congo 
red agar (CRA), according to (Freeman et al., 1989) Isolates were streaked onto the agar 
to obtain single colonies and incubated overnight at 37 °C aerobically and a further 24 
hours at room temperature. The interpretation of results followed  (Freeman et al., 1989) 
and (Arciola et al., 2002)  
  
3.2.4 PFGE analysis  
PFGE was performed according to (Murchan et al., 2003) with minor modifications.  
Approximately 1x109 cells/mL of an overnight TSB suspension of S. capitis were mixed 
with an equal volume of 2.2% low-melting-point agarose (Progen industries Limited, 
Australia) and poured into the block molds (Biorad, Australia). Plugs for each isolate, 1 
mm in diameter were equilibrated in SacII buffer (New England Biolab) at room 
temperature prior to digestion, and then covered with 80 µLof SacII restriction buffer 
containing 30 U of SacII restriction enzyme. The reaction tubes were mixed gently and 
incubated overnight at 37 °C as recommended by the manufacture. 
 
A 1.4% gel was prepared by using PFGE grade agarose (Amresco, Australia) in a 100 
mL 0.5 × TBE and poured into a freshly cleaned gel casting frame once the agarose had 
cooled to 50-60 °C. Once set, the gel was positioned centrally in a contour-clamped 
homogenous electric field (CHEF) (Bio-Rad, Australia) tank and covered with 2000 mL of 
0.5 x Tris/Borate/EDTA (TBE). The running temperature was set at 14 °C. A lamda 
Freeman et al. (1989).
Fre man et al. (1989) 
Arciola et al. (2002).
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marker (New England Biolab) was positioned in every 3 or 4 lanes to allow later 
normalization of electrophoretic patterns across the gel. The total running time was 23 
hours, the initial block switch time was 15 s to 60 s for 13 hours, and the second block 
switch time was 5 s to 15 s for 10 hours. The voltage for the run was 6 V/cm.  
 
The gels were stained for 45 min in ethidium bromide (1 µg/mL) and destained for 1 hour 
and photographed using a gel document system (Bio-Rad, Australia). Digital images were 
stored electronically as JPG files and analysed visually with GelCompare (Applied 
Maths), using the Dice coefficient, represented by UPGMA with 1% optimization and 
1.5% tolerance setting. Of cut-off values 75% and 80% were applied to assess similarity. 
 
3.2.5 Statistical analysis  
Antibiotic susceptibility experiments were performed at least twice. A binary logistic 
regression analysis was performed to assess whether the biofilm formation and antibiotic 
resistance was associated independently with the two subspecies, and how the biofilm 
formation related to the antibiotic profile. Statistical analyses were performed using 
GraphPad Prism 5.0 (Motulsky, 1999). This program computes P values using Fisher’s 
exact test contingency table and summarizes the data by computing the odds ratio along 
with 95% confidence intervals.  
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3.3 Results 
3.3.1 Molecular epidemiology of clinical Staphylococcus capitis isolates 
over 6-year period  
 
Isolates were obtained from blood cultures from sixty episodes of sepsis at the NICU, 
Royal Women’s Hospital, Melbourne, between 2000 and 2005 (5 from 2000, 11 from 
2001, 16 from 2002, 14 from 2003, 10 from 2004 and 6 from 2005). Initially, the SmaI 
restriction enzyme was applied to 20 of the S. capitis isolates, but failed to differentiate 
adequently between these isolates (Figure 3.1). As this suggested the sequence 
recognized by Smal is highly conserved in the S. capitis genome, the SacII enzyme was 
used to analyse all 60 isolates as it provided substantial discrimination (Figure 3.2). 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. PFGE digested with SmaI in S. capitis. λ, λ PFGE marker. 
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Figure 3.2. PFGE digested with SacII in S. capitis. This is a representative of PFGE gel photos. The PFGE for 
all the isolates were performed under the same conditions. λ, λ PFGE marker. 
 
The annual number of episodes of sepsis at the NICU varied over the six years of the 
study, peaking in 2002 and 2003 (Figure 3.3).  The PFGE results clearly revealed that 
certain isolates of S. capitis became predominant in the NICU.  Analysis of PFGE gels by 
GelCompar II yielded four major clusters of at least five isolates with ≥ 80% similarity, 
comprising 53 (88.3%) of all isolates.  Another minor cluster comprised two isolates (52 
and 61). Five isolates (39, 62, 65, 70 and 90) that were randomly distributed over the 
years could not be typed.  There was no difference in the allocation of clusters between 
the 75% and 80% cut-off levels. The only exception was one isolate clustered in the 
PFGE type I according to the 75% cut-off and non-clustered according to the 80% cut-off 
level.  
 
Cluster II, the largest cluster, comprising 34 isolates, was associated with more than half 
of all cases in the NICU and was apparently capable of persisting for a prolonged period. 
Isolates belonging to this cluster were distributed throughout the 6-year period. The 
194.0 
291.0 
388.0 
Kb 
λ λ λ λ 
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highest occurrence was in 2002 (11 isolates, 84.6% of isolates in this year). The other 
clusters were less prevalent, but appeared in most years throughout the period of the 
study (Figure 3.3). 
 
 
 
 
 
 
 
 
 
Figure 3.3.  Contributions of PFGE clusters to the total infections in each year. 
 
 
3.3.2 Quantitative and qualitative biofilm formation in clinical S. capitis 
isolates 
 
The biofilm-forming ability of the sixty isolates was examined using two methods, the 
microtitre plate (Mtp) and appearance on Congo red agar (CRA). Fifty isolates were 
biofilm-positive by the microtiter plate assay, in TSB supplemented with 4% NaCl, and the 
remaining 10 isolates were biofilm-negative.  There was a complete agreement between 
the results of the microtitre plate assay and production of extracellular polysaccharide 
indicated by colonial appearance on CRA plates. Figure 3.4 & 3.5 show the biofilm 
formation in Mtp and on CRA, respectively.  
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Figure 3.4. Biofilm assay with 96-well microtiter plate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Detection of biofilm formation with congo red agar in clinical S. capitis. Colourimetric scale 
adopted for colony evaluation by Congo red agar on the clinical S. capitis isolates: a. black; b. borderline; c. 
black in the center; d. red. a, b, and c are categorized as biofilm positive, d was categorized as biofilm  
negative, according to Arciola et al. (2005). 
 
Strong biofilm 
Weak biofilm 
biofilm-negative 
a
 
b
 
c
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3.3.3 Antibiotic susceptibility profile and relationship to biofilm 
production  
 
Biofilm-positive isolates were, in general, more resistant than biofilm-negative isolates.  
The great majority of isolates were resistant to penicillin and oxacillin (87 and 85% 
respectively). All S. capitis isolated in 2005 were resistant to both antibiotics. Carriage of 
mecA gene was consistently high and was almost always associated with biofilm 
positivity.  Forty-three isolates (72%) showed resistance to erythromycin.  Limited 
numbers of isolates were resistant or intermediate in resistance to clindamycin (6.7%) 
and 10% were resistant to teicoplanin.  Based on MICs, no isolates of S. capitis displayed 
reduced susceptibility to vancomycin; however, this method may not detect small 
populations of resistant cells, which can only be detected by population analysis profiling.  
Resistance to teicoplanin was observed in 10% of isolates (Table 3.1).   
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Table 3.1. MIC antibiotic susceptibility pattern and mecA gene carriage and their correlations between biofilm formation phenotype 
in clinical Staphylococcus capitis.  
Antimicrobial 
agent 
No. (%) of resistant isolates by year 
     No. (%) resistant isolates by  
           biofilm    phenotype              Pb value 
2000 2001 2002 2003 2004 2005  
Biofilm+ 
na = 50 
Biofilm- 
n = 10  
Penicillin 5 (100) 9 (90) 14 (87.5) 10 (76.9) 9 (90) 5 (83.3)  48 (96) 4 (40) 0.0001 
Erythromycin 4 (80) 8 (80) 8 (50) 9 (69.2) 8 (80) 6 (100)  41 (82) 2 (20) 0.0003 
Clindamycin 0 1 (10) 2 (12.5) 0 0 1 (16.7)  4 (8) 0 1.0000 
Teicoplanin 0 3 (30) 2 (12.5) 1 (7.7) 0 0  5 (10) 1 (10) 1.0000 
Vancomycin 0 0 0 0 0 0  0 0 1.0000 
Oxacillin 4 (80) 8 (80) 14 (87.5) 11 (84.6) 8 (80) 6 (100)  48 (96) 3 (30) < 0.0001 
mecA+c 4 (80) 8 (80) 15 (93.8) 13 (100) 8 (80) 6 (100)  49 (98) 5 (50) 0.0003 
 
 
 
 
 
a  n is the number of isolates. 
b P value is calculated. P value represents the comparision of the antibiotic resistance between the biofilm- positive and-negative clinical S. capitis 
isolates.  A binary logistic regression analysis was performed using Fisher’s test from a contingency table.  p < 0.05 is defined as significant difference.    
c mecA+  is mecA gene carrier. 
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3.3.4 Genotype of subspecies and their relatedness to antibiotic 
resistance and biofilm production.  
 
Fifty-two isolates identified as subsp. urealyticus were mainly distributed in three major 
PFGE clusters (I, II and III) and one minor cluster (IV).  Two non-clustered isolates were 
also grouped into this subspecies.  Members of subsp. urealyticus were generally 
resistant to oxacillin (98%) and biofilm-positive (94%).  One exception was a non-
clustered isolate, which were oxacillin-susceptible according to its MIC, although they 
carried mecA.  Subsp. capitis comprised only eight isolates, which were mainly clustered 
in PFGE cluster V.  These isolates were susceptible to all antibiotics according to MIC 
data, although mecA was identified in three of them. Only one (isolate 62) produced 
biofilm (Figure 3.7). 
  
 
  
 
 
 
 
 
 
Figure 3.6. PCR detection of mecA gene in isolates of S. capitis. The isolates numbers are denoted on the 
top of each lane. M, low range of DNA ladder. This is a representative of mecA PCR photos.  The PCRs of 
mecA gene for all the isolates were performed under the same conditions.   
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3.4 Discussion 
3.4.1 Significance of antibiotic resistance profile 
Consistent with previous studies on CoNS from NICUs (Akinkunmi and Lamikanra, 2010), 
there were a high level of oxacillin resistance (85%) among the isolates in this study. 
Oxacillin resistance and mecA carriage reached 100% among isolates belonging to the 
three major PFGE clusters (I, II, and III), and a minor cluster IV (Table 3.2).  All such 
isolates were S. capitis subsp. urealyticus.  Although there was generally good 
agreement between the prevalence of mecA and expression of oxacillin resistance, there 
were some exceptions. Three isolates that carried mecA failed to express oxacillin 
resistance (Table 3.2).  This could be explained by low levels of expression of mecA, 
resulting in small subpopulations levels that were not detected by phenotypic methods.  
Alternatively, the mecA gene may be defective in these isolates (Al-Talib et al., 2010). We 
did not detect isolates expressing non-mecA mediated resistance to oxacillin. High levels 
of resistance to erythromycin and clindamycin in S. epidermidis were reported by many 
studies (Gristina et al., 1989, Hamilton-Miller and Shah, 2000). In this study, about 71.7% 
of the isolates were resistant to erythromycin and only a few (6.7%) were resistant or 
showed intermediate resistance to clindamycin.  
 
 
 
Figure 3.7. Pulsed-field gel electrophoresis dendogram of the clinical Staphylococcus capitis isolates. The 
scale bar at the top of the dendogram indicates similarity. The dot line indicates the cut-off value 80% that 
was applied for separating the clusters. 
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Table 3.2. Correlations of antibiotic susceptibility profiles and mecA gene carriage with pulsed-field gel electrophoresis (PFGE) 
clusters in Staphylococcus capitis clinical isolates. 
Antimicrobial agent 
No. (%) of resistant isolates in PFGE clusters No. (%) of non-clustered 
resistant isolates I II III IV V 
Penicillin 6 (85.7) 34 (100) 7 (100) 2 (100) 0  2 (40) 
Erythromycin 7 (100) 28 (82.4) 6 (85.7) 2 (100) 0 0 
Clindamycin 0 1 (2.9) 0 2 (100) 0 1 (20) 
Teicoplanin 2 (28.6) 3 (8.8) 1 (14.3) 0 0 0 
vancomycin 0 0 0 0 0 0 
Oxacillin 7 (100) 34 (100) 7 (100) 2 (100) 0 1 (20) 
mecA+a 7 (100) 34 (100) 7 (100) 2 (100) 2 (40) 2 (40) 
a mecA+  is mecA gene carrier 
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3.4.2 Biofilm formation of clinical S. capitis isolates and their prevalence 
in the NICU   
 
The predominant S. capitis clones in the NICU setting were biofilm producing subsp. 
urealyticus.  Three isolates failed to produce biofilm yet were classified into the major 
PFGE clusters and presented similar antibiotic resistance profiles to the other members in 
the major clusters.  The other isolates displaying a biofilm-negative phenotype belonged 
to subsp. capitis and were susceptible to antibiotics and members of cluster V.  These 
isolates were few in number and appeared only sporadically over the study period (Figure 
3.7).   
 
Consistent with previous studies (Ziebuhr et al., 2006),,biofilm formation of the S. capitis 
isolates showed a strong correlation with the antibiotic resistance profile.  It is likely that 
antibiotic use led to the selection of PFGE types that contained resistant strains capable 
of expressing biofilm.  As a consequence, the ability to express biofilm under specific 
conditions encountered in the NICU could be the factor giving subsp. urealyticus a 
selective advantage.  Biofilms form a barrier around bacteria, protecting them from 
antibiotics and phagocytes and thus making treatment of infections very difficult 
(Boynukara et al., 2007, Begun et al., 2007).  However, given the likely value of biofilm 
formation in providing a positive selective advantage, the question remains why biofilm-
negative antibiotic-susceptible subsp. capitis isolates remained in the NICU.  One 
possibility is that the conditions under which the ica operon of subsp. capitis expresses 
PIA are not the same as for subsp. urealyticus.   
 
Ziebuhr et al. ( ), 
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3.4.3 Relatedness of biofilm production and antibiotic resistance to two 
subspecies  
 
One striking observation in this study is that biofilm formation and the presence of the 
mecA gene in these clinical S. capitis isolates were mainly displayed only in subsp. 
urealyticus (Figure 3.7).  A global comparison of the genomes of diverse clinical strains of 
these two subspecies with known endemic potential would contribute our understanding 
S. capitis survival and infections in hospitals.   
 
In conclusion, the findings presented in this chapter suggest that the endemic S. capitis 
clones confirmed to be S. capitis subsp. urealyticus are more important causes of 
bloodstream infections in very-low-birth-weight infants than subsp. capitis. It would 
therefore be beneficial to subspeciate S. capitis isolates, especially those isolated from 
newborn babies.  The results also emphasize the importance of examining the 
composition and expression of the ica operon in relation to the pathogenic potential of S. 
capitis.  
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CHAPTER 4 
 
Sequence analysis of ica operon in 
Staphylococcus capitis 
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4.1 Introduction 
Cramton et al. (1999) showed that the ica operon is responsible for the extracellular 
biofilm matrix of S. epidermidis. The matrix is composed of polysaccharide intercellular 
adhesion (PIA), which consist mainly of β-1,6-linked N-acetylglucosamine.  The entire 
DNA sequence of ica operon in S. epidermidis, S. aureus and S. caprae has been 
reported (NCBI accession numbers: SEU43366, AF086783 and AF246926). IcaA is a N-
acetylglucosaminyltransferase, but no transferase activity was observed with the other 
proteins encoded by the ica operon (Gerke et al., 1998).  
 
The complete DNA sequence of ica operon of S. capitis was determined in this study. 
It was present in the same length in all sixty isolates of S. capitis subspecies capitis and 
urealyticus that were examined; however, these isolates exhibited different biofilm 
phenotypes. Most were biofilm positive, 10 isolates were biofilm-negative (Chapter 3). 
Whether their phenotype and the genotype correspond for biofilm formation and the 
function of ica operon in S. capitis have not been investigated. 
  
Recently, the online bioinformatics tools have become available to facilitate making 
biological discoveries in silico in a highly time- and cost-efficient manner. By utilizing 
various bioinformatics prediction and analysis tools, hypotheses and theoretical models 
can be quickly generated, which could then guide the design of experiments for further 
validation. 
 
The aim of this study is to determine if the ica operon is essential for biofilm formation in 
S. capitis. I addressed this aim in three ways: 1. to determine the status of the ica operon 
in both biofilm-positive and -negative isolates of S. capitis. 2. To deduce the function of 
78 
 
Ica proteins of S. capitis and propose their putative mechanisms in the polysaccharide 
biosynthesis pathway by comparing with the protein sequences of known functions. 3. To 
speculate the origin of ica operon in S. capitis, how they were selected in hospital setting.    
 
4.2 Materials and methods  
4.2.1 Bacterial isolates and growth conditions 
For details of the sixty S. capitis isolates used for verifying the presence of the ica operon, 
One Shot® TOP10 Electrocomp™ E. coli for cloning and growth conditions refer to 
Chapter 2. 
  
4.2.2 PCR amplification, cloning, southern blot, DNA sequence 
assembling and analyses 
 
The total chromosomal DNA isolation was performed as described in Chapter 2. The 
entire DNA sequence of S. capitis ica operon was obtained by PCR. All the primers used 
for PCR and sequencing were listed in Table 4.1. The PCR conditions and gel 
electrophoresis, and purification were described in Chapter 2. PCR products were 
analysed by gel electrophoresis on a 1.2% agarose gel (Bioline, Australia), purified with 
QIAquick gel extraction kit (Qiagen). DNA sequencing was performed by Microcom 
Sequencing Facilities, Monash University, Melbourne. Each PCR fragment was 
sequenced at least twice to three times. The sequence information was obtained by blast 
search with data in NCBI. 
 
The flanking region of the icaR was obtained by semi-random PCR, using the forward 
primer (Af2) designed from ica chromosomal region of S. capitis in the NCBI database. 
The reverse primer (SeipL4) was designed based on S. epidermidis RP62A DNA 
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sequence upstream of the icaR gene.  The resulting PCR product was cloned into pCR-
XL-TOPO vector according to the manufacture’s instruction, and confirmed by southern 
blot with a 300 bp PCR product generated from primers Af2 and Ar2 as probe, and 
labelled with digoxigenin using the DIG labelling kit (Roche, Australia), according to the 
manufacture’s instruction. The flanking sequence of the icaC gene was obtained with 
primers Cf and gehCb.  
 
All the sequence information was identified by basic local alignment search tool (BLAST) 
analysis at the National Center for Biotechnology Information (NCBI) website. The PCR 
fragments were assembled with the CAP3 program, using the default parameters (Huang 
and Madan, 1999). 
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                        Table 4.1. Primers used for PCR experiments. 
Primer Sequence (5’-3’) Gene Accession No. Position Origin (Source) 
SepiL4 TGGAGGGCTACTCAAGTC    This study 
Rf CAACAACGATTCTAACTACT icaR AY146584 4051 This study 
Rr  TGGATAATTGGACGTATAACC icaR AY146584 4154 This study 
Ar1  CGCCTTCGTTTAAAGCGTTAGC icaA  3325 This study 
Af 1 GGCCTGTTACAACGAGAG icaA  3530 This study 
Ar2 AACGGCGGCATTGATAATCC icaA  2540 This study 
Af2 CAGCAAACTTCTTAGATTACAC icaA AY146582 2739 This study 
Dr CTCCACGTTAAGAGCGATAC icaD  2295 This study 
Df ATGGTCAAGCCCAGACAG icaD  2486 This study 
Br TTAGTAGCAGACACATTAGAC icaB AY146583 1571 This study 
Bf  CAACTGGCTTCGTGATTAC icaB AY146583 1763 This study 
Cr  TAGAACAAGAGAACTCCCTG icaC AY945929 1203 This study 
Cf  TGTCAGGGAGTTCTCTTG icaC AY945929 1225 This study 
gehCb CAAGACAGTTCAGATACAGTACGC gehC   (Allignet et al., 2001) 
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4.2.3 Detection of ica operon using expand long PCR 
The ica operon was amplified according to the expand long template PCR system 
protocol (Roche Applied Science). The primers used were:  forward SepiL4 5' 
TGGAGGGCTACTCAAGTC 3' (this study), reverse gehCb 5’ 
CAAGACAGTTCAGATACAGTACGC 3’ (3). Briefly, A 50 µL PCR mixture consisted of 5 µL of 
10 x PCR buffer 1 with 1.25 mM MgCl2, 350 µM of each deoxyribonucleotide (Bioline, 
Australia), 300 µM of each primer and 3.75 U of expand long enzyme, 50 ng of DNA. The 
first PCR cycling conditions used were 10 cycles of 10 s at 94 °C, annealing at 50 °C for 
30 s and 4 mins for elongation at 68 °C, the second cycling conditions were 25 cycles at 
94 °C for 15 s, annealing at 50 °C for 30 s and 4 mins for elongation at 68 °C. Reaction 
mixtures 5 µL were analysed by 1% agarose (Bioline, Australia) gel electrophoresis.  
 
4.2.4 PCR-Restriction Fragment Length Polymorphism (RFLP) 
The entire ica operon were amplified with forward primer SepiL4 and reverse primer 
gehCb in Table 1. By using Elongase enzyme (Roche) under the reaction conditions 
described by the manufacturer, with annealing temperature at 52 °C and extension time 
at 7 mins, respectively. The PCR product was subjected to digestion with HindIII and TaqI 
restriction enzymes (Promega, Australia), which were used according to the 
manufacture’s instruction, refer to Chapter 2. 
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4.2.5 Bioinformatics tools 
Database searches 
The PSI-BLAST ALIGNMENT (Altschul et al., 1997) program was used for the protein 
sequence database search, with default parameters. The family-based resources pfam 
version 26.0 was used for searching significant matched proteins. A list of related known 
protein data bank (PDB) structures was recognized as potential templates for protein 
modelling. Conserved domain search in NCBI was used for searching homologous 
proteins.  
 
DNA and protein primary sequence alignment 
Clone manager version 7.11 (Scientific and Education software, USA) was used to 
compare the primary DNA and protein sequences. 
 
Multiple sequence alignment 
Related sequences with a comparably high degree of similarity (15% identity) were 
aligned using Clustal Omega, with defalt parameters, which is a new multiple sequence 
alignment program that uses seeded guide trees and HMM profile-profile techniques to 
generate alignments (Sievers et al., 2011).  
 
Secondary structures  
Protein secondary structures were derived the PDB coordinates of the representative 
proteins. Hydrophobicity analysis was carried out using web-predictor TopPred II (von 
Heijne, 1992). All the possible topologies that include the certain transmembrane 
segments and either include or exclude each of the candidate segments were 
automatically generated SignalP 3.0 was used to predict the presence and location of 
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signal peptide cleavage sites in amino acid sequences (Dyrløv Bendtsen et al., 2004) 
PSORTb v3.0 (Yu et al., 2010) was used for protein localization prediction. 
 
4.2.6 Nucleotide submission  
The sequenced complete ica operon of clinical biofilm-positive S. capitis isolate 6 has 
been deposited in GenBank under accession number JF930147. 
 
4.3 Results 
4.3.1 Sequence of the ica operon in S. capitis  
The type of genes and their organisation from 5’ to 3’ end are similar to those of S. 
aureus, S. epidermidis and S. caprae. The ica operon contains four structural genes icaA, 
icaD, icaB and icaD and one regulatory gene icaR. The structural genes are co-
transcribed from the mapped icaA promoter, and icaR gene located upstream of icaA 
gene, is transcribed in opposite direction. However, in S. capitis, the presence of a 
putative surface protein gene (Sp6) upstream of icaR gene and in the same orientation as 
in the surrounding sequence showed no similarity to the corresponding area in the other 
species. The ica operon was present in all the sixty clinical isolates. Most subsp. 
urealyticus isolates produced biofilm, except three isolates (17, 25 and 55), and all the 
subsp. capitis isolates were biofilm-negative. All isolates carried an ica operon of the 
same length and in the same chromosomal position, suggesting the absence of biofilm 
formation was not related to the insertion of a mobile element. Figure 4.1 shows the map 
of the ica operon in S. capitis isolate 6, which is a biofilm producer. 
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Figure 4.1. Map of the ica locus and surrounding chromosomal region in S. capitis strain 6 (accession 
number JF930147).  
 
 
4.3.2 Sequence comparison with S. epidermids, S. aureus and S. caparae 
A comparison of sequence identities between S. capitis isolate 6 and S. epidermidis, S. 
aureus, and S. caprae is shown in Table 4.2. In general, the entire ica operons in these 
species are about from 4000 bp to 5000 bp in length. They share identities ≥ 65% in DNA 
sequences and ≥ 66% at the protein levels. 
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       Table 4.2. Sequence comparison of the ica locus between other species 
Locus 
Accession 
No. 
DNA 
identity 
Length 
(nt) 
Protein 
identity 
Length 
(aa) 
icaR 
S. capitis JF930147  561  186 
S. epidermidis SEU43366 76 558 77 185 
S. aureus AF086783 70 561 69 186 
S. caprae AF246926 89 573 89 190 
icaA 
S. capitis JF930147  1239  412 
S. epidermidis SEU43366 79 1239 83 412 
S. aureus AF086783 77 1239 81 412 
S. caprae AF246926 85 1236 91 411 
icaD 
S. capitis JF930147  306  101 
S. epidermidis SEU43366 77 306 79 101 
S. aureus AF086783 69 306 66 101 
S. caprae AF246926 86 306 91 101 
icaB 
S. capitis JF930147  864  287 
S. epidermidis SEU43366 73 870 71 289 
S. aureus AF086783 65 873 66 290 
S. caprae AF246926 85 870 88 289 
icaC 
S. capitis JF930147  1074  357 
S. epidermidis SEU43366 81 1068 82 355 
S. aureus AF086783 75 1053 75 350 
S. caprae AF246926 93 1074 94 356 
 
 
4.3.3 Sequence comparison between biofilm-positive and -negative 
isolates 
 
The entire ica operon was present in all sixty isolates in the same length (Figure 4.2). 
Sequence analysis was performed on the ica operon in five isolates: two biofilm-positive 
subsp. urealyticus (isolates 6 and 70) and one biofilm-negative subsp. urealyticus (isolate 
17), and two biofilm-negative subsp. capitis (44 and 65). These isolates were selected by 
identifying different restriction patterns of the ica operon in accordance with PCR-RFLP 
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digested with TaqI and HindIII, respectively. TaqI patterns were consistent with those cut 
with HindIII (Figure 4.3).  
 
The detailed mutations in the ica operon are summarized in Table 4.3, the ica operon of 
isolate 6 was used as the master sequence for comparison. Sequence analysis revealed, 
the ica operon of isolate 70 is identical to that of isolate 6; three in-frame deletions 
occurred in the ica operon of isolate 17. Various point mutations happened in the icaC 
gene of isolate 44, but none of them leads to the change of amino acid of IcaC while the 
mutations in icaR to icaA, D and B genes resulted in changes in amino acid sequences. 
In isolate 65, a stop codon was found in icaB gene, which led to nonsense protein 
missing 69 C-terminal amino acids.      
 
 
 
 
 
 
 
 
Figure 4.2. PCR of the ica operon in S. capitis. The isolates numbers are shown on the top of the gel. Isolates 
6, 70, and 95 are biofilm-positive, subsp. urealyticus; isolates 17 and 25 are biofilm-negative subsp. 
urealyticus; isolates 44, 49, 77, 65 and 85 are biofilm-negative subsp. capitis. λ/PstI was used as DNA ladder. 
This photo is used as a representive of PCR results of ica operons. The PCRs of the ica operon gene for all 
the isolates were performed under the same conditions.   
5077 
bp 
λ/pstI  6   17   25  44   49  77   85  65   70  95 
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Figure 4.3. PCR-RFLP profiles of the ica operon in S. capitis isolates. a.&  b. HindIII and TaqI digestion of the 
ica operon PCR product of biofilm-positive subsp. urealyticus isolates, respectively. The isolates numbers are 
labelled on the top of the lanes.  c & d. HindIII and TaqI digestion of ica operon PCR product biofilm-negative 
subsp. capitis  isolates, respectively. The isolates numbers are labelled on the top of the lanes, and the RFLP 
types are indicated under the lanes of each isolates. Isolates 6 and 70 are biofilm-positive, supsp. urealyticus, 
used as controls; isolates 17, 25, and 57 are biofilm-negative subsp. capitis; isolates 44, 49, 65, 73, 85 and 
90 are biofilm-negative subsp. capitis. λ/PstI was used as DNA ladder, and the Ms on b & d are 
correspondent to the λ/PstI marker. 
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Table 4.3. Summary of the mutations in the ica operon of S. capitis clinical isolates 
Isolate Mutation position 
Substitution, 
deletion or 
insertion 
Gene loci Translation to amino acid 
6a          
17b 
1587 to 
1595 
Deletion of 
AATCACTTG icaA 
Deletion amino acids of Q, S, 
I and change A to P 
70c       100% identity 
44c 319 A to G icaR Y to H 
44 362 G to A icaR No change in amino acid 
44 503 T to A icaR L to F 
44 556 G to T icaR Q to K 
44 971 Deletion of T intergenic region 
 44 984 G to A intergenic region 
 44 1331 A to G icaA N to D 
44 1342 A toT icaA No change in amino acid 
44 1400 G to A icaA V to I 
44 1485 G to A icaA G to D 
44 1561 T to C icaA No change in amino acid 
44 1603 T to C icaA No change in amino acid 
44 1781 G to A icaA V to I 
44 1870 A to G icaA No change in amino acid 
44 1908 G to T icaA V to F 
44 2427 C to T icaD No change in amino acid 
44 2477 T to A icaD F to Y 
44 2500 A to G icaD K to E 
44 2585 T to C icaB No change in amino acid 
44 2636 A to G icaB No change in amino acid 
44 2948 T to C icaB No change in amino acid 
44 2964 A to G icaB I to V 
44 3158 G to A icaB No change in amino acid 
44 3447 A to G icaC No change in amino acid 
44 3519 A to T icaC No change in amino acid 
44 3624 C to T icaC No change in amino acid 
44 3736 C to T icaC No change in amino acid 
44 3780 C to T icaC No change in amino acid 
44 3888 C to T icaC No change in amino acid 
44 4098 A to C icaC No change in amino acid 
44 4389 T to C icaC No change in amino acid 
44 4405 T to C icaC No change in amino acid 
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Table 4.3. Continued. 
65e 457 G to A icaR P to S 
65 1105 A to T icaA L to F 
65 1120 A to G icaA No change in amino acid 
65 1331 A to G icaA No change in amino acid 
65 1429 A to T icaA No change in amino acid 
65 1513 C to T icaA No change in amino acid 
65 1561 T to C icaA No change in amino acid 
65 1603 T to C icaA No change in amino acid 
65 1666 C to T icaA No change in amino acid 
65 1780 A to G icaA No change in amino acid 
65 2585 T to C icaB  
65 2636 A to G icaB  
65 2724 G to T icaB  
65 2948 T to C icaB  
65 2964 A to G icaB   
65 3127 C to T icaB   
65 3158 G to A icaB   
65 3951 C to T icaC No change in amino acid 
65 4389 T to C icaC No change in amino acid 
65 4405 T to C icaC No change in amino acid 
a 6, biofilm-positive, subsp. urealyticus, used as the master sequence for the comparison;  
b 17, biofilm-negative, subsp. urealyticus; c  70, biofilm-positive, subsp. urealyticus;  
d 44, biofilm-negative, subsp. capitis; e 65, biofilm-negative, subsp. capitis. 
  Stars indicate the same mutations occurred in DNA sequences between isolates 44 and 65. 
 
The number of matching mutations between isolates 44 and 65 indicates a common 
anscester with the same eight mutations. According to the small proportion of matching of 
mutations indicates the divergence of the two sequences occurred a long time ago, 
therefore, pre-date the development of modern hospital. 
 
4.3.4 Sequence-structure relationships of Ica proteins in S. capitis 
From the deduced primary protein sequences, the IcaA protein sequence significantly 
matched the functional superfamily glycosyltransferase (GTs; EC 2.4.x.y), which 
constitutes a large family of enzymes involved in the biosynthesis of oligosaccharides, 
polysaccharides, and glycoconjugates (Breton et al., 2006), and is present in both 
There is a stop codon 
on icaB gene of isolate 
65. Nonsense protein 
missing 69 C-terminal 
amino acids. 
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prokaryotes and eukaryotes. The secondary structure elements of IcaA were derived from 
comparison to a chondroitin polymerase from E. coli (2Z86, Protein Data Bank code), 
which presents the highest identity to IcaA (19% identity) from multiple alignment. The 
similar residues, DXD motif, which has been identified among glycosyltransferases and 
was thought to play a role in metal ion binding and catalysis (Li et al., 2001) (Figure 4.4) 
was also recognized in IcaA.  
 
The deduced IcaB sequence showed similarity to those of polysaccharide deacetylases, 
the most similar being a carbohydrate esterase from Bacillus anthracis (19% overall 
identity) (2J13, Protein Data Bank code). This identity suggests that IcaB has deacetylase 
activity. The functional residues responsible for binding and catalysis were identified by 
alignment with related known Protein Data Bank (PDB) structures (Figure 4.5).  
 
IcaC exhibits similarity to acyltransferase, from conserved domain search. The highest 
identity was to a membrane-bound acyltransferase from Bacillus subtilis (26% identity). 
Alignment of the sequence with related acyltransferases is shown in Figure 4.6.  
 
Analysis from the deduced IcaD sequence revealed that it is a cytoplasmic membrane 
protein. No significant protein structures can be matched. Hydrophobicity plots suggested 
two transmembrane domains are present in the IcaD (Figure 4.7). 
 
A conserved domain search revealed that IcaR belongs to the tetracycline repressor 
(TetR) family of proteins. The IcaR crystal structure of S. epidermidis has been reported. 
Figure 4.8 shows the interaction of the IcaR with the ica operator in S. epidermidis. The 
palindromic sequence of S. capitis was therefore deduced as shown in Figure 4.9.The 
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key residues and their locations are identical to those of S. epidermidis. The location of 
the palindromatic sequence in S. capitis was drawn in Figure 4.10. The alignment of the 
helix-turn-helix sequence is shown in IcaR proteins from four Staphylococcus species: S. 
epidermidis, S. aureus, S. caprae and S. capitis in Figure 4.11.  
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Figure 4.4. Alignment of IcaA with its homologues. Partial IcaA sequence, identified as capiA in the 
alignment, which were deleted 44 amino acids in N-termino and 116 amino acids in C-terminois from the 
wildtype IcaA sequence, to have a better alignment. The Putative conserved domains have been detected in 
NCBI, showed it is case-like glycosyltransferase. Aligned with a glycosyltransferase from a Mycobacterium 
species (Protein Data Bank code 3E25 and 3CKJ), a chondroitin polymerase from E. coli (Protein Data Bank 
code 2Z86), and a nucleotide-diphospho-sugar transferase from B. subtilis (Protein Data Bank code 1QG8). 
Yellow colour with a black arrow over the alignment represents β-sheet, light grey colour represents α-helics. 
DXD are denoted by red and indicated with blue dot over the sequence. 
 
3E25_A      MTASELVAGDLAGG--R--APG-ALPLDTTWHRPGWTIGELEAAKAGRTI 45 
3CKJ_A      MTTSDLVAGELAGDGLRDTRPGDTWLADRSWNRPGWTVAELEAAKAGRTI 50 
capiA       ---------------------------------------QIEG------I 5 
2z86        -------------------------------------------------- 
1QG8_A      -----------------------------------------------PKV 3 
                                                                 
 
3E25_A      SVVLPALNEEATIESVIDSISPLVDGLVDELIVLDSGSTDDTEIRAIASG 95 
3CKJ_A      SVVLPALDEEDTIGSVIDSISPLVDGLVDELIVLDSGSTDDTEIRAVAAG 100 
capiA       SFLLACYNESETVRDTLSNVLALNY-PKKEIIIINDGSSDNTAEIIYEMK 54 
2z86        -IVIPTYNRAKILAITLACLCNQKTIYDYEVIVADDGSKENIEEIVREFE 49 
1QG8_A      SVIMTSYNKSDYVAKSISSILSQTF-SDFELFIMDDNSNEETLNVIRPFL 52 
             .::.  :.   :   :  :         *::: :..*.::          
 
3E25_A      AR----VVSREQALPEVP-VRPGKGEALWRSLAATSGDIVVFIDSDLINP 140 
3CKJ_A      AR----VVSREQALPEVP-IRPGKGEALWRSLAASRGDIVVFVDSDLINP 145 
capiA       Q-------HHDFKFVNLQ-VNRGKANALNEGVKHSSYDYVMCLDADTIVN 96 
2z86        S-------LLNIKYVRQKDYGYQLCAVRNLGLRAAKYNYVAILDCDMAPN 92 
1QG8_A      NDNRVRFYQSDISGVKERTEKTRYAALINQAIEMAEGEYITYATDDNIYM 102 
                      :    .              .:  :  : :     *     
 
3E25_A      HPLFVPWLVGPLLTGEGIQLVKSFYRRPLQVSDVTSGVCATGGGRVT--E 188 
3CKJ_A      HPMFVPWLVGPLLTGDGVHLVKSFYRRPLNVGDAGGGAGATGGGRVT--E 193 
capiA       QD--APY-----------YMMDNFKQDP-KLGAVTGNPRIRNKSSIL--G 130 
2z86        P-----------------LWVQSYMELLAVDDNVALIG----PRKYI--D 119 
1QG8_A      PDR-------------LLKMVRELDTHPEKAVIYSASKTYHLNENRDIVK 139 
                                : .      :      .              
 
3E25_A      LVARPLLAALRPELGCVL--QPLSGEYAASRELLTSLPFAPGYGVEIGLL 236 
3CKJ_A      LVARPLLAALRPELGCIL--QPLGGEYAATRELLTSVPFAPGYGVEIGLL 241 
capiA       KIQTIEYASL---IGCIKRSQSLAGAINTISGVFT--LFKKSALKEVG-Y 174 
2z86        TSKHTYLDFLS-----------QKSLINEIPEIITNNQVAGKVEQNKSVD 158 
1QG8_A      ETVRPAAQVT----------WNAPCAIDHCS-VMHRYSVLEKVKEKFGSY 178 
                                            ::    .      : .   
 
3E25_A      IDTFDRLGLDAIAQVNLGVRAHRNRPLDELGAMSRQVIATLLSRCGIPDS 286 
3CKJ_A      VDTFDRLGLDAIAQVNLGVREHRNRPLAELGAMSRQVIATLLSRCGIPDS 291 
capiA       WDT-DMITEDIAVSWKLHLADFRIN--YEPRAMCWMLVPETVG--GLWKQ 219 
2z86        WRIEHFKNTDNLRLCNTPFRFFSGG--NVAFAKKWLFRA------GWFDE 200 
1QG8_A      WDE----SPAFYRIGDARF-FWRVNHFYPFYPLDEELDLNYITDQSIHFQ 223 
                           .  .            .    .        .   . 
 
3E25_A      GVGLTQFLPGGPDDSDYTRHTWPVSLVDRPPMKVMRPRKLAAALEHHHHH 336 
3CKJ_A      GVGLTQFVADGPEGQSYTQHTWPVSLADRPPMQAIRPR------------ 329 
capiA       RL---RWAQGG--HEVLLRDFW-ATMKKKLSLYILMF------------- 250 
2z86        EFTHWGGEDNEFGYRLYREGCYFRSVEGAMAYHQE--------------- 235 
1QG8_A      LF---ELEKNEFVRNLPPQRNC-RELRESLKKLGMG-------------- 255 
             .       .        .      :                         
 
3E25_A      H 337 
3CKJ_A      - 
capiA       - 
2z86        - 
1QG8_A      - 
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Figure 4.5. Alignment of IcaB with its homologues. IcaB sequence, identified as capiB in the alignment, is 
aligned with a peptidoglycan deacetylases  from  Clostridium thermocellum  (Protein Data Bank code 2C79), 
a carbohydrate esterase from Bacillus anthracis  (Protein Data Bank code 2J13), polysaccharide deacetylase  
from Streptococcus mutans (Protein Data Bank code 2W3Z). Secondary structure elements deriving from 
2J13 Protein Data Bank coordinates which presents the highest identity to capiB (19% identity) are drawn 
over the alignment, yellow colour  with a black arrow over the alignment represents β-sheet, light grey colour 
represents α-helics. Conserved residues are denoted by red and other binding sites are indicated with blue 
dot over the sequence. 
 
 
2C79            MP---------------------------------------------------------- 
2J13            MGS----------------------------------------S-HHHHHHMAYTNTPHN 
2W3Z            MTVQQHWKKWQAKIFSAKNRPNLLFSLLIIGLVLGVVLVQAKSMQKQHKNHIRSSRISKK 
capiB           MKPF---------------------KFIFISLVVMLVMTNVTPSF-HHY---AQADEDHK 
                *                                                            
 
2C79            ------------------------------------------------------------ 
2J13            WGIP-----------RP-KNETVPDAG-------------------KLYTDLLQKNGGF- 
2W3Z            KT-------------TP-KPNINPNAL-------------------KIGSNHNNQAEGY 
capiB           KLKYKKNSALALNYHRVRKNDPLNDFITIFSSSKEIKNYSVTDKEFESQIKWLKKHDAK- 
                                                                             
 
2C79            ------------------ANKLVALTFDDGPDNVLTARVLDKLDKYNVKATFMVVGQRVN 
2J13            Y-------------LGDTKKKDIYLTFDNGYENGYTGKILDVLKEKKVPATFFVTGHYIK 
2W3Z            YSAETVRQMMNNK-QASAKQKLVFLTFDDGVDPNMTPKILDVLAQQHVHATFFLVGCNIT 
capiB           FL--TLKEFLKYKQKGKFPKRSVWINFDDM-DKTIYQNAYPVLKKYKIPATGFVITGHIG 
                                   :: : :.**:  :     .    * : :: ** ::    :  
 
2C79            DSTA----AIIRRMVNSGHEIGNHSWSYSG-------------MANMSPDQIRKSIADTN 
2J13            TQ-----KDLLLRMKDEGHIIGNHSWSHPD-------------FTAVNDEKLREELTSVT 
2W3Z            DKVK----PILQRQITEGHALGIHSFSHVY--------SLLYPNRVGNTQQIVSEVTRTQ 
capiB           EKNFHNLDMITQPQLSKMYRSGLWDFETHTNDLHSLKKGNKSKFLEASNVSATKDIEVSE 
                 .       :      . :  *  .:.                     . .::..:     
 
2C79            AVIQKYAGTT--PKFFRPPNLETSPTL-FN-NVDLVFVG---GLTANDWIPST------- 
2J13            EEIKKVTGQKE-VKYVRPPRGVFS-ERTLALTKEMGYYNVFWSLAFLDWKV--------- 
2W3Z            NALKDQLGQNFKTGVWRYPGGHLSWTGLEAADKQLA-AQ---GIQWMDWNAAVGDAEPLA 
capiB           DELKSKFGKTQ--HAIAYPYGLINNSKIQAS-KDAGMKY---GFTL-------------- 
                  ::.  * .        *    .         :        .:                 
 
2C79            -----TAEQR----A-AAVINGVRDGTIILLHDVQPEPHPTPEALDIIIPTLKSRGYEFV 
2J13            ------DEQRGWQYAHNNVMTMIHPGSILLLHAIS-KD--NAEALAKIIDDLREKGYHFK 
2W3Z            TRPTTVASMLAFLDG-SAKIATNPNVQVVLMHDIS-EKTITLASLPQIIRYYKDRGYTFA 
capiB           ------------------------KEQAVTPHDN-------NYKIPRILV----SNDAFE 
                                            :  *            :  *:      .  *  
 
2C79            TLTELFTLKGVPIDPSVKRMYNSVPLEHHHHHH 
2J13            SLDDLVK----------------------SNQP 
2W3Z            VL------------------------------K 
capiB           TLIKKW----------------------DGFHE 
                 *                                
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capiC           ---MNKNRLELVYLRTFICIIIIVTHLLTQITLEHEHLSGSSLVLQYYIRNIVIFGTPSF 57 
YFIQ_BACSU      -----MQIKEIFMIRCISCLSVVLLHIISMVLMLQAEALADISHTVDSFRTLLMFSTPAF 55 
MDMB_STRMY      MPPRVVRLPSLTGLRWFAALAVFACHIAQQQFFADQQVG----TALLHITTLGSIAVSVF 56 
OAC_BPSFV       ----MHKSNCFDTARLVAAMMVLVSHHYALSGQPEPYLFG--------FESAGGIAVIIF 48 
                      .   :   * . .: :.  *        .             : .   :..  * 
 
capiC           IVLSQLLTTLNYKS--VSVQYLISRFKYIFIPYLLVG-----LFYSYSESLLTASSFKKQ 110 
YFIQ_BACSU      IFISEFLLARSYPDG-VPDGFLKKRGKVIFVPFLFIAAIDALLMTSAMGGEVTFLAFVQK 114 
MDMB_STRMY      FLLSGFVLAWSARDKDSVTTFWRRRFAKIYPLHLVTFLIAGVIIFSLAEPTLPGGSVWDG 116 
OAC_BPSFV       FSISGYLISKSAIRSDSFIDFMAKRARRIFP-ALVPCSILTYFLFGWILNDFSAEYFSHD 107 
                : :*  : : .         :   *   *:   *.       :: .     ..   . .  
 
capiC           FFENVILGQWYG-------------YFIIIIMQFFILSYLIYKINYKLFNSKILLVLAFV 157 
YFIQ_BACSU      YLANVFLGNFIG-------------YFILVIFQFYMLHMMFHEY-LKKASPKWVLSISFV 160 
MDMB_STRMY      LVPDLLLVQSWLPEPTIIAGFNTPSWSLSCEFAFYLTFPLWYRLVRKIPVRRLWWCAAGI 176 
OAC_BPSFV       IVRKTISSIFMS-------------QAPDADITSHLIHAGINGSLWTLPLEFLCYIITGV 154 
                 . . :                         :  .:          .          : : 
 
capiC           VQQTFLYYFNHSDAFHTFVKHYYPLSENTMILGWIFYFFLGGFIGYNYQRVLSFLEKYLV 217 
YFIQ_BACSU      VTAAYLGYFSAASPAPASEEGGAFPFFWVPFAGWLFYFCLAYYCGKEYKRFLALLNQYRW 220 
MDMB_STRMY      AAAVICVPFVTSQFPASAETAPGMPLNELWFACWLPPVRMLEFV---LGIVMALILRTGV 233 
OAC_BPSFV       AVAHLKNGKAFIVILLVFVS-LSLIGSVSENRDVMFSIPLWLYP----LRGLAFFFGATM 209 
                .                                 :  . :  :        ::::      
 
capiC           IMIMLALGSYVLFIALSGD-DYWNVTSFTYSLTLYNSIMFFVLIG---ICAHFKTMLLNT 273 
YFIQ_BACSU      VVYGAAIASGALVVTVSYVGEIGMISSKRPDIMLYSTSMIFLCFH---LFSKMKHVPK-I 276 
MDMB_STRMY      WRGPGVVSSALLLAAAYGVTQVVPPMFTIAACSIVPAALLITALANADVQGLRTGLRSAV 293 
OAC_BPSFV       AMYEKSWNVSNVKITVVSLLAMYAYASYGKGIDYTMTCYILVSFS---TIAICTSVGDPL 266 
                           :  :                     :  ::  :      .  . :     
 
capiC           VQMISAFSFFIYLLHPIILDSLFAYTN-------IFEDNTVVFLAVSLLMIIGICIGVGM 326 
YFIQ_BACSU      MMFISNYSFSIYLLHAYFMIIGYVLLL-------NMPEIPAVPAVLLLFAVCTAGPIMTS 329 
MDMB_STRMY      LVRLGEWSFAFYLVHFMVIRYGHRLMGGELGYARQWSTASAGALALAMLAVAIVAGGLLH 353 
OAC_BPSFV       VKGRFDYSYGVYIYAFPVQQVVINTLH--------------MGFYPSMLLSAVTVLFLSH 312 
                :     :*: .*:    .                             ::        :   
 
capiC           MLREFYIFRFVIGKQPYKLQFNNYQPSWKSH--- 357 
YFIQ_BACSU      WALNKFKYGYLFVGKIYQPKQKKVTVEVRDHAG- 362 
MDMB_STRMY      TVVENPCMRLLGRRRPVATAPDPATDEAPKLTRA 387 
OAC_BPSFV       LSWNLVEKRFLTRSSPKLSLD------------- 333 
                   :      :                        
Figure 4.6. Alignment of amino acid sequence of IcaC with several acyltransferases. Highly conserved amino 
acid residues are indicated by stars under the alignment. YFIQ_BACSU, acyltransferase mdmB from 
Streptomyces mycarofaciens. capiC, IcaC from S. capitis. MDMB_STRMY, membrane-bound acyltransferase 
yfiQ from Bacillus subtilis. OAC_BPSFV, O-acetyl transferase from Enterobacteria phage. Highly conserved 
amino acid residues are indicated with stars under the alignment. Conserved residues are denoted by red. 
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capiD           MVKPRQRKYPTVKSSLNIVRESLFIAISCAFWIYCVVVMIVYIGTLINSQVESVITIRIA 60 
epiD            MVKPRQRQYPTVTSYLNIVRESLFITISGVFWMYCIVVMIVYIGTLINSQMESVITIRIA 60 
                *******:****.* **********:** .**:**:**************:********* 
 
capiD           LNVENIEIYKIFELMGLFSIIIFLFFTFSLIFQKIKKGREV 101 
epiD            LNVENTEIYKLFGWMSLFVLIIFIFFTFSLAFQKYKKGRDI 101 
                ***** ****:*  *.** :***:****** *** ****:: 
Figure 4.7. Alignment of S. capitis IcaD with its counterparts of S. epidermidis. capiD, IcaD of S. capitis. epiD, 
IcaD of S. epidermidis. Conserved residues are indicated with stars under the alignment. 
 
 
 
 
 
 
 
Figure 4.8. Interaction of IcaR and the ica operator in S. epidermidis. The partial palindromic sequence is 
highlighted with yellow. Approximate locations of the interface with different IcaR monomers are shown as 
colour bars. Triangles, circles and stars indicate the locations of the key residues Leu23, Lys33 and Ala35, 
respectively (Jeng et al., 2008). The palindromic sequence is located from 730 to 757 bp in the published 
sequence (accession number, SEU43366). 
 
 
 
 
 
 
capiR     ACAGCCTAACTAACGAAAGGTAGGTAGA 
epiR      ACAACCTAACTAACGAAAGGTAGGTGAA 
          *** *********************  * 
Figure 4.9. Comparison of the Deduced IcaR palindromic sequence of S. capitis with that of S. epidermidis. 
The partial palindromic sequence of S. epidermidis is highlighted with yellow. Approximate locations of the 
interface with different IcaR monomers are shown as colour bars. The identical sequences were indicated 
with stars under the alignment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10. The position of the deduced palindromic sequence of S. capitis in the ica operon of isolate 6. The 
deduced palindromic sequence is a 28-bp fragment, highlighted with blue, locating from position 981 to 1008 
bp from 5’ to 3’ end, the sequence is indicated. 
 
 
5’ acaacctaactaacgaaaggtaggtgaa 3’ 
3’ tgttggattgattgctttccatccactt 5’ 
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capiR           LKNKIIDNAITLFSEKGYYGTTLDDIAKSVNIKKASLYYHYDNKEEIYRKSVENCFNYFK 60 
Caprae          LKNKIIDNAITLFSEKGYYGTTLDDIAKSVNIKKASLYYHYSNKEEIYRKSVENCFNYFK 60 
epiR            MKDKIIDNAITLFSEKGYDGTTLDDISKSVNIKKASLYYHYDNKEEIYRKSVENCFNYFI 60 
AurR            LKDKIIDNAITLFSEKGYDGTTLDDIAKSVNIKKASLYYHFDSKKSIYEQSVKCCFDYLN 60 
                :*:*************** *******:*************:..*:.**.:**: **:*:  
 
capiR           TFILESNNDSNYSIDGLYQFLFEFIFDIDERYIRLYVQLSSAPEELSSEIHNHLLGVNEV 120 
Caprae          TFILENNSDSNYSIDGLYQFLFEFIFDIDERYIRLYVQLSSAPDELTPEIHNHLKEVNEV 120 
epiR            DFLLR-NHDDNYSIDGLYQFLFKFIFDVDERYIKLYVQLSSAPEALNSEIKHHLQEINTT 119 
AurR            NIIMMNQNKSNYSIDALYQFLFEFIFDIEERYIRMYVQLSNTPEEFSGNIYGQIQDLNQS 120 
                 :::  : ..*****.******:****::****::*****.:*: :. :*  ::  :*   
 
capiR           LDSEIIKYYDPSNISMGKEDFQNLILLFLESWYLRASFSQRFGVTEENKNCYKDQVYSLL 180 
Caprae          LDSEIIRYYDPSEMSMGKEDFQNLILLFLESWYLRASFSQKFGVIEENKNCYKDQVYSLL 180 
epiR            LHDELIKYYDPTHIALDKEDFINLILLFLETWYFRASFSQKFGIIEDSKNRFKDQVYSLL 179 
AurR            LSKEIAKFYDESKIKMTKEDFQNLILLFLESWYLKASFSQKFGAVEESKSQFKDEVYSLL 180 
                * .*: ::** :.: : **** ********:**::*****:**  *:.*. :**:***** 
 
capiR           NVFIKK---- 186 
Caprae          NVFVKNNFGN 190 
epiR            NVFLKK---- 185 
AurR            NIFLKK---- 186 
                *:*:*:     
 
Figure 4.11. Alignment of the helix-turn-helix of S. epidermidis with other staphylococcus icaR genes. capiR, 
icaR of S. capitis. Caprae, icaR of S. caprae. epiR, icaR of S. epidermidis. AurR, icaR of S. aureus. The H-T-
H sequence is highlighted with yellow colour. 
 
 
 
4.3.5 Putative mechanisms of Ica proteins in the polysaccharide 
synthesis pathway  
 
IcaA is a protein of 412 amino acids length, which shares 83% identity to that of in S. 
epidermidis and functions as a glycosyltransferase by secondary structure prediction. 
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Figure 4.12.  The putative catalytic mechanism for an inverting nucleotide-sugar glycosyltransferase 
(Charnock and Davies, 1999). Likely catalytic mechanism for an inverting NDP-sugar transferase. An α-linked 
nucleotide-diphospho-sugar donor yields a product with β-configuration. The sugar acceptor is activated for 
nucleophilic attack by a general base. It is widely believed that a divalent metal ion (Mn2+) assists leaving 
group departure. 
 
 
 
 
 
 
 
Figure 4.13. Schematic representation of a nucleotide-diphosho-sugar transferase from Bacillus subtili, SpsA 
(protein data bank code), which has similarity to IcaA of S. capitis (18% identity). This figure is indicating the 
position of important catalytic and UDP-binding residues. 
 
Similar to SpsA (Figure 4.13), In IcaA of S. capitis, the N-terminal region is a classical 
nucleotide-binding domain, the “signature motifs” DXD of family GT-2 are contained in 
this N-terminal UDP binding domain. The C-terminal domain is the site for binding of the 
acceptor species. 
 
Similar to that of S. epidermidis, the topology of IcaA in S. capitis shows that it is 
membrane-bound (Figure 4.14), which is a correlate with its essential transferase activity. 
 
 
D D 
A domain 
Nucleotide-binding 
B domain 
Acceptor-binding 
“DXD” 
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Figure 4.14. Hydrophobicity plots of IcaA of S. capitis 6. Five transmembrane helices in IcaA are present, with 
one is located at the N terminus and four at the C terminus. 
 
  
IcaD is predicted to be a 101 amino acid cytoplasmic membrane protein. No concrete 
function has been proposed for IcaD in the pathway of polysaccharide synthesis. It has 
been reported that, in S. epidermidis, IcaA alone exhibited a weak glycosyltransferase 
activity. Analysis by thin layer chromatography revealed that the IcaAD mature protein 
synthesized extended oligomers of a maximal length of 20 residues, but did not form 
polymers comprising full-length polysaccharide intercellular adhesion (PIA), which are at 
least 130 residues in length (Gerke et al., 1998). It has been proposed that IcaD might be 
necessary to activate the conformation of IcaA protein. Two transmembrane domains are 
presented in IcaD (Figure 4.15), it might act as a chaperone to direct the membrane 
insertion of IcaA according to Gerke et al. (1998).  
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Figure 4.15. Hydrophobicity plot of IcaD of S. capitis 6. Two transmembrane helices in IcaA are present. 
 
IcaB is predicted to have a length of 287-amino-acids, with an N-terminal 30-amino-acid 
signal sequence (Figure 4.16), resulting in 257 amino acids in length for the final mature 
protein. Figure 4.17 shows the hodrophobicity of the matured IcaB protein, without the 
signal peptide. Secondary structure analysis revealed that IcaB contains a putative 
polysaccharide N-deacetylase and belongs to the carbohydrate esterase family 4 (CE4), 
(Wang et al., 2004) suggesting that IcaB may modify polysaccharides during synthesis. 
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Figure 4.16. Signal protein prediction of IcaB. The presence and location of signal peptide cleavage site in 
amino acid sequences is indicated.  Most likely cleavage site is between position 30 and 31: AQA-DE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17. Hydrophobicity plot of IcaB of S. capitis 6 with removal of the 30 amino acid signal peptide.  
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The IcaC protein of S. capitis is predicted to be a transmembrane protein has a length of 
357 amino acids with 10 transmembrane domains (Figure 4.18). The conserved 
functional domain search revealed that IcaC is homologous to an acetyltransferase from 
Bacillus subtilis (26% identity). The activity of IcaC may be required for modifying the 
growing polysaccharide chain according to the reaction:  
   
Acetyl-CoA + polysaccharide              Acetyl-polysacchride + CoA.  
 
The enzyme requires acetyl-CoA for its activity. It might transfers the acetyl-group from 
the acetyl-CoA to polysaccharide located outside of membrane, and CoA returns to the 
cell. The conserved histidine residue highlighted in the alignment is likely to be 
responsible for the deprotonation of the substrates. The other conserved residues may 
have functions in the catalysis. This protein confers an opposite modification of 
polysaccharide correspond to that of IcaB. The combination of IcaBC might be necessary 
for the bacteria to avoid the host immune system. Similarly, the oatA acetyltransferase of 
S. aureus aids resistance to the host immune defence. OatA is distantly related to IcaC.   
(Bera et al., 2006).  
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Figure 4.18. Hydrophobicity plot of IcaC of S. capitis isolate 6. 
 
4.4 Discussion 
4.4.1 The status of ica operon in S. capitis  
The DNA sequence of ica operon in S. capitis were identified in this study. It contains four 
structural genes closely related to S. caprae, S. epidermidis and S. aureus icaA, icaD, 
icaB and icaC gene (≥65% identity). The regulatory icaR gene (≥ 70% identity), is located 
upstream of icaA, transcribed in an opposite direction. The amino acid sequences 
deduced from the genes exhibited 66% to 94% identity to those of S. caprae, S. 
epidermidis and S. aureus. This operon was present in all the sixty clinical isolates in the 
same length, suggesting the biofilm-negative phenotype is not related to the insertion of a 
mobile element such as an insertion sequence or a transposon. The ica operon has been 
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verified is required for the biosynthesis of polysaccharide intercellular adhesion (PIA) in S. 
epidermidis and S. aureus. The degree of identity to other staphylococcus species at 
DNA and protein level suggests a similar function of ica operon in S. capitis. 
 
Sequence comparison between the ica operon of the two bofilm positive isolates revealed 
even belonging to two PFGE types, the ica operon are of 100% identity. However, the 
three biofilm-negative isolates showed sequence variations. Isolate 44 had a deletion 
mutation in the -10 promoter element compared with that of biofilm-positive isolates 
(Chapter 6). This mutation might prevent the transcription of the ica genes, resulting in 
the inability to express PIA. In isolate 65, a stop codon occurred in the icaB gene; this 
nonsense mutation resulted in a predicted truncated protein, missing 69 C-terminal amino 
acids. An in-frame three amino acid deletion in the icaA gene of isolate 17 was identified 
(in IcaA, Gln192, Ser193, and Ile194) and Ala195 was substituted with Pro. Figure 4.19 shows 
the topology of icaA in 17. The changes of its membrane-protein topology (four 
transmembrane locations) compared with that of 6 (five transmembrane locations) (Figure 
4.14), might lead to the inability to produce biofilm in this isolate. 
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Figure 4.19. Hydrophobicity plot of IcaA of isolate 17. The arrow shows the position of change of 
hydrophobicity in isolate 17 compared with the wildtype profile (Figure 4.14). 
 
4.4.2 The putative function of Ica proteins in S. capitis  
The structures of Ica proteins have been proposed by performing multiple alignments with 
known protein structures. IcaA protein was shown similarity to a superfamily 
glycosyltransferase, at the highest identity of 19%. IcaB was shown homologous to 
polysaccharide deacetylase with 19% the highest identity. IcaC contains a conserved 
domain which is homologous to acyltransferase with 26% the highest identity. The IcaB 
and IcaC proteins in S. capitis seem to exhibit opposite functions. This might assist the 
bacteria escaping from the host immune system by modifying the polysaachrides. No 
functional structure has been identified homologous to lcaD, it shows 79% identity to that 
to S. epidermidis, might confer the similar function, that the gene is co-expressed with 
IcaA, produces a longer N-Acetylglucosamine oligomers and increases the enzyme 
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activities (Gerke et al., 1998). The sequence analyses presented here suggest that IcaA 
and IcaD, are involved in the biosynthesis of the sugar backbone of PIA. IcaAD may 
constitute N-acetylglucosaminyltransferase activity in which IcaA represents the structual 
transferase that requires IcaD for full activity. IcaC may facilitate transfer of synthesised 
sugar to the outside of the membrane, and IcaB, might be responsible for modification of 
the polysaachride polymer.  
 
4.4.3 Origin of the ica operon in S. capitis 
The Ica proteins show remote homology to the well-defined functional protein families. 
This suggests the ica operon has existed for millions of years, long time before the 
hospitals were established. The accumulation of many mutations in the ica operon of 
biofilm-negative isolates, suggests the ancient origin of this phenotype. It is possible that 
the ica operon in biofilm-negative isolates has existed longer time due to the mutations on 
the genes. The genetic origin of ica genes in staphylococci is unknown. It is also 
uncertain how biofilm-forming isolates establish and disseminate within the hospital 
setting. The operon might be initially transmitted into hospital by transduction mediated 
via bacterial phage. It was suggested that horizontal gene transfer between staphylococci 
and other low-GC gram-positive bacteria is common and contributes to resistance and 
virulence development (Al-Talib et al., 2010). Occurrence of the ica operon in S. capitis 
strains of different genetic backgrounds would suggest mobility and horizontal transfer of 
the operon of biofilm-mediating genes among these strains. The close contact of bacteria 
within a biofilm may facilitate horizontal exchange of genetic information.  
 
In summary, the entire ica operon was identified and analysed. It showed similarities to 
that of other staphylococcus species. And it showed identical DNA sequences between 
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two biofilm-positive isolates, which belong to subsp. urealyticus. Several point mutations 
occurred in the ica operon in biofilm-negative isolates confirmed to be subsp. capitis. 
Whether these mutations were critical factors causing the biofilm-negative phenotype in 
these isolates remains a question to be answered, as biofilm formation is regulated by 
numerous factors. Many of the variations in the ica operons of bioflim-negative subsp. 
capitis might simply be natural variation in this group of S. capitis isolates. The putative 
function of Ica proteins in S. capitis was also proposed based on online bioinformatics 
tools. However, the computer-based prediction remains to be examined by actual 
experiments such as gene knock-out.  
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CHAPTER 5 
 
Effects of sub-inhibitory concentrations of 
erythromycin on the expression of biofilm-
related genes and biofilm formation in 
clinical Staphylococcus capitis isolates 
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5.1 Introduction 
Recent studies indicated the emergence of S. capitis as a significant pathogen causing 
late-onset sepsis in very-low-birth-weight (VLBW) infants (1,500g) (Ng et al., 2006, Van 
Der Zwet et al., 2002). The pathogenic potential of S. capitis has been attributed to the 
ability to form biofilms on polymer surface (Nalmas et al., 2008).  
 
Biofilm formation proceeds in two processes (Heilmann et al., 1996). Primary attachment 
of bacterial cells to a polymer surface is followed by accumulation of bacteria in a 
multilayered biofilm. The synthesis of polysaccharide intercellular adhesion (PIA), which 
mediates cell-to-cell adhesion, has been recognized to be essential for cell accumulation 
in S. epidermidis. The icaADBC operon is responsible for its synthesis (Cramton et al., 
1999). The icaADBC locus has been detected in S. aureus and a range of other 
coagulase negative staphylococci (CoNS) and was confirmed to be prevalent in all sixty 
clinical isolates that examined (Chapter 4). 
 
Phenotypically, biofilm formation is affected by various environmental conditions 
(Dobinsky et al., 2003, Knobloch et al., 2001a, Cotter et al., 2009). Although there is 
limited knowledge on the regulation of the ica operon, recent data suggest the 
involvement of positive sigma factor rsbU, icaR, and sarA (Weiss et al., 2009, Knobloch 
et al., 2004). 
 
It has been shown that sub-inhibitory antibiotic concentrations can influence the 
expression of important bacterial virulence factors of bacteria, such as adhesins and 
toxins (Bernardo et al., 2004b, Cummins et al., 2009). In addition, several reports showed 
sub-inhibitory concentrations of tetracycline and erythromycin enhanced biofilm formation 
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in S. epidermidis (Rachid et al., 2000, Wang et al., 2010). However, there is no 
information on S. capitis. 
 
The aim of this study was: 1. to examine the effects of sub-inhibitory concentrations of 
erythromycin on biofilm formation in the two subspecies of S. capitis. 2. To assess 
transcriptional activities of biofilm-related genes in the two subspecies in the presence of 
erythromycin to gain an insight into the regulatory mechanisms.  
 
5.2 Materials and methods 
5.2.1 Bacterial strains and growth conditions 
Clinical isolates 6, 17, 44, 65 and 70 which have had the ica operons sequenced 
(Chapter 4) were used for testing the effects of sub-inhibitory concentrations of 
erythromycin on biofilm formation. Two isolates, 6 and 44, were selected as 
representatives for the gene expression study. Isolate 6 belongs to subspecies 
urealyticus, is a biofilm producer in TSB supplemented with 4% NaCl. Isolate 44 belongs 
to subspecies capitis, exhibits a biofilm-negative phenotype when grown in TSB 
supplemented with NaCl. Both isolates carry the ica operon in the same length, however, 
some mutations occurred in the ica operon of isolate 44, based on sequence analysis.  
 
Because the bacterial cell pellets in TSB were too sticky for RNA isolation, therefore, 
Brain Heart Infusion (BHI) (Oxiod, Australia) was used in gene expression experiment as 
a substitution. The two isolates 6 and 44 selected for gene expression assay were grown 
in BHI broth containing 0.85% NaCl (not supplemented) in the presence of erythromycin 
concentrations at 1/32 and 1/2 of the MICs of 6 and 44, respectively. Cultures were 
incubated at 37 °C aerobically with gentle shaking. The MIC of erythromycin for isolate 6 
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is 512 µg/mL; it was grown in 16 µg/mL of erythromycin, which is the serum achievable 
concentration (Baltch et al., 1998). The MIC of erythromycin for isolate 44 is 0.5 µg/mL, a 
sub-inhibitory concentration 0.25 µg/mL, was used to grow this bacterium. After 
measurement of the optical density of the cultures, the bacteria were harvested for RNA 
extractions as described subsequently. 
 
5.2.2 Phenotypic characterization of biofilm formation by microtitre 
plate assay (MtP) 
 
The test was performed following the method described by Christensen et al. (1985), with 
minor modifications. Briefly, overnight cultures were diluted 1:100 with Trypticase Soy 
Broth (TSB) (Oxiod, Australia) containing 0.85% NaCl with various concentrations of 
erythromycin, dependent on the MICs of each isolate, and 200 µL per well were seeded 
in 96-well microtiter plates (Corning, Australia). The plates were incubated at 37°C for 20 
hours. After four washes in phosphate buffered saline solution (pH 7.2), wells were dried 
for 1 hour at 55°C, and the adherent biofilms were stained with Hücker crystal violet. 
Finally, the plates were rinsed under running tap water, air-dried, and OD595nm was read 
by a POLARstar Omega (BMG, Labtech pty. Ltd., Australia). In accordance with the 
original method, isolates with OD595nm 0.12 were considered as negative (NP), those with 
OD values 0.12 and 0.24 were regarded as weak biofilm-producers (WP). An OD 0.24 
was indicative of biofilm-producing bacteria strains (P). For each isolate the MtP test was 
repeated in duplicate, and consistent results were obtained.  
 
The dose-dependent responses of biofilm formation in isolate 6 were examined. The 
concentraions used were from 1/2 × MIC (256 µg/mL) to 1/128 × MIC (4 µg/mL) 
according to MIC test for erythromycin.  
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5.2.3 Growth curve construction for isolates 6 and 44 
Isolates 6 and 44 were grown in 10 mL of BHI broth in 37 °C for 16 hours with shaking at 
170 rpm. Five hundred microliters of each overnight culture was inoculated into 50 mL of 
pre-warmed BHI containing 0.85% NaCl with 16 or 0.25 µg/mL of erythromycin (for 
isolates 6 and 44, respectively). Cultures were incubated at 37°C, with gentle shaking. 
The amount of growth of bacterial cultures was measured by spectrophotometry at 
OD600nm and viable counts were performed by standard plate count every two hours for 
the first 8 hours, then at longer intervals for 24 hours for isolate 6 or 48 hours for isolate 
44. Each growth curve was repeated in a separate experiment and plate count was 
duplicated for each growth.  
 
5.2.4 RNA isolation  
For RNA isolation from culture, bacteria were grown in BHI containing 0.85% NaCl with 
and without erythromycin to the desired growth phase. A pellet of approximately 5×109 
bacteria was then resuspended in 1 ml RLT buffer  (QIAGEN), and the mixture was 
disrupted with 0.5 ml of 0.1mm glass beads in a high-speed Mini BeadBeater-8 (BioSpec 
Products, USA). Total RNA was isolated as directed in the instructions provided by the 
manufacturer of QIAGEN. RNA was isolated and purified as described previously 
(Chapter 2 section 2.5.2). 
 
Contaminating DNA was degraded by digesting RNA samples with TURBO DNA-free Kit 
as described previously (Chapter 2 section 2.5.2.2). 
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5.2.5 Quantification of specific transcripts with real-time RT-PCR 
Oligonucleotide primers used in the gene regulation study are listed in Table 5.1. Forward 
primers were used for reverse transcription. The cDNA synthesis was performed using 
the RNeasy® Mini Kit (QIAGEN, Australia) according to manufacture’s instruction with 
modification. For each gene, a dilution series of newly synthesized cDNA was included in 
quantitative PCR to examine the efficiency of PCR and subsequent relative quantitative 
calculations. 
 
RNA for reverse transcription was isolated from two separate cultures of isolates of 6 and 
44. Briefly, one microgram of RNA and 0.4 µM of primer in a total volume of 14 µL were 
heated at 65 °C for 10 mins and immediately chilled on ice for at least 3 mins. The 
reverse transcription reaction master mix was prepared in a total volume of 5 µL, which 
consisted of 2 µL of 1×RT buffer, 2 µL of 5mM dNTP, and 2 U of RNAase inhibitor. The 
mixture was gently mixed, added to the RNA-primer mixture followed by addition of 1 µL 
of reverse transcriptase (200 U/µL). Reverse transcriptase was substituted by RNase-free 
water for the negative control. The reaction mixture was gently mixed, incubated at 37 °C 
for 1 hour. After cDNA synthesis, 230 µL of molecular-grade water was added to the 
samples. 
 
Quantitative PCR was performed with the MiniOpticon (Bio-Rad) using iQ SYBR Green 
Supermix (Bio-Rad) according to the manufacturer’s instructions. The PCR reaction was 
performed in a total volume of 25 µL consisting of 12.5 µL of iQ SYBR Green Supermix, 1 
µL of 10 µM forward and reverse primers respectively, 2.5 µL of the diluted cDNA 
solution, and 8 µL of molecular-grade water. Primers icaAf/r, icaRf/r, sarAf/r and rsbUf/r 
were used for amplifying the cDNA-specific fragments for the icaA, icaR, sarA and rsbU 
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gene, respectively. Each PCR was performed in triplicate. PCR conditions were as 
follows: cycle1 (1×): 95 °C for 5 min; cycle 2 (40×): 95 °C for 30 s, 55 °C for 30 s, 72 °C 
for 30 s; cycle 3 (100×): 95 °C for 10 s (decrease setpoint temperature after cycle 2 by 
0.5 °C, and enable melt curve data collection and analysis). Each specific amplicon was 
verified by the presence of a single melting temperature peak and by the presence of a 
single band of expected size on a 2.5% agarose gel after electrophoresis. Cycle threshold 
values were determined by the CFX softeware (Bio-Rad).  
 
The relative changes in gene transcription between the included and calibrated samples 
were calculated using the method described by QIGEN. Briefly, mid-log phase RNA was 
extracted and reverse transcribed to cDNA, 10 fold dilutions were used to generate a 
standard curve for every gene by using the Cycle Threshold (Ct) versus the logarithm of 
each dilution factor. Total RNA was extracted from two independent bacterial cultures. All 
reactions for each target gene were performed in triplicate and in the same PCR run. 
 
Standard curves were constructed for both target and reference gene by plotting Ct 
values (Y-axis) against the log of template amount of dilution (X-axis). The amount of 
target and reference cDNA was calculated in samples of interest using the Ct value and 
corresponding standard curve. The amount of target cDNA was divided by the amount of 
reference cDNA to calculate the normalized amount of target. The normalized target 
amount of untreated sample (calibrator) was set as 1; the relative expression level of 
target gene in samples of interest calculated by dividing the normalized target amounts by 
the value of the calibrator.
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                  Table 5.1. Primers used for gene regulations in this study. 
Gene Forward primer (5’ to 3’) Reverse primer (5’ to 3’) Accession No. Origin (source) 
icaA GGGCTATGGAAACAACG TGTCGGATACCAACTCAC AY146582 This study 
icaR CAACAACGATTCTAACTACTC TGGATAATTGGACGTATAACC AY146584 This study 
sarA ACGAACACGATGAAAGAACAG TTCGCTTCAGTGATACGTTTG NZ_ACFR01000002 This study 
rsbU CTCTATTTCGTGCCTCAG GTGTGCTTGGAGTAAGTC AFTX01000024 This study 
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5.2.6 Validation of housekeeping genes for quantitative PCR 
Candidate reference genes were selected from those most commonly used in the 
literature (Vandecasteele et al., 2001, Theis et al., 2007). All the primers for these 
housekeeping genes are listed in Table 5.2. The genes: gyrB, encoding the B subunit of 
the DNA gyrase; recA, encoding protein RecA, which contributes to homologous 
recombination, DNA repair, and the SOS response; tuf, encoding elongation factor Tu;  
rpoB, encoding the β subunit of bacterial RNA polymerase; and sodA, encoding the 
manganese-dependent superoxide dismutase selected and validated. PCR primers used 
in this study are listed in Table 5.2. All the primers were designed using Clone manager 7 
(Scientific and Educational Software, USA). The reverse transcriptase quantitative PCR 
reactions and standard curves were set up as described above. 
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              Table 5.2. Primers of the housekeeping genes used in this study. 
Gene Forward primer (5’ to 3’) Reverse primer (5’ to 3’) Accession No. Origin (source) 
gyrB CCTCCAGCATGTAATACC GAGGCTTGCACCATTTAG CP000029 Conlon et al., 2002 
recA TAAAGTAGCACCTCCATTCAG CCAAGCACCAGATTTATCAAC 
   
FN554702 This study 
rpoB AGTTGTAACCGTCCCAAGTC AATGGCACTGAACACGAAGG NZ_ACFR01000002 This study 
tuf CTGAAGCTGGTGACAACATC ACGTCCACCTTCGTCTTTAG AF298798 This study 
sodA TCAGCAGTTGAAGGAACAG TGACCGCCACCATTATTAC AJ343941 This study 
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5.2.7 Statistical analysis 
Data were presented as means ± standard errors of the mean (SEM). A statistical test 
was applied to look for significant differences between experimental conditions for each 
candidate housekeeping gene. A one-way analysis of variance (ANOVA) was conducted, 
followed by Dunnett’s post-hoc analysis to compare each time set against the control 
group mean. A p value < 0.05 was considered statistically different. Calculations were 
performed using the SPSS software (SPSS Inc).   
 
5.2.8 Sequence alignment 
Intergenic regions between icaA and icaR gene in the ica operon of isolates 6 and 44 
were aligned by using ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) with default 
parameter in this study.  
 
5.3 Results 
5.3.1 Biofilm formation of S. capitis in response to erythromycin 
The five isolates (6, 17, 44, 65 and 70) for which the ica operons had been sequenced 
were tested their biofilm formation in the presence of erythromycin. They represented the 
two subspecies. The concentrations of erythromycin used in biofilm assay were 
determined by their MIC values, respectively. Sub-inhibitory concentrations were 
employed. 
 
The results showed that erythromycin induced biofilm formation in isolate 6, a strong 
biofilm producer under standard biofilm assay conditions (TSB with 4% NaCl), in a dose 
dependent manner (Figure 5.1); the OD595nm in the presence of 1/32 × MIC (16 µg/mL) 
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the amount of biofilm produced was only half of that produced at 1/2 × MIC (256 µg/mL).  
However, the other biofilm-positive isolate 70, only marginally enhanced its biofilm 
production in the presence of ½ (0.25 µg/mL) × MIC. This is probably due to its low MIC 
value (0.5 µg/mL), the sub-inhibitory concentrations were not high enough to increase its 
biofilm production. Among the three biofilm-negative isolates, 17 (MIC, 2 µg/mL) formed 
weak biofilm in the presence of 1 µg/mL of erythromycin, its OD595nm increased from 0.06 
± 0.004 to 0.24 ± 0.008. The other two biofilm-negative isolates, 44 (MIC, 0.5 µg/mL) and 
65 (MIC, 0.25 µg/mL), remained biofilm-negative in the presence of erythromycin (Figure 
5.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Biofilm formation of isolate 6 in the presence of sub-inhibitory concentrations of erythromycin. 
Error bars indicate standard error means, and the assay was tested in triplicate experiments. 
 
 
Biofilm formation decreased at 256 µg/mL of erythromycin, it is probably due to the 
inhibition of erythromycin at this high concentration, resulted in lower cell number for 
biofilm production. The actual values of biofilm formation at 128 and 64 µg/mL were 
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probably higher than shown in the figure; it was believed go beyond the range of the 
measure of the machine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2. Biofilm formation of isolates in the presence and absence of erythromycin (ERY). The 
concentration of ERY used for isolate 6 is 16 µg/mL, 1/32 × MIC. The concentrations for all the other isolates 
were 1/2 × MICs, respectively. (Isolate 17, 1 µg/mL; isolate 44, 0.25 µg/mL; isolate 65, 0.125 µg/mL; isolate 
70, 0.25 µg/mL). Error bars indicate standard error means, and the assay was tested in duplicate 
experiments.    p < 0.05;        p < 0.01. 
 
 
 
5.3.2 Growth curves 
To determine the desired growth phase to be employed for the gene regulation study, the 
growth of isolates 6 and 44 were examined in the presence and absence of erythromycin 
(Figures 5.3 and 5.4). 
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Figure 5.3. Growth of isolate 6 in the presence of 16 µg/mL (1/32 × MIC) of erythromycin compared with no 
erythromycin. Error bars indicate standard error means. The growth curves were tested in duplicate 
experiments. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4. Growth of isolate 44 in the presence of 0.25 µg/mL (1/2 × MIC) of erythromycin compared with no 
erythromycin. Error bars indicate standard error means.  The growth curves were tested in duplicate 
experiments. 
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From the growth curves shown above, it can be seen that isolate 6, of which MIC is 512 
µg/mL, delayed the time to reach mid log phase in the presence of erythromycin. It 
reached mid-log phased approximately 2 hours latter when it was grown in the presence 
of 16 µg/mL of erythromycin, compare with growth in BHI without erythromycin. The level 
of 16 µg/mL of erythromycin is a serum achievable concentration (Baltch et al., 1998). 
Isolate 44 displayed a different growth manner in the presence of its 1/2 × MIC (0.25 
µg/mL), probably because the resistant bacterial population grew out the inhibition of the 
antibiotic. The cell population was still increasing after 12 hours incubation and continued 
to increase until 24 hours of incubation. However, erythromycin did not change its time to 
reach mid log phase. This isolate reached mid-log phase at about 4 hours’ growth in both 
the absence and presence of erythromycin.  
 
5.3.3 Validation of housekeeping genes for reverse transcriptase real-
time PCR 
 
The gene expression of candidate housekeeping genes tuf, recA, gyrB, rpoB and sodA, 
was examined for isolate 6. The bacterial pellets were collected at mid-log phase in the 
presence and absence of erythromycin, and were shown in Figure 5.5. 
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As shown in the graphs, the expression of three housekeeping genes tuf, sodA and rpoB 
differed significantly under the two conditions. The expression of tuf and rpoB decreased, 
whereas the expression of sodA increased in the presence of erythromycin. The gyrB and 
recA genes were stable under this stress factor. 
 
5.3.4 Primary sequence analysis of intergenic region located between the 
icaR and icaA in S. capitis 
 
The primary sequence of the intergenic region from icaA to icaR gene in the ica operon of 
isolate 6 is shown in Figure 5.6, with deduced promoter elements for icaA and icaR gene 
and the SarA binding site. Figure 5.7 shows the comparison of the intergenic regions of 
ica operon of isolates 6 and 44. A single nucleiotide T was deleted in the -10 elecment of 
isolate 44.  
 
 
   1  ttctaaaatc tcccccttat ttaatttaaa ttcgttatat tacaggaaaa 
      aagattttag agggggaata aattaaattt aagcaatata atgtcctttt 
 
  51  ttaagttaaa attacaaata ttactgttca agtataacaa cattctattg 
      aattcaattt taatgtttat aatgacaagt tcatattgtt gtaagataac 
 
 101  caaattgaaa cactttcgat tagtatatgc gatacagcct aactaacgaa 
      gtttaacttt gtgaaagcta atcatatacg ctatgtcgga ttgattgctt 
 
 151  aggtaggtag ataag 
      tccatccatc tattc 
 
Figure 5.6. The primary intergenic region of isolate 6.The putative promoter region of icaA gene -10 and -35 
boxes and its ribosome binding site (RBS) deduced from Vadeboncoeur et al. (2000)  are highlighted with 
grey. The icaR promoter regions and ribosome binding site are highlighted with yellow. The SarA binding site 
deduced from (Chien et al., 1999) is highlighted with red. 
Figure 5.5. Effects of erythromycin (16 µg/mL) on the expression of housekeeping genes: a, tuf; b, gyrB; c, recA; 
d, rpoB; e, sodA. Changes in gene expression were analysed by One-way ANOVA (see methods for details). 
Error bars indicate standard error means.  Each gene was assessed in triplicate experiment.      p < 0.05,         
     p < 0.01 vs. no erythromycin controls. ERY, erythromycin.   
-10 RBS 
-35 
-35 
-10 RBS 
SarA binding site 
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6      TTCTAAAATCTCCCCCTTATTTAATTTAAATTCGTTATATTACAGGAAAATTAAGTTAAA 60 
44     TTCTAAAATCTCCCCCTTATTTAATTTAAATTCGTTATATTACAGGAAAATTAAGTTAAA 60 
       ************************************************************ 
 
6      ATTACAAATATTACTGTTCAAGTATAACAACATTCTATTGCAAATTGAAACACTTTCGAT 120 
44     ATTACAAATATTACTGTTCAAGTATAACAACATTCTATTGCAAATTGAAACACTTTCGAT 120 
       ************************************************************ 
 
6      TAGTATATGCGATACAGCCTAACTAACGAAAGGTAGGTAGATAAG 165 
44     TAG-ATATGCGATACAACCTAACTAACGAAAGGTAGGTAGATAAG 164 
       *** ************ **************************** 
Figure 5.7. Alignment of intergenic region of ica operon in isolate 6 and 44. The putative promoter region of 
icaA -35 and -10 boxes and the ribosome binding site are indicated by underlining the selected sequence in 
the sequence of 6. 
 
5.3.5 Example of calculation to demonstrate calculation of relative gene 
expression   
 
Expression of the four genes: icaA, icaR, sarA, and rsbU was assessed in response to 
erythromycin in clinical isolates 6 and 44 using mid-log planktonic cells.  
 
Standard curves of the four target genes and the housekeeping gene gyrB were 
constructed based on the cycle threshold values versus the log cDNA of isolate 6. These 
curves were used as consensus standards for both isolates in subsequent relative 
expression calculations (Figure 5.8).  
-35 
RBS -10 
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Figure 5.8. Relative quantification with different PCR efficiencies. Standard curves were generated for icaA, 
icaR, sarA, rsbU and the housekeeping gene gyrB using cDNA. Real-time RT-PCR was performed using 
gene-specific primers indicated previously. Error bars indicate standard error means, each gene was run 
duplicated, if an unexpected value occurred, another run was performed.   
 
 
The relative amounts of target and reference cDNA were determined using the 
appropriate standard curve.  Relative gene expression of the four target genes in the 
presence of erythromycin is summarized in Table 5.5. 
 
Generally, the results revealed the two isolates 6 and 44 responded differently to 
erythromycin at mid-log phase. In isolate 6, icaA and sarA gene showed elevated 
expression, whereas rsbU and icaR were down-regulated compared with untreated cells. 
A reverse manner of reaction to erythromycin was observed in isolate 44. In mid-log 
phase, icaR, the repressor of ica operon, showed a strong up-regulation. However, the 
icaA and sarA genes were down-regulated. The rsbU gene was weakly up-regulated in 
this growth stage. 
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The relative expression of the icaA gene of isolate 6 in the presence of erythromycin was 
used as an example to demonstrate relative quantification. Table 5.3 shows the data 
used to generate standard curves. 
 
               Table 5.3. Data used to generate standard curve of icaA gene.  
Template 
amount (ng) 
Log ng total 
cDNA (gyrB) 
Ct (Mean) 
gyrB icaA 
1000 3 14.12 19.25833 
100 2 17.24833 22.49833 
10 1 20.36167 25.88 
1 0 23.79667 29.29167 
0.1 -1 27.43 32.56 
0.01 -2 30.39833 36.62 
Slope 
 
-3.2963 -3.4401 
PCR efficiency 
 
93.30% 91.35% 
 
 
 
 
 Table 5.4. Quantification and normalization of icaA and gyrB expression levels. 
Sample icaA Ct gyrB Ct 
icaA cDNA 
amount 
gyrB cDNA 
amount 
Normalized 
amount  Ratio 
ERY 0 31.16833 27.62833 -0.51258 -1.13895 0.45 1 
ERY 16 33.30167 27.27167 -1.13272 -1.03075 1.09893 2.4421 
 
Bacterial cells were untreated or treated with 16 µg/mL of erythromycin. Total RNA was 
purified and, after real-time RT-PCR, the relative amounts of target and reference cDNA 
were determined using the appropriate standard curve (see Figure 5.7). The calculation 
of normalized amount of both treated and untreated was described in methods.  
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Table 5.5. Relative gene expression of biofilm-related genes in S. capitis in the presence 
of erythromycin at mid-log phase. 
Gene 
Relative gene expression 
Isolate 6 
(subsp. urealyticus 
biofilm-positive) 
Isolate 44 
(subsp. capitis 
biofilm-negative) 
icaA 2.4421 0.257462 
icaR 0.6641 8.0586 
SarA 1.522337 0.76512 
rsbU 0.665441 1.1241 
 
 
 
5.4 Discussion 
5.4.1 Validation of housekeeping genes 
Accurate normalization of gene-expression levels is an absolute prerequisite for reliable 
results for expression of genes of interest. Ideally, the internal control genes for 
expression studies should not be influenced by the conditions of the experiments. Five 
housekeeping genes tuf, gyrB, recA, rpoB and sodA have been demonstrated to be the 
least affected in the presence of a range of conditions (Theis et al., 2007). They were 
chosen and evaluated by real-time reverse transcriptase PCR in this study. The genes 
gyrB and recA were shown to be stably expressed, whereas all the others were 
influenced by the current experimental conditions. The gyrB gene was selected for the 
subsequent regulation study due to its reliable cycle threshold value (about 27 ± 0.13) in 
the presence and absence of erythromycin. Therefore, the internal control used for the 
gene expression study as the normaliser has been validated.    
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5.4.2 Transcriptional analysis of biofilm-related genes in response to 
erythromycin  
 
It has been reported that numerous environmental factors such as high osmolarity (NaCl), 
ethanol, oxygen, antibiotics can affect biofilm formation in staphylococci (Cotter et al., 
2009, Dobinsky et al., 2003, Rachid et al., 2000). In this study, the phenotypic expression 
of biofilm formation of clinical S. capitis was shown to be influenced by erythromycin. Four 
genes, icaA, icaR, sarA (which encodes a global factor) and rsbU (a positive regulator for 
the activity of σB) have been identified to be involved in biofilm formation in S. epidermidis 
and S. aureus (Trotonda et al., 2005, Tormo et al., 2005). To assess whether the 
expression of these genes in S. capitis is affected by erythromycin and to what extent, 
real-time reverse transcriptase PCR was performed with RNA prepared from mid-log 
phase planktonic cells of clinical isolates 6 and 44, which represent the two subspecies of 
S. capitis.  
 
The results revealed different responses of these two isolates to erythromycin. In isolate 
6, which is a biofilm producer and belonging to subsp. urealyticus, the expression of icaA 
and sarA gene were up-regulated, and icaR was down-expressed. This result is 
consistent with the results of the phenotypic assay and the findings of other studies which 
demonstrated that SarA is an essential positive regulator of biofilm formation in S. 
epidermidis (Tormo et al., 2005); however, it represses icaR expression in S. aureus 
(Cerca et al., 2008). (Handke et al., 2007) suggested that SarA has a direct effect on the 
ica transcription. In this study, the conserved SarA binding site was identified, located 
upstream of the icaA promoter and overlapping with the icaR promoter at the -35 region 
in the primary sequence of the intergenic region of S. capitis (Figure 5.5). Combined with 
the results of the expression study, these results suggested that SarA confers a similar 
role in biofilm formation in S. capitis to that of S. epidermidis. RsbU regulates biofilm 
andke et al. ( ) 
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formation via activation of sigma factor repressing the icaR expression in S. epidermidis. 
In contrast to this study, rsbU was shown down-regulated in mid log phase compared with 
untreated cells in S. capitis. The down-regulation did not lead to the decrease of icaA 
expression and up-regulation of icaR in this isolate. A probable explanation for this finding 
is the presence an alternative sigma factor which activates sigma B, thereby, modulating 
biofilm development in S. capitis. Alternatively, the regulation by RsbU may start at a 
different time point, such as stationary phase. This possibly needs testing by further 
experiments.  
 
Surprisingly, in isolate 44, the same four genes displayed a reverse expression manner, 
compared with expression in isolate 6. Both icaA and sarA were down-regulated and icaR 
was up-expressed in the presence of erythromycin. This result indirectly demonstrated 
the icaA promoter in isolate 44 is functional, even though a single nucleotide deletion was 
revealed by sequence comparison, as shown in Figure 5.6. rsbU expression was 
marginally increased, however, the expected effects on icaA and icaR were not observed. 
It can’t be concluded that the biofilm-negative phenotype of this isolate is due to its gene 
regulation system at this stage. Further experiments are needed to assess the gene 
expression at different time points. Also, several clinical isolates with similar background 
(PFGE type) should be used to investigate the gene expression to address the roles of 
these regulators in biofilm formation in this subspecies. 
 
In addition, isolate 17, which exhibits a biofilm-negative phenotype in 4% NaCl, and 
belongs to subsp. urealyticus, produced weak biofilm in the presence of its half MIC of 
erythromycin. This suggests an alternative biofilm formation pathway was adopted in the 
presence of erythromycin in this isolate.    
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In summary, despite the observations presented above, the mechanisms underlying the 
biofilm formation induced by erythromycin in S. capitis is far from being elucidated. 
However, these preliminary studies provide a fundamental knowledge guiding future 
experiments. 
  
In addition to sarA and rsbU, several other global regulators have recently been identified 
impacting biofilm formation in staphylococci. In Bacillus subtilis, Spx was characterized as 
a novel type of global regulator whose activity is regulated by the redox status of the cells 
(Rochat et al., 2012). In S. aureus, Spx affects biofilm formation via modulating the 
expression of icaR (Pamp  et al., 2006). LuxS, the two-component of quorum sensing 
system, negatively regulates biofilm formation in S. epidermidis (Xu et al., 2006a). The 
erythromycin-induced biofilm formation shown in this study might be representative of the 
macrolide class of antibiotics, and may have clinical implications, particular for medical 
device-related bacterial biofilm infections, since the levels of erythromycin at which S. 
capitis biofilm formation were enhanced are readily achievable in the clinical setting. 
Further studies of erythromycin-induced biofilm growth in S. capitis are warranted. 
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CHAPTER 6 
 
ica operon disruption for the analysis of 
its function in clinical Staphylococcus 
capitis isolate 
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6.1 Introduction  
Clinical isolates of coagulase-negative staphylococci (CoNS) often elaborate a biofilm 
involved in adherence and accumulation on medical devices and resistance to host 
defences.  The staphylococci elaborate a polysaccharide adhesion (PIA), which mediates 
cell adherence to biomaterials, termed polysaccharide intercellular adhesin (PIA), which 
is thought to mediate bacterial accumulation into cellular aggregates. PIA is a polymer of 
β-1, 6-linked N-acetyl glucosamine, encoded by the ica locus and is well studied in S. 
epidermidis and S. aureus (Heilmann et al., 1996, Gerke et al., 1998).  
 
Biofilm formation in S. capitis has been rarely studied, and whether the biofilm is 
biosynthesized by products of ica locus is unknown. The ica locus was present in all sixty 
clinical isolates examined in this study (Chapter 4). Most of the isolates produced biofilm 
only under certain conditions. Sequencing results showed some single nucleotide 
variations between the biofilm positive and negative isolates.  
 
Gene targeting is a powerful molecular genetic technique that has been widely used to 
understand specific gene function in vivo (Lenaerts et al., 2003, Matsuda et al., 2004). To 
elucidate the function of the ica locus in S. capitis, attempts were made to generate a 
gene knock-out mutant of a biofilm positive isolate. Although the attempts were 
unsuccessful, the process of troubleshooting and the problems encountered provides 
valuable lessons for future research. 
 
Construction of stable knockouts requires the exchange by homologous recombination of 
a chromosomal wild-type gene with a mutated or inactivated allele. The established 
method for allele replacement requires the use of an antibiotic resistance cassette to 
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mark the mutated allele or gene deletion. A tetracycline resistant gene from S. aureus 
was used as the selective marker for allele exchange in this study. The method involves 
the construction of a plasmid that is temperature sensitive for replication and is a shuttle 
vector that can replicate in both Escherichia coli and Staphylococcus spp. Initially, the 
shuttle vector was constructed in E. coli and then transformed into a clinical S. capitis 
isolate of interest. 
 
6.2 Materials and Methods 
6.2.1 Antibiotic susceptibility tests  
Antibiotic susceptibility tests were used to select an appropriate antibiotic sensitive strain 
as the cloning host. Eleven biofilm positive isolates, that displayed a susceptible 
phenotype, were initially selected according to the antibiotic resistant profile determined in 
previous tests. Minimum inhibition concentrations (MICs) of chloramphenicol and 
tetracycline were determined according to the CLSI guidelines (Wikler, 2006). 
Chloramphenicol and tetracycline were used as antibiotic selection markers in the 
subsequent allele exchange. 
 
6.2.2 Bacterial strains and growth conditions 
The bacterial strains and plasmids used in this study are listed in Table 6.1. For genetic 
manipulation, clinical isolate 60 was chosen. This isolate and its derivatives were grown 
in trypticase soy broth (TSB) at 30, 37 and 42 °C. When necessary, tetracycline at 2 or 3 
µg/mL, chloramphenicol at 8 or 10 µg/mL were added to the medium. Escherichia coli 
DH5α was grown in nutrient broth (NB) containing, when necessary, ampicillin at 100 µg/ 
mL. Solid medium was prepared by addition of 1.3% agar. 
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Table 6.1. Strains and plasmids used in this study. 
Strain or 
plasmid Genotype or relevant characteristics 
Origin or 
references 
S. capitis 60 Wild-type clinical isolate, biofilm positive 
(Royal Children 
Hospital, 
Melbourne) 
E. coli DH5α 
F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK- mK+), λ- (Laboratory stock) 
pBT2 
Low-copy-number shuttle vector with Ampr in E. coli and 
temperature-sensitive replication with Cmr in S. aureus (Brükner, 1997) 
pSK7749 
Donator of tet gene (Tetr). A HindIII fragment carrying the 
tetA(K) gene 
(Simpson et al., 
2000) 
pBT∆tetA(K) 
Mutant vector for homologous recombination of the ica 
gene cluster in S. capitis. tetA(K) was used to insert into 
ica locus as resistance selection marker (This study) 
Abbreviations: Ampr, Tetr, Cmr, resistance to ampicillin, tetracycline and chloramphenicol, respectively. 
 
6.2.3 Construction of the tetracycline resistance cassette plasmids 
The ica operon was replaced with the tetracycline resistant gene tetA(K)from plasmid 
pSK7749 (Simpson et al., 2000) by homologous recombination. The E. coli-
Staphylococcus shuttle vector pBT2 was used for cloning the mutagenesis construct. 
Plasmid constructions were carried out in E. coli DH5α.  
 
First, a 700 bp DNA fragment upstream and containing part of icaR gene of clinical isolate 
6 was amplified by phusion DNA polymerase (NEB, Australia) with primers EcoRI-RF2 
(5’-CTCCGAATTCAAGAGCACCCACAATGAC-3’) and SacI-RR (5’-
CGCCGAGCTCCTATAGATGGGCTTTACCAG-3’).  PCRs were performed according to 
manufacture’s instruction, as follows: PCR master mixes were prepared containing 1x 
Phusion HF Buffer, 250 µM dNTPs, 0.4 µM of each forward and reverse primer, 0.5 U 
Taq DNA polymerase and 50 ng DNA. PCR reactions were performed on a PCR Express 
thermal cycler at one cycle at 98 °C for 30 s, followed by 25 cycles of 98 °C, 10 s; 52 °C, 
30 s; 72 °C for 23 mins, final elongation 7 mins at 72 °C for 1 cycle and hold at 4 °C.  The 
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PCR product was digested with EcoRI and SacI enzymes (Section 2.4.1.5) (NEB, 
Australia), and then cloned into the plasmid pBT2 via EcoRI and SacI sites, resulted in 
plasmid pBT2-A. This construct was transformed into competent E. coli DH5α by 
electroporation (Section 2.4.1.8). Positive clones were selected on NA plates containing 
100 µg/mL of ampicillin. Secondly, a 720 bp DNA fragment downstream and containing 
partial icaC gene was amplified with primers Xmal-CR (5’-
TGCGCCCGGGTACGGTTCAAATGGTAAGC-3’) and BamHI-lipF (5’-
CTGCGGATCCTTCCCATTCACGGTAACTG-3’).  The PCRs were performed the same 
as the previous insert, except for annealing at 58 °C. This PCR product was digested with 
XmaI and BamHI (Section 2.4.1.5) (NEB, Australia), and cloned into pBT2-A via XmaI 
and BamHI sites (Section 2.4.1.8), resulted in plasmid pBT2-B. Finally, the pBT2-B 
plasmid was linearized with SmaI (Section 2.4.1.5). A 1700 bp HindIII (NEB, Australia) 
fragment from pSK7749, encompassing the tetA(K) gene and its promoter was digested 
with HindIII and filled in with klenow (NEB, Australia) according to manufacture’s 
instructions. Briefly, master mix containing 10 U of Klenow, 1× NEBuffer 2, and 1 µL of 
2.5 mM dNTPs (Bioline, Australia) were incubated at 37 °C for 30 mins. The Klenow was 
then heat inactivated at 75 °C for 20 mins. The linearized vector was dephosphorylated 
with Antarctic Phosphatase (NEB, Australia) according to the manufacture’s instructions. 
Briefly, 1× Antarctic Phosphatase Reaction Buffer was added to 4 µg of DNA cut with 
SmaI. Five units of Antarctic Phosphatase was added and mixed gently. The reaction 
mixture was incubated for 15 mins at 37°C. Heat inactivated for 5 mins at 65°C. Both the 
filled-in fragment and the dephosphorylated vector were purified with QIAEX® II Gel 
Extraction Kit according to manufacture’s instruction.  Then proceeded blunt end ligation 
as follows: the ligation mixture contained 1 × T4 Buffer, 2 µg of the linearized vector, 2 µg 
of insert, 10 U of T4 DNA ligase, and Polyethylene glycol (PEG) (13 %) (Sigma) in a 20-
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µL of reaction, the mixture was incubated at 22 °C for 4 hours, resulted in the final 
mutagenesis construct pBT2∆tetA(K). These plasmids were confirmed by sequencing 
using the ABI sequencing mix V3.1 according to the manufacturer’s instructions. Figure 
6.1 shows the flow chart for the series of cloning. 
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Figure 6.1. Construction of the mutant vector pBT2∆tetA(K). The blue and pink fragments represent the inserted flanking fragments, upstream of icaR gene and 
downstream of icaC gene respectively. 
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6.2.4 Plasmid isolation 
Plasmid DNA prepared from E. coli was purified with QIAprep spin Miniprep Kit 
(Qiagen, Australia) according to the manufacturer’s instructions. After purification, the 
DNA was concentrated by ethanol precipitation. Briefly, 1/10 volume of 3 M Na-acetate 
pH 5.2, and 2 to 2.5 volumes of ice-cold 100% ethanol were added to the DNA sample , 
mixed, and stored at -20°C for at least 1 hour to precipitate the DNA. The precipitated 
DNA was recovered by centrifugation at full speed in a microcentrifuge for 15-20 mins at 
4 °C. The ethanol was poured off and the pellet was washed twice with room-temperature 
70% ethanol. The DNA pellets were air-dried. The DNA was resuspended in a suitable 
volume of molecular grade water to a final concentration of at least 4 µg/µL. 
 
6.2.5 Introduction of recombinant plasmid DNA into S. capitis isolate 
6.2.5.1 Preparation of electro-competent cells of clinical S. capitis isolate 60  
Staphylococcus capitis strain 60 was used as bacterial host in the allele exchange 
experiments. The bacterial cells were grown in TSB medium.  
 
First, to determine the effects of growth phase and optimal cell number for making 
electroporation-competent cells, a growth curve was generated by growing the bacteria in 
TSB at 37°C for 5 hours, sampling at 1-hour intervals.  The OD600nm was measured; 
colonies were counted on NA plates. 
 
6.2.5.2 Making competent cells according to the optimized protocol: 
A 5 mL volume of an overnight culture of a fresh colony of S. capitis isolate 60 was 
inoculated into 500 mL of TSB. The culture was incubated with shaking at 200 rpm at 37 
°C until the OD600nm was 0.5. The cells were divided into 4 sterile bottles, and placed on 
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ice for 30 min to stop the cell growth. The cells were harvested by centrifugation at 
12,000 g for 15 mins at 4 °C, then washed three times with 500 mL, 250 mL then 80 mL 
of sterile ice-cold MilliQ water, harvesting by centrifugation at 12,000 g for 15 mins at 4 °C 
between each washing. The cells were resuspended in 10 mL ice-cold 10% glycerol, then 
washed once with 5 mL ice-cold 10% glycerol. Finally, the cells were resuspended with 1 
mL ice-cold 10% glycerol at a cell density of about 4.5×1010 cells/mL. Aliquots of 100 µL 
of cells were immediately distributed in ice-chilled eppendorf tubes and stored in -80 °C 
for no more than three months. 
 
6.2.5.3 Heat inactivation of the host restriction system of S. capitis isolate 60    
In order to determine the optimal temperature and exposure time intervals for inactivation 
of the host restriction system, a viability test was performed at 46, 49, 52 and 55 °C. 
Three vials of electrocompetent cells for each temperature were incubated at different 
temperatures and the samples were removed from the heat block every minute for 5 
mins. Immediately after removal from the heat block, the samples were diluted in TSB. 
Five dilutions were chosen for subsequent viable counts: 10-3, 10-4, 10-5, 10-6 and 10-7. 
Duplicate aliquots were spread on NA plates without antibiotics, and incubated at 37 °C 
for 24 hours. The optimal temperature and time combination for transformation of 
electrocompetent cells was determined as the highest temperature which did not affect 
cell viability during a given exposure time.   
 
6.2.5.4 Electroporation procedures  
The optimized electroporation protocol was as follows: competent cells were placed on 
ice for 5 mins or until thawed and incubated at room temperature for 20 mins. The host 
restriction system was heat inactivated by exposure to 55 °C for 1 min. Immediately after 
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removal from the heat block, competent cells were placed on ice and 500 µL 
electroporation buffer at room temperature consisting of 0.5 M sucrose and 10% glycerol 
was added to the cells, then the cells were pelleted by centrifugation at 5000 g for 15 
mins at 4 °C and resuspended in 60-70 µL of the electroporation buffer. The cells were 
incubated at room temperature for 30 mins. The plasmid from E. coli was thawed; about 
4-5 µg was added to the cells and the mixture was incubated at room temperature for 10 
mins prior to electroporation. Parameters for electroporation were set as: 100 Ω, field 
strength 2.1 kV/cm, at room temperature, and with 1 mm gap electroporation cuvettes. 
Immediately after electroporation, 1 mL of fresh TSB medium was added and the cells 
were transferred into a 10 mL tube, and incubated at 37 °C for 2 hours. The cells were 
diluted 1/10 in TSB medium, plated on Heart Infusion Agar (HIA) (Oxiod, Australia) 
containing 5 µg/mL of chloramphenicol, and incubated at 30 °C for 4-5 days. 
 
6.2.5.4 Analysing and interpreting results: calculating transformation efficiency 
The average colonies grown on the chloramphenicol plates were determined and the 
amount of DNA that was spread on each plate was calculated. The example below was 
used to calculate the transformation efficiency. 
 
The amount of DNA plated on each plate: 1 µL of 4 µg/µL of freshly made stock plasmid 
DNA was added to 100 µL of competent cells. After transformation, 900 µL of TSB was 
added prior to expression. 10 µL (equivalent to 40 ng of DNA) was then diluted in 990 µL 
of TSB broth and 100 µL (equivalent to 4 ng) is plated on a single plate. 
 
If 100 colonies are counted on the plate, the transformation efficiency is:  
100 transformants/4 ng X 1000ng/µg=2.5 x104 transformants/µg of DNA 
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6.2.6 Confirmation of the transformants 
Confirmation of transformants was performed as follows: first, colonies on the 
chloramphenicol plates were gram stained to make sure they are not contaminated, then 
the colonies were streaked on fresh chloramphenicol plates to obtain a pure culture, then 
incubated at 30 °C for 72 hours. Finally, plasmid isolations were performed using 
QIAGEN kit with modifications: four to five fresh colonies were inoculated into 4 x10 mL of 
5 µg/mL chloramphenicol TSB broth, incubated at 30 °C with shaking at 170 rpm for 16 
hours, until the OD600nm reached 1.3, (~1×108 cell/mL). This number is critical to 
determine the amount of enzymes used subsequently. The overnight bacterial culture 
was centrifuged at 4700 rpm, 15 mins at 4 °C, then the cells were resuspended with 2 mL 
of P1 buffer (0.5 mL for each tube) and 300 µg/mL of lysostaphin and 300 µg/mL of 
lysozyme were added. The cells were incubated at 37 °C, with shaking at 100 rpm, for 15 
mins to partially break cell wall. After this, 200 µg/mL of proteinase K was added to 
remove native cell proteins, such as DNase, and incubated at 37 °C, for 30 mins, with 
shaking at 100 rpm. Then the instructions of the QIAGEN kit were followed. The plasmid 
concentrations were 10 to 20 µg/mL for recombinant strain 60. About 500 ng of the 
purified plasmid was run on a DNA gel to confirm that transformation had been 
successful. Also, the constructed mutant vector was further confirmed by digested with 
EcoRI and PstI restriction enzymes. 
 
6.2.7 Induction of tetracycline resistance in S. capitis 
A single colony of the transfermant under test was inoculated in 10 mL of NB containing 
0.25, 0.5, 0.75, 1, and 1.9 µg/mL of tetracycline, respectively, and incubated at 30 °C for 
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14-16 hours with shaking. When the culture reached to stationary phase, the OD600nm 1.0, 
the cell density was ~ 108 cell/mL, 100 µL aliquot of each culture were inoculated onto NA 
plates containing 0.5, 1, 2, 3, 5, 8, and 10 µg/mL of tetracycline, and incubated at 30 °C 
for 4-5 days. Uninduced culture and the host strain were used as controls.  
 
6.2.8 Glycerol stock  
The colonies obtained after induction with tetracycline were streaked on NA containing 3 
µg/mL of tetracycline and incubated at 30 °C to obtain a pure culture. A single colony was 
grown in NB containing 2 µg/mL of tetracycline at 30 °C until the OD600nm measured 0.5, 
0.85 mL of this bacterial culture was added 0.15 mL of sterile glycerol, mixed, then stored 
in -80 °C.  
 
6.2.9 Optimized procedure for gene replacement in S. capitis  
6.2.9.1 Plasmid curing 
Ethidium bromide (EB) was used as chemical curing agent to eliminate plasmid(s) of the 
recombinant strain. Prior to curing, inhibition tests were performed on this strain to 
determine a sub-lethal concentration of EB. Concentrations of 10, 20, 30, 40, 50, 60, 70, 
80, 90, 100 120, 150 and 200 µg/mL of EB were tested. The EB was inoculated with the 
recombinant strain (107 cells/mL) in 96-well microtitre plates, and incubated at 37 and 42 
°C for 24 hours, in the dark. All EB concentrations were set up in triplicate. The sub-lethal 
concentration was defined as the highest concentration which did not affect bacterial 
growth. 
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6.2.9.2 Growth curves of the recombinant strain in EB combined at different temperatures 
A single colony of the recombinant strain being tested was inoculated into a 10-mL of 
TSB containing 2 µg/mL of tetracycline, incubated at 30 °C with shaking at 100 rpm 
overnight. This overnight culture was diluted 1:100 in a 50-mL TSB containing EB, and 
incubated at 42, 44 and 46 °C, with shaking at 100 rpm for 8 hours. The OD600nm was 
measured, and 100 µL of the cell cultures were plated on NA every 2 hours to generate 
growth curves. This test was performed in triplicate. A control without EB was performed 
at the same time at each temperature. Regression analysis was performed to examine 
whether the addition of EB affected cell growth for each temperature. In addition, the 
growth of recombinant bacteria at 37 and 40 °C without EB was examined in the same 
way. 
 
6.2.9.3 Isolation of colonies of S. capitis that had undergone allele exchange 
The recombinant strain was grown in TSB containing 2 µg Tet/mL at 30 °C to late 
stationary phase. Subsequently, the culture was diluted 1:100 in 500 mL fresh TSB 
containing EB, and the temperature was shifted to 37 and 42 °C, with shaking at 150 rpm 
for 24 hours. Then a 1/100 dilution of each culture is made into fresh TSB plus EB. These 
serial passages were continued for twelve passages. Cell plating was performed starting 
from the fourth passage. Appropriate dilutions were spread on NA and incubated at 37 °C 
for 24 hours. The colonies from these plates were patched onto chloramphenicol plates (5 
µg/mL) and NA plates. Colonies that failed to grow on the antibiotic plates were 
subcultured from the matched nutrient agar plates onto a second set of chloramphenicol 
plates to confirm curing of the plasmid. The desired tetracycline-resistant, 
chloramphenicol-sensitive colonies were further evaluated by PCR to confirm inactivation 
of ica gene cluster. Figure 6.2 shows the allelic exchange diagram. 
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Figure 6.2. Allelic exchange mutagenesis. Chromosome DNA is depicted as thick lines. Plasmid DNA is 
depicted as thin lines. Genetic features are depicted as rectangles or boxes that are differentiated by shading 
or a pattern. Arrows point to the results of recombination events. A. A chromosomally encoded wildtype copy 
of a target gene contains DNA that is homologous to a cloned mutant allele that is disrupted using a unique 
selectable marker. The mutant allele of the target gene is carried on a plasmid with a temperature-sensitive 
origin of replication and a second selectable marker. B. Bacteria mediated homologous recombination, the 
location denoted with a large cross, allows for the chromosomal integration of the plasmid containing the 
mutant allele. C. A second recombination event excises a plasmid. The resulting products are either the 
original DNA elements or a strain which now has the mutant allele of the target gene within the chromosome 
the wild-type allele on the plasmid. The products are determined by the location of the recombination events. 
If the second crossover occurs on the opposite side of the target gene-disrupting marker, the chromosome of 
the resulting bacterial will contain the mutant allele of the target gene. 
 
 
6.3 Results 
6.3.1 Confirmation of the constructed tetracycline resistance cassette in 
E. coli  
 
The mutant constructions were verified by restriction digestion, PCR and sequencing as 
shown in the Figure 6.3 and Figure 6.4. 
 
 
 
 
 
 
 
 
Figure 6.3. PCR confirmations for the flanking regions which inserted into pBT2-A and pBT2-B. a. The 
fragments flanking icaR gene, with primers EcoRI-RF2 and SacI-RR. b. The fragment flanking icaC gene, 
with primers Xmal-CR and BamHI-lipF. The fragmens for both a & b are of expected sizes. λ/PstI, DNA 
Ladder. 
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Fgure 6.4. Verification of the mutant construction with restriction digestion. Lane1 and Lane 5, uncut vector 
from the same colony 1. Lane 2 to Lane 4, the vector was cut with EcoRI, BamHI and HindIII, respectively. 
Lane 6 and Lane 10, uncut vector from another colony 2. Lane 7 to Lane 9, the vector was cut with EcoRI, 
BamHI and HindIII, respectively.  
 
 
6.3.2 Selection of a clinical isolate as a host strain for allele exchange  
Genetic and physiological properties of a strain can critically influence the results of 
genetic manipulation. Most clinical isolates harbour plasmids which frequently confer 
antibiotic resistance to potential host strains. This intrinsic resistance can severely limit 
the scope of genetic manipulation. The first step in genetic engineering with clinical 
isolates is to select an appropriate strain which is plasmid-free and sensitive to the 
antibiotics to be used for selection. In this study, eleven biofilm positive isolates were 
initially chosen according to their antibiotic resistant profiles: they were susceptible to 
antibiotics used in the hospital. The MICs of chloramphenicol and tetracycline were 
further determined for these isolates, since the constructed mutagenesis plasmid carried 
the antibiotic resistant genes to those two antibiotics as selection for subsequent cloning 
and allele exchange.  
  
λ/pstI  
bp  
11501  
  1     2    3    4    5    6    7     8    9   10 
148 
 
Isolates 35, 60 and 91 were shown to be sensitive to both of the antibiotics (MICs of 
chloramphenicol were 4 µg/mL, and tetracycline were 1 µg/mL). Typing by pulsed-field 
electrophoresis (PFGE) had shown previously (Chapter 3) that these isolates belong to 
two PFGE types (35 and 91 belong to type I, 60 belongs to type II). Finally, isolate 60 was 
chosen as the host strain for genetic manipulation. 
 
6.3.3 Optimization of electroporation transformation 
Several parameters for transformation of plasmid into S. capitis were investigated as 
described below. 
 
6.3.3.1 Preparation of electrocompetent cells.  
Growth condition is important for preparing electro-competent cells. According to the 
literature (Schenk and Laddaga, 1992), B2 medium consisting of 1.0% casein 
hydrolysate, 2.5% yeast extract, 0.5% glucose, 2.5% NaCl and 0.1% K2HPO4 (pH 7.5) 
was initially chosen for growing bacteria. However, the high salt composition of this 
medium induced biofilm in strain 60, and this was considered to potentially reduce the 
competency of the cells. TSB medium was therefore used as a replacement.  
 
To determine the effects of growth phase on transformation, S. capitis isolate 60 was 
grown in TSB at 37 °C for five hours, until late log phase or early stationary phase was 
reached. Cells were harvested at three different OD600nm readings 0.2, 0.5, and 1.2 which 
represented early, mid and late exponential (log) phase stages (Figure 6.5).  The results 
demonstrated that the OD600nm 0.45-0.55 gave approximately 4- to 10-fold increase in 
transformation efficiency compared with the other time points (Figure 6.6). 
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Figure 6.5. Growth curve of the recombinant strain 60 in TSB. The means and SE values from triplicates are 
presented. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
               Figure 6.6. Effects of growth phase on transformation efficiency. The means and SE values from triplicates 
are presented.      p < 0.01. 
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6.3.3.2 Inactivation of S. capitis restriction system by heat treatment.  
Host restriction systems hinder the introduction of foreign DNA, such as plasmids, into 
bacterial strains and limit the construction of mutants and other analyses. Previous 
authors have overcome this problem by temporary inactivation of host restriction systems 
by heat treatment before electroporation (Kienesberger et al., 2007), and obtained an 
approximately 1000-fold increase in transformation efficiency for interspecies DNA 
transfer between E. coli and Salmonella Typhimurium/enteritidis.  
 
This study used a shuttle vector and DNA prepared from E. coli. To examine the effect of 
heat treatment on host restriction systems, a series of optimization experiments was 
performed. The viability of the recipient host at different temperatures and times was first 
determined by viable counts.   
 
At 55 °C, the majority of S. capitis cells were killed within the first five minutes. At 49 and 
52 °C, the viability decreased much more slowly. In contrast, heating to 46 °C for 5 mins 
had no effect on the viability within the first five minutes (Figure 6.7). 
 
The optimal conditions for heat treatment were also determined. After thawing the 
electrocompetent cells on ice, cells were incubated on a heat block at 55 °C for 1 min. A 
washing step after the heat treatment was introduced, and proved to be necessary in 
order to reduce conductivity and prevent arcing in the electroporation step.  
  
The transformation efficiency was investigated under both heat-treated and untreated 
conditions. The result showed that the short heat treatment before electroporation 
improved the transformation efficiency dramatically (Figure 6.8). 
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Figure 6.7. Cell viability after heat treatment within 5 mins. Data was shown in triplicated for each temperature 
and  time duration. Each data point represents the mean and SE of three experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8. Effects of heat-treatment on transformation efficiency. The results were shown the transformation 
efficiency by pre-treated the competent cells at 55 °C for 1 min comparing with the untreated cells.       p < 
0.01. 
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6.3.3.3 The electroporation step  
Several parameters were evaluated to study their effects on transformation frequency.  
i. Different amounts of plasmid DNA from 0.1 to 6 µg were added to the 
electroporation mixture containing about 1×1010 cells/mL. Figure 6.9 shows that 
the maximum number of transformants was obtained at 4 µg of plasmid DNA. The 
transformation efficiency reduced with increasing the plasmid DNA amount. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.9. Effects of plasmid DNA amounts in the electroporation mixture on the transformation frequency. 
The results are present as transformation efficiency. Each data point represents the mean and SE of three 
experiments. 
 
 
ii. Pre-incubation of cells with DNA  
According to a previous study, pre-incubation of cells with plasmid DNA increased 
the transformation efficiency; it was suggested that binding the DNA to the cell 
surface is necessary for efficient transformation.  
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In this study, however, no improvement in transformation efficiency was observed 
by introducing a pre-electroporation step.  Four microgram of plasmid DNA was 
incubated with electroporation mixture for 1 min, 5 mins, 10 mins and 30 mins 
prior to electroporation, but no changes in the transformation efficiency were 
observed. At 30 mins pre-incubation, the transformation efficiency decreased 
significantly at 30 mins incubation (Figure 6.10), possibly due to cell lysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.10. Effects of pre-incubation of DNA with cells on transformation efficiency. Each data point 
represents the mean and SE of three experiments.         p < 0.01. 
 
 
 
iii. Effect of temperature during electroporation on transformation efficiency 
Temperature during the electroporation process is considered to be an important 
factor affecting the efficiency of transformation (Schenk and Laddaga, 1992). In 
the current study, to examine the effect of temperature on the transformation 
efficiency, the complete electroporation procedure was performed both on ice and 
at room temperature. 
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Following procedure was performed: thawing the electrocompetent cells on ice, 
following incubation at room temperature for 30 mins, then subsequently 
performing the electroporation at room temperature resulted in at least eightfold 
increase in the transformation efficiency compared with cells kept on ice and 
electroporated with pre-cooled cuvettes. These results were consistent with 
previous studies (Figure 6.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.11. Effect of different temperatures during electroporation on the transformation 
efficiency. Each data point represents the mean and SE of three experiments.        p < 0.01. 
 
 
iv. Electroporation buffer 
Augustin and Götz (1990) reported that the optimal electroporation buffer for S. 
epidermidis was 10% glycerol in distilled water, and that the concentrated S. 
epidermidis cells can be stored in this buffer at -70 °C for four months without 
losing transformation capacity.  
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In this study, 0.5 M sucrose was added to the original 10% glycerol buffer, as an 
additional cryoprotector. There was no difference between the novel 
electroporation buffer compared with the original 10% glycerol buffer on 
transformation efficiency. However, the addition of sucrose reduced the risks of 
arching during electroporation (Figure 6.12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.12. Effects of electroporation buffer on transformation efficiency. Each data point 
represents the mean and SE of three experiments. 
 
 
 
 
v. Electroporation procedure 
Field strength setting up was also considered a critical factor which can affect the 
transformation efficiency. In this study, field strengths 2.1, 2.3 and 2.5 kV/cm were 
tested. The results presented in Figure 6.13 show that the optimal field strength 
was 2.1 kV/cm when using a 0.1 cm gap electroporation cuvette for 75 µL of 
transformation mixture electroporated at room temperature. The transformation 
efficiency decreased with increased field strength, possibly due to cell damages 
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because of the higher field strength.  Also, higher field strength increased the risk 
of arching. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.13. Effects of field strength on the transformation efficiency. Each data point represents the 
mean and SE of three experiments.        p < 0.01. 
 
 
The novel heat-treatment protocol combined with the optimized protocols for the 
preparation of electrocompetent cells and the electroporation procedure yielded a 
transformation efficiency of approximately 104 transformants per transformation when S. 
capitis cells were electrotransformed with plasmid DNA pBT2∆tetA(K) from E. coli. 
 
6.3.3.4 Confirmation of the transformants 
The transformed plasmids were isolated from S. capitis, verified by restriction digestion 
with EcoRI and PstI shown in Figure 6.14. The plasmids isolated from E. coli and from 
the transformed S. capitis were generated fragments of the same size when cut with the 
two restriction enzymes. 
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Figure 6.14. Verification of the transformation from plasmid isolations of the mutant vector from S. capitis. 
Lane 1 & 2, vector from E. coli; Lane 5 & 6, vector from S. capitis. Lane 1, uncut vector, Lane 2, vector was 
digested with EcoRI and PstI. Lane 5, uncut vector, Lane 6, vector was digested with EcoRI and PstI. 
 
 
6.3.4 Induction of tetracycline resistance in S. capitis  
Initially, MIC tests with tetracycline were performed in broth according to the CLSI 
guidelines, to determine the susceptibility of the recombinant strain carrying the tetA(K) 
gene on the transformed recombinant plasmid. The host strain was tested in parallel as a 
control. Cultures were incubated at 30, 37 and 42 °C. In the absence of induction, no 
difference in susceptibility was observed between the recombinant and host strains, 
which both had an MIC of 1 µg/mL of tetracycline.   
 
Next, bacteria were pre-incubated in a range of sub-inhibitory concentrations of 
tetracycline  (0.25 to 1.9 µg/mL) at 30 °C till the cell density reached to 108 cells/mL, then 
100 µL of cell suspensions were plated onto NA containing tetracycline plates (3 µg/mL).  
The untreated culture and host strain were used as controls. When comparing the two 
treatments (no pre-incubation and tetracycline pre-incubation), both the host strain and 
untreated culture only grew on 0.5 µg/mL tetracycline plates. In contrast, the tetracycline 
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pre-incubation led to 6-fold increase in resistance in the recombinant strain, from 0.5 to 3 
µg/mL of tetracycline, and the cells failed to grow in higher concentrations of tetracycline. 
Cell pre-grown with 0.75 µg/mL of tetracycline showed a significantly higher capability of 
induction of tetracycline resistance compared with other concentrations (Figure 6.15).   
 
 
 
 
 
 
 
 
 
 
Figure 6.15. Viable counts for inducible tetracycline resistance in the recombinant S. capitis strain. Each data 
point represents the mean and SE of three experiments. Pre-incubation of cells with different concentrations 
of tetracycline, grown in 30 °C, till cell density to 108 cells/mL, 100 µL of the cell suspension was plated on NA 
containing 3 µg/mL of tetracycline plates, incubated at 30 °C, for 4 to 5 days. Tc, Tetracycline.      P<0.01, 
represent significant differences. 
 
 
6.3.5 Allele exchange 
6.3.5.1 Effects of EB combined with high temperature on plasmid curing of the 
recombinant strain 
 
Initially, recombinant cells were grown at 43 °C in TSB for 7 passages (24 hours for every 
passage). No cured colony was obtained from about 10000 colonies selected. It seems 
the plasmid curing from the cells was very slow. Therefore, the curing agent (EB) 
combined with high temperature was employed to cure the plasmid subsequently.  
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Prior to the plasmid curing experiment, the sub-inhibitory concentration of EB for the 
strain was determined by inhibition tests at 37 °C and 42 °C. The cell concentration 
selected was approximately the starting cell concentration in every passage. The sub- 
inhibitory concentration was defined as the highest concentration which did not affect 
bacterial growth. Fifty microgram per mL of EB was determined to be the sub-inhibitory 
concentration for treating this strain at both temperatures. 
 
Growth of the recombinant strain with and without EB (50 µg/mL) at various temperatures 
was examined to investigate whether the EB addition affected cell growth (Figure 6.16-
18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.16. Recombinant strain grown at 42°C with and without EB in TSB. Each data point represents the 
mean and SE of three experiments. 
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Figure 6.17. Recombinant strain grown at 44°C with and without EB in TSB. Each data point represents the 
mean and SE of three experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.18. Recombinant strain grown at 46 °C with and without EB in TSB. Each data point represents the 
mean and SE of three experiments. 
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Figure 6.19. Recombinant strain grown at 37°C without EB in TSB. Each data point represents the mean and 
SE of three experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.20. Recombinant strain grown at 40°C without EB in TSB. Each data point represents the mean and 
SE of three experiments. 
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According to the results shown in the Figures 11 to 15, bacterial growth were not affected 
by 50 µg/mL of EB at each temperature tested. However, growth rates were reduced 
dramatically above 42 °C with and without EB. 
 
6.3.5.2 Rate of elimination of the mutant plasmid  
In a separate curing experiment, the rate of loss of the plasmid was determined by 
growing the bacteria in TSB containing 50 µg/mL of EB at 37 and 42 °C. Elimination of 
the plasmid was determined by determining the percentage of colonies with reduced 
resistance to chloramphenicol. Reduced chloramphenicol resistance was determined by 
streaking the colonies on NA containing 5 µg/mL of chloramphenicol and comparing with 
non-cured recombinant strain as positive control (grows at 10 µg/mL). The first observed 
elimination of plasmid was in the 4th passage (24 hours for every passage) at 42 °C.  
Between the 4th and 12th passage, totally about 4000 colonies were examined for plasmid 
curing. The plasmid curing rate ranged from 0.14% (4th passage) to 3% (12th passage).  
 
In contrast, bacteria grown in EB at 37 °C revealed that no cured colony was present 
even up to the 12th passage.  
 
Table 6.2. Plasmid curing during passage at 42 °C 
Passage 
No. of 
colonies 
Tested 
No. of 
Cured 
colonies 
aTetR (%) 
(2 µg/mL) 
bChloras 
(%) 
(5 µg/mL) 
4th 700 1 100 0.14 
6th 800 0 100 0 
8th 700 3 100 0.43 
10th 800 11 100 1.4 
12th 1000 30 100 3 
a, TetR: Tetracycline resistance. 
b, Chloras: Chloramphenicol sensitive. 
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6.3.6 Allele replacement in S. capitis 
Eight of the colonies displaying tetracycline-resistance and reduced resistance to 
chloramphenicol were selected for genotyping by PCR to determine whether the ica loci 
was replaced by the tetracycline resistant gene. It was shown that the crossover did not 
occur on both sides of the ica gene cluster by amplifying crossover regions. 
 
6.4 Discussion 
6.4.1 Optimization of the procedures for transformation 
Gram-positive bacteria are in general more resistant to plasmid DNA transformation than 
gram-negative bacteria. This is mainly attributed to its thicker cell wall, which consists of a 
single membrane and a very large exterior peptidoglycan layer, acting as a physical 
barrier for the DNA, and making efficient transformation of Gram-positive bacteria far 
more challenging (Lacks et al., 1974). 
 
In this study, the electroporation parameters were optimized for the Gram-positive 
bacterium S. capitis, yielded an approximate transformation efficiency of 4×104 
transformants per µg of DNA. A number of parameters were thoroughly investigated, 
including: (i) the preparation of electrocompetent cells; (ii) the heat treatment of cells 
before electroporation; and (iii) the electroporation step itself.  
 
6.4.1.1 Improvement of transformation efficiency via cell growth phase 
The exponential phase is the most critical cell growth phase and cells in this phase are 
recommended for use in transformation experiments to facilitate maximum exogenous 
DNA uptake. The observations of this study were consistent with the study for S. 
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epidermidis (Schenk and Laddaga, 1992). This study found optimal transformation 
efficiency was obtained when cells were harvested at mid log phase. In contrast, (Wu et 
al., 2010) found that the highest cell transformation occurred at early log phase. This is 
surprising since early log phase stage is generally coupled with lower cell density, which 
leads to lower transformation efficiency. The effect of cell number on transformation 
efficiency was not examined in the current study. Studies conducted in other species 
such as S. aureus revealed a continuous increase in cell transformation in response to a 
continuous increase in electroporation cell number (Schenk and Laddaga, 1992). In 
addition, the differences in cell wall composition during different growth phases might be 
a major contributor to the variations in transformation efficiency.    
 
6.4.1.2 Improvement of transformation efficiency by heat treatment of competent cells 
prior to electroporation 
 
One of the most important bacterial defences against uptake of foreign DNA is restriction-
modification (R-M) system. These systems, comprising restriction endonucleases and 
methyl-transferases, recognize and modify specific DNA sequences, protecting self DNA 
from restriction while eliminating potentially harmful foreign DNA which lacks appropriate 
modifications (Murray, 2000). 
 
To solve the problem of interspecies DNA transfer, a previous study used a short heat 
treatment of the competent cell in order to temporarily inactivate the host restriction 
system (Kienesberger et al., 2007). This method was optimized and successfully 
employed to enable crossing of the species restriction barrier and improve the frequency 
of transformation of S. capitis with DNA prepared from E. coli. The results suggested that 
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the restriction system doesindeed hinder DNA transfer between species, as heat 
treatment dramatically increased transformation efficiency. 
 
6.4.1.3 Effects of DNA amount on transformation efficiency 
The transformation efficiency increased linearly with the enhanced amount of DNA. The 
maximum efficiency was achieved when 4 µg of DNA was used for electroporation in 4 × 
1010 cell/mL, and slightly dropped thereafter. Similar results were obtained by Schenk and 
Laddaga (1992). 
 
There is no clear explanation for these results. Transformation efficiency is defined as the 
number of cells transformed out of one microgram DNA.  It is likely that a limited 
interaction between DNA molecules and bacterial cells could be responsible for the lower 
transformation efficiency with lower amounts of DNA. In some other species such as 
Corynebacterium pseudotuberculosis, there was an inverse proportion relationship 
between the quantity of transforming plasmid DNA and transformation efficiency (Dorella 
et al., 2006). A possible explanation may be competition or interaction of plasmid DNA 
with the cells. In addition, the salt concentration in foreign DNA might contribute to the 
reduced transformation efficiency.(Peng et al., 2009) showed that DNA desalting could 
significantly improve the transformation efficiency of Bacillus thuringiensis. 
 
6.4.1.4 Effects of temperature during electroporation on transformation efficiency. 
In this study, electroporation temperature influenced the transformation efficiency 
dramatically. This is consistent with results from Augustin and Götz, (1990), who 
demonstrated higher transformation frequencies for S. epidermidis at 20 °C than at 4 °C. 
Similar observations have also been made for S. aureus by Schenk and Laddaga (1992). 
 t l (2009) 
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The observed increases in cell transformation efficiency with incubation temperature 
could be due to higher temperature inducing the interaction of DNA molecules and the 
bacterial cell membrane.  
 
6.4.1.5 Electroporation parameters  
Field strength is an important factor in transformation. It was found that 20 KV cm-1 
achieved the highest transformation efficiency. The transformation efficiency reduced 
significantly with increasing field strength. It is suggested that cells were damaged at high 
field strength which resulted in lower efficiency. 
 
6.4.1.6 Electroporation buffer was also evaluated as a factor in electroporation 
In order to optimize electroporation, sucrose (0.5 M) was added to the original 10% 
glycerol buffer. In this buffer, sucrose possibly provided good osmolarity protection after 
heat treatment and in high electric fields. Sucrose did not improve electroporation 
efficiency, but did reduce the risk of arching during electroporation. 
 
In summary, this study supports previous findings, using other staphylococcal species, 
that temporary inactivation of host restriction system by short heat treatment, DNA 
amount, cell growth phase, electroporation temperature and electroporation parameters 
are essential variables that can efficiently be manipulated independently to enhance cell 
electro-transformation efficiency in S. capitis. 
 
6.4.2 Inducible resistance to tetracycline in the recombinant strain 60 
Resistance to tetracycline in Staphylococcus spp. is often plasmid-mediated, and usually 
inducible (Trzcinski et al., 2000). The feature of insertion of a protein or proteins in the 
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membrane envelope may be similar in all the cases. This view is supported by the data of 
(Levy et al., 1974) and (Boldur and Sompolinsky, 1974). 
 
In contrast to the observations of (ASHESHOV, 1975) that inducible tetracycline 
resistance occurred only in tetracycline resistant strains, and not in sensitive strains, the 
results presented here indicate a low-level elevation of tetracycline resistance after 
induction with tetracycline in the recombinant strain carrying a tetA(K) gene on plasmid. 
The basal resistance level of the strain was low (0.5 µg/mL of tetracycline). Similar 
findings with the gram-negative bacterium E. coli were reported by (FRANKLIN, 1967). 
There are two explanations for these findings. One is the bacterial population 
constitutively produces a small amount of the protein responsible for resistance, but this 
amount increases upon induction with tetracycline. A more likely explanation is selection 
from a heterogeneous bacterial population causing the development of tetracycline 
resistance. It might be that the population of the recombinant strain was heterogeneous, 
being composed of cells of both the sensitive and the resistant phenotype, and that only 
the resistant cells developed colonies on tetracycline plates. The experimental results 
reported here supported the second possibility. When 100 µL of the overnight induced 
culture (108 cells/ mL) was plated on tetracycline plates without dilution, no more than 
twenty colonies grew. 
 
In addition, if tetracycline was an inducer and the induction was concentration dependent, 
it would be expected that the highest concentration of the drug with no significant 
inhibitory effect would be the most rapidly effective in induction. The results in Figure 6.11 
show the highest induction was occurred at 0.75 µg/mL, while higher concentrations of 
 ( ) 
FRANKLIN (1967) 
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tetracycline did not increase the number of resistant colonies; this might be due to the 
inhibitory effects of the drug at higher concentrations.  
 
6.4.3 Allelic exchange 
Allele exchange is a classical method of using a suicide plasmid that is unable to 
replicate in the studied strain under certain conditions to deliver an inactivated allele of 
the gene in the chromosome.  Although it is easy to perform with many bacteria, it 
remains very difficult with others.  
 
In this study, a shuttle plasmid pBT2 was used to deliver the mutant allele. Although this 
method has been used to efficiently manipulate inactivation of a gene locus in other 
Staphylococcus species (Brückner, 1997), this is the first study applying it in S. capitis, in 
which the genetic and physiological properties are far less studied. Several problems 
were encountered, which made the gene knockout ultimately impractical. 
 
First, the expression of the tetracycline resistance gene in S. capitis was poor. The 
tetA(K) gene, which was used as a marker for selection to inactive the ica gene cluster,  
is carried on a HindIII fragment from a copy of a pT181-like region on the chromosome of 
a S. aureus clinical isolate (Simpson et al., 2000). After transformtion into S. capitis, the 
transformants induced in the presence of 0.75 µg/mL of tetracycline grew at on NA 
containing 3 µg/mL of tetracycline.  This is only a marginal increase in resistance 
compared with the original host strain, which grows in 0.5 µg/mL of tetracycline. The poor 
gene expression is probably due to a weak promoter (Simpson et al., 2000), or different 
gene regulation in S. capitis from that in S. aureus.  This weak gene expression made it 
extremely difficult to screen out a tetracycline resistant colony when tetA(K) is present as 
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only a single copy in the chromosome of a integrant, rather than multiple copies carried 
by a cell harbouring the mutant construct pBT2∆tetA(K). 
 
Second, the slow cell growth of the S. capitis strain made it difficult to cure plasmid from 
the cells. Initially, passaged the bacteria at 43 °C for seven days, failed to reveal a true 
mutant or cured plasmid in ten thousand colonies. This suggested the plasmids are lost 
slowly in this species or particular strain. Further examination of the growth of this strain 
at different temperatures, revealed only 2 log growths per day at ≤ 42 °C, and growth was 
even slower at higher temperatures. The replication defect of vector pBT2 is not stringent 
at 43 °C (Úbeda et al., 2007). Considering that the rate of plasmid curing depends on the 
relative rates of bacterial growth compared to that of plasmid replication in the bacteria, 
curing treatment by temperature only may not be enough to eliminate the plasmid in this 
situation if the curing frequency was extremely low. Therefore, a curing agent, EB was 
used in combination with incubation at 42 °C. Using this strategy, colonies cured of 
plasmids were obtained after four passages.  
 
Most of the plasmid cured colonies displayed the desired phenotype which is tetrCMs by 
streaking on tetracycline plates (2 µg/mL) and chloramphenicol plates (10 µg/mL). 
However, their genotypes confirmed by PCR on crossover regions revealed that gene 
replacement had not occurred at the desired loci in the chromosome. 
 
Third, reassessment of the sequences of the insertion revealed a 263-bp region located 
in the F3 fragment which was homologous to the whole genome shotgun sequence of S. 
capitis with 98% identity (Figure 6.17). A blast search showed the sequence was part of 
staphylococcal insertion element IS257. The tetA(K) gene came from a copy of a pT181-
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like plasmid co-integrated into the chromosome of SK1660 (a S. aureus clinical isolate) 
as a consequence of IS257 insertion (Simpson et al., 2000). This HindIII fragment 
carrying the tetA(K) gene was obtained from another laboratory, and was not thoroughly  
sequenced before insertion into the constructed vector. 
 
           Generally, longer homologous regions yield higher frequencies of recombination, while 
the frequency variations were observed at different genetic loci. Gene replacement can 
be achieved with 0.3 kb of homology using this system as indicated by the model paper 
(Brückener, 1997). This 263 bp homologous region might interfere with the homologous 
recombination between the flanking fragments (F1 and F2) and chromosome DNA, 
consequently reducing the occurrence of double crossover (Figure 6. 21). 
 
 
 
 
 
 
 
Figure 6.21. Mutant construct of pBT2∆tetA(K). Two flanking fragments F1, 704- bp and F2, 734-bp were 
used as homologous regions for double crossover with the chromosome. Insertion sequence is a 1700- bp 
HindIII fragment carrying the tetA(K) gene, and is located in between the two flanking regions. F3, partial 
staphylococcal insertion element of IS257. F4 plus F5, the tetA(K) gene. 
 
 
In addition, it was assumed that the relative sizes of the deletion and insertion segments 
may have a significant effect on the frequency of mutants generated by allelic exchange 
(about 3400 bp deletion versus 1700 bp insertion in this study). No experiments were 
performed to confirm this assumption. The model paper (Brückener, 1997) did not 
provide this information, while the sizes of inserts were longer or similar to that of 
pBT2∆tetA(K) 
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deletions in this paper. This might be an explanation for the differences in allelic 
exchange efficiency observed between the model paper and the present study. 
 
In summary, although not a true mutant was obtained from about 16000 colonies, 
significant outcomes were achieved in the transformation step. By optimizing parameters, 
the vector from E. coli was successfully delivered to a clinical S. capitis isolate of study 
without using the intermediate host RN4220. This saved the time needed for making 
competent cells and plasmid isolation from RN4220, and made the transformation step 
easier to perform. This method provides a platform for this kind of study and may be 
practical in a range of gram-positive bacteria. 
 
Since the double crossover and plasmid curing can be very rare events because the 
frequencies may be low and because illegitimate recombination may occur (McFadden, 
1996), allelic exchange mutants may represent only a small fraction of the transformants. 
Therefore extensive screening is required to isolate a desired mutant. Double crossover 
may be impractical in some species or a particular strain. A novel allelic replacement 
strategy with counter selectable marker has been applied in several bacterial genetic 
manipulations and proved to be particularly advantageous (Reyrat et al., 1998, Bae and 
Schneewind, 2006). The difficulties in allelic exchange encountered in this study are 
valuable lessons for future studies. 
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CHAPTER 7 
 
General discussion 
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7.1 Correlation of phenotypic biofilm formation, antibiotic 
resistant profiling and epidemiology of clinical S. capitis 
isolates 
 
Coagulase-negative staphylococci (CoNS) are the most frequent cause of late-onset 
sepsis among newborns in neonatal intensive care units (NICU). The high incidence of 
these infections is partially due to their ability to form biofilms (Venkatesh et al., 2006a). 
Biofilm formation is considered to be the most important virulence factors among this 
genus of bacteria, and has been found mediated by numerous factor, such as surface 
proteins and polysaccharide intercellular adhesion (PIA). PIA is encoded by the ica 
operon, and has been recognized to be required for biofilm formation in S. epidermidis 
(Williams et al., 2002, Gerke et al., 1998).  
 
Staphylococcus capitis, which is further divided into two subspecies, subsp. capitis and 
urealyticus, according to their distinct characteristics (urease activities and maltose 
fermentation), is part of the normal flora of the skin of the human scalp, face, neck, and 
ears and has been associated with prosthetic valve endocarditis (Nalmas et al., 2008). 
Staphylococcus capitis has recently been endemic in the Royal Women’s Hospital NICU, 
causing blood-stream infections in newborn infants. In current study, antibiotic resistance 
and biofilm formation in clinically significant S. capitis isolates were examined, to gain an 
insight into their establishment and transmission in the clinical setting. 
 
Most of the biofilm producing S. capitis isolated from newborns belonged to subsp. 
urealyticus, and were clustered into three major PFGE types (I, II and III). These isolates 
represent the predominant clones prevalent in the NICU setting. The other isolates 
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exhibited a biofilm-negative phenotype, mainly belonged to subsp. capitis, were grouped 
into a single PFGE type V, and only sporadically occurred over the years of the study.  
Antibiotic profiling showed increased antibiotic resistance was associated with enhanced 
biofilm formation in the isolates. These results are consistent with other studies (Ziebuhr 
et al., 2006). This association between biofilm formation and antibiotic resistance could 
be explained if the antibiotics utilized in the hospital drove the selection of certain PFGE 
types which containing bacterial communities expressing biofilm under conditions 
encountered on the skin of newborns and and on inserted catheters. One significant 
observation in this study was shown a strong association between the biofilm formation 
and the carriage of the mecA gene, which codes for methicillin (oxacillin) resistance. This 
finding is in agreement with that of (Hira et al., 2007), in which, S. epidermidis isolates 
causing sepsis collected in a NICU were examined for the incidence of mecA and icaA 
genes. MecA was present 87% of the biofilm producing icaA carriers.  
 
Although most subsp. urealyticus isolates belonging to the major PFGE types, exhibited 
the biofilm-positive phenotype, several other isolates classified in these PFGE types were 
biofilm-negative, yet displayed similar antibiotic profiles to their biofilm-positive 
conterparts. These biofilm-negative isolates carried the ica genes, although with various 
substitutions or deletions (Table 4.3). It is likely that these isolates are capable of biofilm 
formation but are regulated by an alternative pathway or mechanism. Isolate 17, for 
example, has an in-frame deletion in icaA gene, resulting in missing one transmembrane 
location compared with its biofilm-positive counterparts (Chapter 4, Figure 4.19). This 
isolates was biofilm-negative in TSB containing 4% NaCl, but displayed biofilm-forming 
capacity when grown in a sub-inhibitory concentration of erythromycin. The PIA-
independent mechanisms of biofilm formation have been discussed in numerous studies 
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recently.  Sublethal doses of vancomycin induce biofilm formation through an autolysis-
dependent mechanism in vancomycin-non-susceptible S. aureus (Hsu et al., 2011).  
Moreover, deletion of saeRS in S. epidermidis resulted in an increase in biofilm-forming 
ability, which was associated with increased eDNA release and up-regulated Aap 
expression. The increased eDNA release from SE1457ΔsaeRS was associated with 
increased bacterial autolysis and decreased bacterial cell viability in the planktonic/biofilm 
states (Lou et al., 2011).  
 
The subsp. capitis isolates examined in this study, although exhibiting an antibiotic-
susceptible phenotype, were mostly non-biofilm producers under the experimental 
conditions used and represented a smaller number compared with the other subspecies. 
However, this subspecies was circulating in the NICU for several years and causing 
infections in newborns. The ica operon of subsp. capitis was generally of the same length 
as the ica operon of biofilm-positive isolates of both subspecies, but single nucleotide 
deletions were common in subsp. capitis (Table 4.3). In terms of biofilm formation, these 
isolates might adopt a different regulatory pathway as discussed above; it is also likely 
that other virulence-associated factors or properties facilitate bacterial fitness in the 
clinical setting.   
 
7.2 The role of ica operon in the biofilm formation in S. 
capitis and its origin 
 
The biofilm matrix of S. epidermidis and S. aureus consists predominantly of PIA, which 
is composed of linear β-1, 6-linked glucosaminylglycans and encoded by products of the 
intercellular adhesion (ica) locus (Gerke et al., 1998, Cramton et al., 1999). 
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The ica operon was identified in S. capitis in this study. Sequence comparisons showed 
similarity to that of S. epidermidis and S. aureus. The structures of Ica proteins in S. 
capitis suggested their responsibilities in the biosynthesis of polysaccharide. IcaA protein 
showed similarity to a superfamily of glycosyltransferase with the highest identity of 19%. 
IcaB was shown to be a signal protein, homologous to polysaccharide deacetylase, it is 
likely to be responsible for modifying the synthesed polysaccharides. IcaC is a 
transmembrane protein, which probably facilitates transporting the sugar outside the cell 
membrane, contains a conserved domain which is homologous to acyltransferases. No 
functional structure has been identified homologous to lcaD, but it shows 79% identity to 
the IcaD of S. epidermidis, and might confer the similar function, that the gene is co-
expressed with icaA, producing a longer N-Acetylglucosamine oligomers and increasing 
the enzyme activities (Gerke et al., 1998). In general, the data of sequence analysis 
suggest the role of the ica operon in the biofilm formation in S. capitis.   
 
Sequence analysis also revealed that the ica operon was identical in the two biofilm-
positive, subsp. urealyticus isolates that was examined, whereas several mutations 
occurred in the biofilm-negative ica operons. Moreover, PCR-RFLP showed that all 10 
biofilm-positive isolates that were examined displayed the same profiles, whereas there 
were variations between the profiles of 10 biofilm-negative isolates. It is not possible to 
draw the conclusion that the biofilm-negative phenotype resulted from these mutations, 
because mutations in DNA/protein sequences do not necessarily lead to the loss of 
protein functions. Also, the expression of ica genes is known to be regulated by 
numerous environmental factors (Lim et al., 2004, Knobloch et al., 2001b, Cotter et al., 
2008, Bernardo et al., 2004a). Once exposed to the appropriate environment, all the S. 
capitis isolates might have the capacity to express biofilm. 
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Knowledge of the origin/reservoir of the ica operon is important to understand the 
evolution of biofilm-positive S. capitis isolates in the hospital environment. Here, the 
single clone hypothesis of the evolutionary origin of methicillin-resistant S. aureus 
(MRSA) is used as a reference example for comparison. This hypothesis is based on 
early analyses of the restriction fragment length polymorphisms (RFLP) obtained for 
MRSA isolates collected worldwide by using probes for mecA, suggesting that mecA 
entered the S. aureus population on one occasion and resulted in the formation of a 
single MRSA clone that has since spread around the world (Kreiswirth et al., 1993). The 
PCR-RFLP showing a single pattern for biofilm-positive isolates and three patterns for 
biofilm-negative isolates, combined with the sequencing data of the ica operon might 
suggest the biofilm-positive ica operon was acquired only once by the bacteria, and 
resulting in a single clone which since spread in the hospital, whereas the biofilm-
negative ica operon was on acquired at least three occasions. However, this results need 
to be further verified with a broader selection of isolates from different sites. In addition, 
the BLAST search of the Ica proteins revealed that they showed low similarities or remote 
relatedness to their closest homologs with the exception of the Ica proteins in other 
Staphylococcus species. This suggests the ica operon has existed among staphylococci 
associated with humans, long before hospitals were established. The ica operon might 
initially have been transmitted into commensal staphylococci from other species by 
transduction via bacterial phage or other mobile elements. Staphylococci capable of 
expressing biofilm and antibiotic resistance would have a selective advantage in modern 
NICU where insertable plastic devices are used extensively.  
 
To further understand the mechanisms underlying the biofilm formation of S. capitis, 
biofilm assays and the expression of the biofilm-related including the structural gene icaA, 
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its negative regulator icaR, and two global regulators sarA and rsbU, were assessed 
under sub-inhibitory conconcentrations of antibiotics which are easily achievable in NICU. 
Two isolates (a biofilm-positive, subsp. urealyticus; a biofilm-negative, subsp. capitis) 
were grown in broth containing serum achievable concentrations of erythromycin, but 
without the usual supplementation with 4% NaCl.  The biofilm-positive isolate responded 
by up-regulation of sarA and rsbU, and down-regulation of the negative regulator icaR. A 
reverse expression of these genes in the biofilm-negative isolate was observed. This 
suggests that gene regulation of ica operon plays a role on biofilm formation in S. capitis. 
However, the mechanism of regulation remains to be characterized. In order to confirm 
the role of the ica operon in biofilm formation in S. capitis and directly address the 
function of the ica operon in biofilm formation in S. capitis. Several attempts were made 
to knock out the ica gene of a biofilm-positive isolate by reciprocal recombination. 
Although colonies containing the mutant plasmid were obtained, double crossover was 
not achieved. 
 
In summary, the data on phenotypic biofilm assays, antibiotic resistant profiling combined 
with the molecular epidemiology shown by PFGE, sequence analysis of the ica operon 
and the gene regulations presented in this study demonstrated the role of ica operon in 
biofilm formation in S. capitis. Also, it suggests that biofilm formation may be a useful 
characteristic distinguishing the two subspecies. 
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7.3 Clinical implication of biofilm formation of S. capitis in 
blood-stream infections in newborn infants  
 
It is now well established that biofilm formation plays a significant role in catheter-related 
bloodstream infections with S. epidermidis (von Eiff et al., 2002). S. capitis is associated 
with biofilm-related infections such as endocarditis (Nalmas et al., 2008). Although, no 
studies have demonstrated biofilm formation by S. capitis in vivo, this species produces 
biofilm in vitro under specific conditions that may exist in the hospital environment, such 
as the presence of sub-inhibitory concentrations of antibiotics. Biofilm production may be 
initiated by particular conditions, which are presently unknown.  
 
The precise source of S. capitis infecting newborns in NICUs is unknown, but evidence 
suggests that human-to human transmission is the most likely mode. To date, no 
environmental isolates of S. capitis have been recovered (Kassem et al., 2011). This was 
demonstrated by swabbing 15 clinical surfaces in an isolation room occupied by a patient 
before and after routine cleaning. (Klánová and Lajèíková, 2006)  (Klánová and 
Lajèíková, 2006 detected S. capitis subsp. urealyticus in the air from a non-infectious 
patient’s room in the hospital. The indoor air was not considered an environmental 
reservoir for the organism, because the bacterial concentrations were low. However, this 
provides evidence that the organism can be frequently shed from humans to the 
environment. A recent study by Hira et al. (2010) demonstrated that NICU personnel 
carried more multiresistant and mecA- and icaA-positive CoNS than community isolates. 
Personnel also carried fewer antibiotic-resistant CoNS after a period of absence. 
Furthermore, almost all blood isolates from the sample period were related to isolates 
from the hands of personnel. These findings suggested that virulent CoNS are acquired 
  Klánová and Lajèíková (2006) 
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in the NICU, and personnel are likely to be an important cause for cross-contamination 
with these CoNS.  
 
The specific factors that promote biofilm formation in S. capitis in NICU are not known, 
but they may be different from those of S. epidermidis, although the pathways and 
sequence of events is probably similar. Critically ill infants require the delivery of nutrients 
and drugs over long periods of time typically delivered by central venous catheters 
(CVCs). The skin insertion site and the catheter hub are the most important sources of 
catheter colonization. At the contaminated hub, the organisms may form biofilm and 
embed themselves in it. As the biofilm matures, small clusters of cells may detach from 
the mature biofilm, forming the basis for continual seeding of bacteria into the 
bloodstream (Liñares, 2007). 
 
7.4 The prevalence of biofilm-negative, subsp. capitis 
isolates in neonatal intensive care unit (NICU) 
 
Subsp. urealyticus isolates in the current study displayed a significant association 
between the biofilm formation, antibiotic resistance and the prevalence of the isolates. 
The isolates of subsp. capitis were biofilm-negative under the experimental conditions 
used; exhibited a more sensitive antibiotic resistant phenotype, and were less prevalent 
than the isolates of subsp. urealyticus. Why they have been circulating in the NICU over 
years is a matter for speculation. One likely explanation for the endemic clones’ 
persistence in the NICU may be their slower growth under various conditions compared 
with the other subspecies as revealed in this study (Chapter 5). With a slow generation 
time, the host’s immune system may not readily recognize the bacteria or may not be 
triggered sufficiently to eliminate them. The slow growth might impart advantageous 
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properties and enhance their pathogenic potential by facilitating their survival in the 
clinical setting. 
 
7.5 Improvement of the hospital practices for controlling 
the spread of S. capitis  
 
According to the data of this study, effective control of bloodstream infections by S. 
capitis requires real-time epidemiological surveillance of each unit. In addition, it has 
been demonstrated that virulent S. capitis isolates are acquired on the NICU, and 
personnel are likely to be the carriers of these isolates. Therefore, the importance of good 
hand hygiene is stressed for reducing the transmission of S. capitis. 
 
In conclusion, the epidemiology of two subspecies of S. capitis combined with their 
biofilm performance and antibiotic resistance profiling suggest that under certain 
conditions, biofilm formation is an important trait to assist the differentiation of the two 
subspecies. It would be beneficial to sub-speciate the bacteria to understand their exact 
role in NICU infections. Sequence analysis of the ica operon indicated its role in biofilm 
formation in S. capitis, and also, suggested a possible origin for the biofilm-positive and -
negative S. capitis isolates. In addition, this preliminary study of biofilm-related gene 
expression in the presence of sub-inhibitory concentrations of antibiotics suggests the 
two subspecies might adopt different regulatory pathways for biofilm formation. However, 
this needs further verification.  
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Appendices 
Appendix 1    Urease and Maltose Fermentation Tests on the clinical S. 
capitis isolates 
 
 
Isolate Urease Test 
Maltose 
Fermentation Isolate Urease Test 
Maltose 
Fermentation 
35 positive positive 87 positive positive 
41 positive positive 84 positive positive 
57 positive positive (w) 89 positive positive (w) 
81 negative positive 94 positive positive 
91 positive positive 19 negative positive 
83 positive (w)a positive 21 positive positive 
70 positive positive 54 positive positive 
42 positive positive 63 positive positive 
64 positive positive 67 positive positive 
60 positive positive 58 positive positive 
53 positive positive 59 positive positive 
11 positive positive 80 positive positive 
18 positive (w) positive 88 positive positive 
25 positive positive (w) 75 positive positive 
33 positive positive 47 positive positive 
34 positive positive (w) 82 negative positive 
45 positive positive 93 positive positive 
69 positive positive 76 positive positive 
92 positive positive (w) 52 positive positive 
6 positive positive 61 positive positive 
50 positive (w) positive 39 positive positive 
55 positive (w) positive 65 negative positive 
17 positive positive (w) 73 negative negative 
40 positive positive 77 negative negative 
48 negative positive (w) 49 negative negative 
71 positive positive 44 negative positive 
86 positive positive 85 negative negative 
95 positive positive 90 negative negative 
66 positive positive 62 negative negative 
79 positive positive    
                  aw:weak
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Appendix 2    Minimum inhibition concentration (MIC) test on the clinical S. capitis isolates 
Isolate Subsp. 
MICs (µg/mL) 
PEN ERY CLIN TEC VAN OXA 
35 urealyticus 4 4 1 1 1 0.25 <2 <2 1 1 2 2 
41 urealyticus >8 >8 512 512 0.25 0.25 <2 <2 1 1 4 4 
57 urealyticus 2 2 1 1 0.25 0.25 16 16 2 2 2 2 
81 urealyticus >8 >8 1 1 0.25 0.25 <2 <2 1 1 4 4 
51 urealyticus 8 8 512 512 0.25 0.25 32 32 2 2 8 8 
91 urealyticus 0.12 0.12 1 1 0.25 0.25 <2 <2 0.5 0.5 2 2 
83 urealyticus >8 >8 1 1 0.25 0.25 <2 <2 1 1 2 2 
70 urealyticus 4 4 0.5 0.5 0.25 0.25 <2 <2 1 1 0.5 0.5 
42 urealyticus >8 >8 512 512 0.25 0.25 <2 <2 1 1 4 4 
64 urealyticus 2 2 512 512 0.125 0.125 <2 <2 1 1 4 4 
60 urealyticus 8 8 1 1 0.125 0.125 <2 <2 <1 <1 4 4 
53 urealyticus 8 8 512 512 0.25 0.25 <2 <2 <0.5 <0.5 4 4 
11 urealyticus 8 8 512 512 0.125 0.125 <2 <2 1 1 4 4 
18 urealyticus >8 >8 256 256 0.125 0.125 <2 <2 <0.5 <0.5 2 2 
25 urealyticus 8 8 1 1 0.125 0.125 16 16 1 1 4 4 
33 urealyticus 8 8 512 512 0.25 0.25 <2 <2 <1 <1 8 8 
34 urealyticus 4 4 512 512 0.25 0.25 <2 <2 1 1 8 8 
45 urealyticus >8 >8 512 512 0.125 0.125 <2 <2 1 1 4 4 
69 urealyticus >8 >8 16 16 0.125 0.125 16 16 2 2 8 8 
92 urealyticus >8 >8 1 1 0.25 0.25 <2 <2 <1 <1 8 8 
6 urealyticus 8 8 512 512 0.125 0.125 32 32 <0.5 <0.5 8 8 
50 urealyticus 2 2 512 512 0.125 0.125 <2 <2 1 1 4 4 
55 urealyticus 8 8 1 1 0.125 0.125 <2 <2 <1 <1 8 8 
17 urealyticus 8 8  2  2 0.125 0.125 8 8 2 2 2 2 
40 urealyticus >8 >8 512 512 0.125 0.125 <2 <2 <0.5 <0.5 8 8 
48 urealyticus 8 8 256 256 0.25 0.25 16 16 1 1 8 8 
71 urealyticus >8 >8 1 1 0.25 0.25 <2 <2 0.5 0.5 2 2 
86 urealyticus >8 >8 1 1 0.25 0.25 <2 <2 1 1 8 8 
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95 urealyticus >8 >8 1 1 0.25 0.25 <2 <2 1 1 2 2 
66 urealyticus 8 8 1 1 0.25 0.25 <2 <2 1 1 8 8 
79 urealyticus >8 >8 1 1 0.25 0.25 <2 <2 1 1 4 4 
87 urealyticus >8 >8 1 1 0.25 0.25 <2 <2 1 1 4 4 
84 urealyticus >8 >8 1 1 0.125 0.125   1 1 8 8 
89 urealyticus >8 >8 >512 >512 0.25 0.25 <2 <2 <0.5 <0.5 4 4 
94 urealyticus >8 >8 1 1 0.125 0.125 <2 <2 1 1 4 4 
19 urealyticus >8 >8 1 1 0.25 0.25 <2 <2 <0.5 <0.5 16 16 
21 urealyticus 8 8 1 1 0.125 0.125 <2 <2 <0.5 <0.5 2 2 
54 urealyticus 2 2 0.5 0.5 0.125 0.125 <2 <2 1 1 2 2 
63 urealyticus 4 4 0.5 0.5 0.25 0.25 <2 <2 1 1 2 2 
67 urealyticus 8 8 0.5 0.5 0.125 0.125 <2 <2 1 1 2 2 
58 urealyticus 2 2 0.5 0.5 0.125 0.125 <2 <2 1 1 2 2 
59 urealyticus 4 4 0.5 0.5 0.125 0.125 <2 <2 1 1 2 2 
80 urealyticus >8 >8 1 1 0.25 0.25 <2 <2 1 1 <1 <1 
88 urealyticus >8 >8 2 2 0.25 0.25 <2 <2 1 1 8 8 
75 urealyticus >8 >8 1 1 0.25 0.25 <2 <2 1 1 4 4 
47 urealyticus 2 2 512 512 0.06 0.06 32 32 4 4 8 8 
82 urealyticus >8 >8 1 1 0.25 0.25 <2 <2 1 1 4 4 
93 urealyticus >8 >8 1 1 0.25 0.25 <2 <2 1 1 4 4 
76 urealyticus >8 >8 0.5 0.5 0.25 0.25 <2 <2 1 1 2 2 
52 urealyticus >8 >8 >512 >512 >1024 >1024 <2 <2 1 1 8 8 
61 urealyticus 4 4 >512 >512 >1024 >1024 4 4 1 1 2 2 
39 urealyticus 2 2 <0.5 <0.5 0.25 0.25 <2 <2 1 1 0.25 0.25 
65 capitis 0.03 0.03 0.25 0.25 0.125 0.125 <2 <2 0.5 0.5 0.125 0.125 
73 capitis 0.03 0.03 0.5 0.5 0.125 0.125 <2 <2 1 1 0.25 0.25 
77 capitis 0.03 0.03 0.5 0.5 0.25 0.25 <2 <2 1 1 0.25 0.25 
49 capitis 0.12 0.12 0.5 0.5 0.125 0.125 <2 <2 1 1 0.125 0.125 
44 capitis 0.06 0.06 0.5 0.5 0.125 0.125 <2 <2 1 1 0.25 0.25 
85 capitis 0.06 0.06 0.5 0.5 0.125 0.125 <2 <2 1 1 0.25 0.25 
90 capitis 0.5 0.5 0.5 0.5 0.125 0.125 <2 <2 1 1 0.25 0.25 
62 capitis 0.03 0.03 0.5 0.5 1 1 <2 <2 1 1 0.25 0.25 
PEN: penicillin, ERY: erythromycin, CLIN: clindamycin, TEC: tecoplainin, VAN: vancomycin, OXA: oxacillin.
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Appendix 3     Biofilm assays by microtitre plate tests 
 
 
A representive of the biofilm assay results: 
 
Medium 
\OD\Isolate RP62aa 91 92 93 94 95 90 44 57 49 85 SP2b 
TSB+4%NaCl 1.469 2.064 3.203 3.313 1.698 3.101 0.051 0.053 0.051 0.049 0.056 0.061 
TSB+4%NaCl 1.518 0.910 3.299 3.296 1.546 2.978 0.054 0.053 0.053 0.049 0.055 0.062 
TSB+4%NaCl 1.386 0.855 3.256 3.303 1.958 3.032 0.050 0.051 0.053 0.049 0.054 0.068 
TSB+4%NaCl 1.270 1.164 3.348 3.268 2.959 3.310 0.053 0.048 0.057 0.049 0.054 0.068 
TSB+4%NaCl 2.238 1.530 3.253 3.212 2.919 3.343 0.054 0.053 0.055 0.053 0.051 0.059 
TSB+4%NaCl 2.592 1.837 3.294 3.286 3.039 3.281 0.053 0.052 0.055 0.054 0.052 0.063 
TSB+4%NaCl 2.580 2.223 3.281 3.309 3.035 3.316 0.053 0.051 0.054 0.052 0.053 0.064 
TSB+4%NaCl 2.260 2.455 3.296 3.255 2.997 3.278 0.054 0.051 0.060 0.053 0.055 0.064 
TSB+4%NaCl 2.943 2.810 3.284 3.340 3.247 3.319 0.055 0.058 0.056 0.057 0.056 0.065 
TSB+4%NaCl 2.808 3.278 3.306 3.285 1.947 3.326 0.049 0.060 0.058 0.056 0.056 0.084 
TSB+4%NaCl 2.632 3.230 3.288 3.356 3.350 3.312 0.050 0.064 0.057 0.057 0.054 0.060 
TSB+4%NaCl 2.497 3.236 3.247 3.263 3.132 3.268 0.056 0.060 0.056 0.062 0.057 0.065 
aRP62A was used as the positive control;  
bSP2 was used as the negative control. 
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Appendix 4     Biofim assays of S. capitis in erythromycin 
 
 
 
 
 
 
 
 
 
 
 
 
               ERY: erythromycin 
 
Medium\Isolate 6 17 44 65 70 
  2.359 0.223 0.062 0.055 0.452 
BHI+0.85%NaCl 2.359 0.223 0.062 0.055 0.452 
With ERY 2.359 0.223 0.062 0.055 0.452 
  2.7 0.25 0.062 0.051 0.51 
  2.7 0.25 0.062 0.051 0.51 
  2.7 0.25 0.062 0.051 0.51 
  1.226 0.053 0.063 0.059 0.342 
BHI+0.85%NaCl 1.226 0.053 0.063 0.059 0.342 
Without ERY 1.226 0.053 0.063 0.059 0.342 
  1.091 0.066 0.063 0.058 0.43 
  1.091 0.066 0.063 0.058 0.43 
  1.091 0.066 0.063 0.058 0.43 
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Appendix 6    RNA integrity and the removal of DNA contamination 
 
Isolation of intact RNA is essential for gene expression assay, RNA integrity was tested 
on FA gel before gene expression analysis. 
 
 
 
 
 
 
Figure 1. RNA gel photo for testing RNA integrity. The isolate numbers are indicated on the top of each lane.  
 
 
 
 
 
 
 
 
 
 
Figure 2. Testing the removal of DNA contamination by Reverse transcript-PCR with primers for icaA gene 
expression. The isolate numbers are indicated on the top of each lane. a, reverse transcriptase negative; b, 
reverse transcriptase positive. 
 
 
 
 
23S 
18S 
   6       17       44      65      70 
  6a    6b     17a    17b    44a   44b   65a     65b    70a    70b   
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Appendix 7   Validation of housekeeping genes in the presence and 
absence of erythromycin with isolate 6 
 
 
tuf gene             
Condition Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
No ERY 25.19 25.18 25.12 25.68 24.95 24.77 
16 ERY 24.48 24.76 24.35 22.9 23.09 23.03 
  
     
  
recA gene 
    
  
Condition Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
No ERY 31.85 32.18 32.25 31.59 32.03 31.21 
16 ERY 31.69 31.38 31.33 31.6 31.52 31.87 
  
     
  
gyrB gene 
    
  
Condition Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
No ERY 27.23 27.45 27.26 27.12 27.46 27.74 
16 ERY 27.12 27.29 27 27.26 27.6 27.36 
  
     
  
rpoB gene 
    
  
Condition Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
No ERY 32.51 32.14 33.16 32.8 33.1 32.49 
16 ERY 31.72 31.54 31.65 31.67 31.49 31.28 
  
     
  
sodA gene 
    
  
Condition Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
No ERY 29.24 29.57 29.27 28.56 28.8 28.46 
16 ERY 30.52 30.29 30.47 29.24 29.7 29.59 
                     Ct, Cycle threshold. ERY, erythromycin 
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Appendix 8    Target gene expression data 
 
                Table 1. Cycle Threshold (Ct) values for standard curve of each gene 
Log ng total 
cDNA gyrB Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
3 14.07 14.18 14.24 13.98 14.2 14.05 
2 17.05 17.41 17.44 17.21 17.01 17.37 
1 20.42 20.57 20.3 20.22 20.31 20.35 
0 23.72 23.8 24.06 23.58 23.67 23.95 
-1 27.05 27.57 27.39 27.56 27.89 27.12 
-2 30.37 30.1 31 29.86 30.6 30.46 
Log ng total 
cDNA icaA Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
3 19.19 19.3 19.49 19.25 19.21 19.11 
2 22.34 22.74 22.63 22.5 22.68 22.1 
1 25.88 25.96 25.8 25.87 26.01 25.76 
0 29.35 29.17 29.44 29.22 29.3 29.27 
-1 32.65 33.01 32.16 32.89 32.98 31.67 
-2 36.7 37.01 36.9 35.9 37.2 36.01 
Log ng total 
cDNA icaR Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
2 25.1 25.12 25.07 25.8 24.9 25.02 
1 28.67 28.19 27.9 29.01 28.3 28.16 
0 30.68 31.13 31.27 31.75 31.34 31.36 
Log ng total 
cDNA sarA Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
3 12.43 12.41 12.23 12.45 12.63 12.36 
2 15.36 15.09 15.27 15.1 15.61 14.98 
1 19.06 19.1 19.06 19.1 19.2 18.99 
0 22.83 23.07 23.11 23.01 22.98 23.24 
-1 24.43 26.14 26.51 25.67 26.19 24.98 
Log ng total 
cDNA rsbU Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
3 21.3 21.67 20.69 21.5 21.9 20.39 
2 24.5 24.49 24.25 24.56 25.1 24.96 
1 29.41 30.2 30.39 29.13 30.26 30.41 
0 33.23 33.93 33.71 33.29 33.76 33.49 
-1 36.96 36.09 36.65 36.79 36.43 36.1 
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Table 2. Cycle threshold (Ct) in the presence or absence of erythromycin for target genes 
and house keeping gene gyrBf in isolate 6. 
 
 
 
 
 
 
 
 
 
           N, no erythromycin, E, in the presence of erythromycin. 
 
 
 
 
Table 3. Cycle threshold (Ct) in the presence or absence of erythromycin for target genes 
and house keeping gene gyrBf in isolate 44. 
icaA Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
N 32.85 33.34 32.64 32.9 33.01 32.97 
E 30.1 30.01 30.89 30.1 29.98 30.56 
icaR Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
N 29.26 30.31 29.9 29.46 29.67 29.61 
E 27.08 27.36 27.1 27.01 26.98 27.31 
SarA Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
N 28.57 29.64 29.53 29.01 28.99 29.91 
E 26.96 27.36 28.28 26.98 27.01 28.01 
rsbU Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
N 30.11 29.45 29.66 30.01 29.59 30.1 
E 30.31 29.4 28.2 30.31 29.56 29.77 
                   N, no erythromycin, E, in the presence of erythromycin 
 
 
 
 
gyrB Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
N 28.12 27.97 27.74 27.23 27.45 27.26 
E 27.26 27.6 27.36 27.12 27 27.29 
icaA Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
N 31.07 31.22 30.82 31.23 31.76 30.91 
E 33.58 33.41 33.06 33.6 33.2 32.96 
icaR Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
N 28.06 27.75 27.7 27.68 27.51 27.92 
E 29.08 29.1 29.28 29.3 28.92 29.41 
SarA Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
N 26.92 27.16 27.98 27.26 27.65 27.29 
E 29.24 29.25 29.28 29.34 29.16 29.01 
rsbU Ct1 Ct2 Ct3 Ct4 Ct5 Ct6 
N 28.42 27.82 27.94 27.9 26.69 27.49 
E 29.55 30.01 29.36 30.26 30.67 29.64 
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Appendix 9    Data for ica gene Knock out  
 
 
 
Table 1. Effect of cell growth phase on the transformation efficiency 
 
OD Transformans1 Transformants2 Transformants3 
 
16 10 24 
0.2 25 27 18 
 
13 11 13 
 
178 134 160 
0.5 150 167 124 
 
201 183 212 
 
51 26 31 
1.2 32 43 44 
 
44 39 38 
 
 
 
 
 
Table 2. Effect of heat-treatment on transformation efficiency 
 
Treatment Transformants1 Transformants2 Transformants3 
55 °C, 1 min 179 185 173 
Untreated 0 2 6 
55 °C, 1 min 212 138 156 
Untreated 1 0 2 
55 °C, 1 min 191 176 154 
Untreated 0 9 11 
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Table 3. Viable cells after heat treatment with different temperatures (CFU/mL) 
      Time (min)     
Temp 
(°C) 1 2 3 4 5 
46 39000000000 40100000000 31000000000 29000000000 23500000000 
49 41000000000 27000000000 6700000000 210000000 17200000 
52 35000000000 5100000000 1620000000 330000000 21000000 
55 41000000000 56000000 9670000 560000 1300 
      Time (min)     
Temp 
(°C) 1 2 3 4 5 
46 42000000000 35000000000 43000000000 27000000000 25000000000 
49 39000000000 20000000000 5900000000 190000000 19000000 
52 31000000000 4200000000 1500000000 230000000 16000000 
55 36700000000 7000000 8100000 430000 1140 
      Time (min)     
Temp 
(°C) 1 2 3 4 5 
46 45000000000 35000000000 46000000000 38000000000 37000000000 
49 38500000000 27000000000 6300000000 167000000 23000000 
52 36000000000 4800000000 1120000000 176000000 13000000 
55 38000000000 53000000 4600000 590000 1900 
 
Table 4. Effect of DNA amount on transformation efficiency 
DNA 
(µg) Transformants1 Transformants2 Transformants3 
0.1 1 0 0 
1 9 3 7 
2 53 37 46 
3 72 99 91 
4 153 116 205 
5 113 196 135 
6 173 237 198 
0.1 0 0 0 
1 3 2 8 
2 26 56 41 
3 57 175 94 
4 179 143 200 
5 177 210 195 
6 163 207 243 
0.1 0 0 0 
1 10 5 4 
2 29 22 31 
3 67 78 146 
4 159 157 182 
5 195 203 189 
6 176 165 173 
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Table 5. Incubation of DNA with competent cells 
Time (min) Transformants1 Transformants2 Transformants3 
1 127 113 203 
5 139 201 130 
10 143 176 151 
30 32 12 26 
1 163 189 144 
5 201 169 175 
10 231 126 136 
30 11 10 16 
1 98 163 213 
5 146 175 216 
10 211 186 173 
30 9 0 18 
 
 
 
 
Table 6. Transformation temperature on transformation efficiency 
Temperaure °C Transformants1 Transformants2 Transformants3 
0 46 37 25 
20 189 210 176 
0 12 56 71 
20 175 201 97 
0 34 10 44 
20 153 165 176 
 
 
 
 
Table 7. Effects of Electroporation buffer on transformation efficiency 
Buffer condition Transformants1 Transformants2 Transformants3 
with sucrose 193 201 136 
without sucrose 167 157 198 
with sucrose 186 133 106 
without sucrose 174 131 116 
with sucrose 98 186 130 
without sucrose 109 193 203 
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Table 8. Effects of field strength on transformation efficiency 
Field strength (KV) Transformants1 Transformants2 Transformants3 
2.1 191 176 139 
2.3 176 201 165 
2.5 75 53 89 
2.1 220 116 165 
2.3 107 153 100 
2.5 31 70 65 
2.1 167 134 185 
2.3 176 168 103 
2.5 25 67 46 
 
 
 
 
 
 
 
 
 
Table 9. Inducible tetracycline resistance in S. capitis 
Pre-incubation 
with Tc (µg/mL) 
Colonies resistant to 3 µg/mL 
of Tc 
0.25 1 1 1 
0.5 2 2 3 
0.75 20 17 15 
1 9 14 11 
1.9 6 5 4 
0.25 1 2 3 
0.5 4 2 1 
0.75 21 3 15 
1 18 5 17 
1.9 6 8 9 
0.25 0 0 0 
0.5 0 0 0 
0.75 0 0 0 
1 0 0 0 
1.9 0 0 0 
 
 
